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Abstract 
The Regulation of Mitochondrial Complex I Biogenesis in Drosophila Flight Muscles 
Christian Joel Garcia 
 
Mitochondrial Complex I (CI) is composed of 44 distinct subunits that are assembled with eight Fe-
S clusters and a single flavin mononucleotide. Mitochondria is highly enriched in the flight muscles of 
Drosophila melanogaster, however the assembly mechanism of Drosophila CI has not been described. We 
report that the mechanism of CI biogenesis in Drosophila flight muscles proceeds via the formation of ~315-
, ~550-, and ~815 kDa CI assembly intermediates. Additionally, we define specific roles for several CI 
subunits in the assembly process. In particular, we show that dNDUFS5 is required for converting the ~700 
kDa transient CI assembly intermediate into the ~815 kDa assembly intermediate, by stabilizing or 
promoting the incorporation of dNDUFA10 into the complex. Our findings highlight the potential values of 
Drosophila as a suitable model organism and resource to study the CI biogenesis in vivo, and to address 
questions relevant to CI biogenesis in humans.  
CI biogenesis is regulated by transient interactors known as CI assembly factors (CIAFs). To date, 
about half of CI disorders are attributed to the mutations in the CI subunits and the known CIAFs. The cause 
for the other half remains to be discovered, warranting the investigation for additional regulators of CI 
biogenesis such as novel CIAFs. To identify novel regulators, we cataloged interactors of a core subunit, 
NDUFS3, knocked each one down by RNAi in the Drosophila flight muscle, and analyzed its effect in the 
stability of CI by blue-native PAGE. We identified the Drosophila Fragile X Mental Retardation protein 
(dFMRP) to destabilize the holoenzyme of CI and cause it to misassemble. Therefore, we report dFMRP 
as a novel regulator of CI biogenesis, and demonstrate the utilization of Drosophila as an effective model 
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Chapter 1: Introduction 
1
Overview 
This chapter is aimed to provide a thorough overview of mitochondria complex I (CI) and the roles 
it plays inside the cell. First, the localization and the role of CI in the context of metabolism will be discussed. 
A comprehensive background on the structure, function, and mechanism of CI will follow, going into detail 
on the proteins involved in the biogenesis of the structure. Next, the role of CI in mitochondria function 
outside of bioenergetics will be introduced. Finally the known diseases and pathologies that occur due to 




Over a billion years ago, alpha proteobacteria cells survived endocytosis by a prokaryotic cell, later 
to be termed mitochondria (Boxma et al., 2005; DiMauro and Schon, 2003; Dyall et al., 2004; Martin, 2010). 
Through this symbiotic relationship, the eukaryotic cell was born and was enabled to create and expend 
more energy by using oxygen from the air (Lyons et al., 2014; Spinelli and Haigis, 2018). Because 
mitochondria originated from bacteria, their structures are quite similar. Mitochondria are dual membrane 
organelles with an outer mitochondrial membrane (OMM) and an inner mitochondrial membrane (IMM) 
(DiMauro and Schon, 2003). The space between the OMM and IMM is called the intermembrane space 
(IMS) and the area enclosed by the IMM is called the matrix (DiMauro and Schon, 2003). Similar to bacterial 
cells, mitochondria contain their own circular DNA (mtDNA) inside the matrix (Meyer et al., 2018). This is a 
very unique characteristic of mitochondria, as they are the only organelle besides the nucleus that contain 
their own DNA. Since mitochondria are thought to predate the eukaryotic cell in evolution, they can be found 
ubiquitously in eukaryotic cells. However, some cells such as the red blood cell lack mitochondria (Zhang 
et al., 2011). 
 
Mitochondria DNA  
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The building blocks of the mitochondria are made up of pieces encoded by both the mtDNA and 
the nuclear DNA (nDNA). Each individual’s mtDNA is maternally inherited with each cell containing several 
copies. MtDNA is a compact circular genome of 16.5 kb that encodes 11 mRNAs (Jeandard et al., 2019). 
These are translated to 37 gene products: the 12S and 16S mitochondria ribosomal RNAs, 22 tRNAs 
required for mitochondrial protein synthesis, and 13 subunits of the protein complexes in the mitochondrial 
electron transport chain (Jeandard et al., 2019). Mutations in mtDNA can lead to a diverse population of 
these molecules (termed mtDNA heteroplasmy) among different cells in the same tissue of a person 
(Stewart and Chinnery, 2015). Interestingly, a person can live normally with up to 80% of mutations in their 
mtDNA (Stewart and Chinnery, 2015). Recently, mtDNA has been shown to eject itself from the 
mitochondria into the cytosol and be free floating outside of the cell, suggesting new roles as a signaling 
molecule (Ingelsson et al., 2018; Trumpff et al., 2018). The nDNA encodes over 1000 gene products that 
are localized to the mitochondria (Calvo et al., 2016; Pagliarini et al., 2008). The majority of these genes 
are important for making up the rest of the mitochondrial electron transport chain, the import machinery, 
the proteins responsible for mitochondrial dynamics, and the proteins involved with metabolism (Jeandard 
et al., 2019). Although scientists have reported that several of these gene products are localized to the 
mitochondria, their roles remain to be characterized (Calvo et al., 2016; Pagliarini et al., 2008). Additionally, 
several nDNA-encoded genes have been shown to be involved in alternative roles to help the cells adapt 
during mitochondrial dysfunction; these discoveries have shed light on how the nucleus and mitochondria 
communicate with one another (Haynes and Ron, 2010). 
 
Bioenergetics and Metabolism 
Electron Transport Chain 
Mitochondria generate ~90% of the cell’s energy from the Electron Transport Chain (ETC) (Wallace 
and Chalkia, 2013). The ETC consists of 4 complexes that are located in the folds of the IMM, also referred 
to as the cristae. Their names are NADH:ubiquinone oxidoreductase (complex I), succinate dehydrogenase 
(complex II), ubiquinol-cytochrome c oxidoreductase (complex III), and cytochrome c oxidase (complex IV) 
(Figure 1.1). The ETC generates ATP through a process known as oxidative phosphorylation (OXPHOS) 
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(Cogliati et al., 2018; Sazanov, 2015). OXPHOS is the transfer of electrons from high-energy molecules 
such as NADH or FADH2 to oxygen through electron carriers (i.e. ETC) (Perales-Clemente et al., 2008). 
These high energy molecules donate their electrons to either complex I or II to initiate the transfer of 
electrons. NADH is oxidized by complex I and FADH2 is oxidized by complex II (Cogliati et al., 2018). The 
electrons are passed along to complex III by the electron carrier ubiquinone. After passing through complex 
III, the electrons are transferred by the electron carrier cytochrome c to complex IV, where the electrons 
undergo a reaction with oxygen to make water. This process is coupled tightly to the pumping of hydrogen 
ions, or protons, across the IMM. Complex I and complex III pump 4 protons each and complex IV pumps 
2 protons (Perales-Clemente et al., 2008).  This creates a proton gradient for the rotor ATP synthase 
(complex V) to make ATP from ADP and inorganic phosphate (Jonckheere et al., 2012). This process is 
the underlying theory to the evolution of higher ordered organisms by allowing the cells to perform intricate 
processes that require more energy (Lyons et al., 2014). 
 
Tri-Carboxylic Acid Cycle 
Inside the mitochondrial matrix, the tri-carboxylic acid cycle (TCA) produces the high energy 
molecules (NADH and FADH2) needed to initiate the ETC (Sharma et al., 2005). The TCA cycle produces 
3 NADH and 1 FADH2 from eight reactions and eight intermediates that begins with the oxidization of acetyl-
CoA (Sharma et al., 2005). Acetyl-CoA is generated from the carbohydrates, fats, and proteins we 
consume. Each of these nutrients enter the matrix via different processes. First, carbohydrates are broken 
down into glucose where it undergoes glycolysis in the cytoplasm of the cell to make pyruvate. Glycolysis 
will produce 2 ATP per molecule and is the main contributor of ATP production during anaerobic respiration 
(Rafikov et al., 2015). Interestingly, cancer cells have been known to favor glycolysis (Liberti and Locasale, 
2016). Pyruvate is transported into the mitochondria matrix by the mitochondrial pyruvate carriers 1 and 2 
(MPC), which form a dimer in the IMM (McCommis and Finck, 2015). Inside the matrix, pyruvate 
dehydrogenase (PDH) converts pyruvate into acetyl-CoA to initiate the start of the TCA cycle (Sharma et 
al., 2005). The process of glucose oxidation yields about 32 moles of ATP per molecule of glucose 
(Schönfeld and Reiser, 2013). Alternatively, acetyl-CoA can be generated from the breakdown of fats into 
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fatty acids. This process begins in the cytosol where fatty acids are modified to acylcarnitine by carnitine 
palmitoyltransferase 1 (CPT1) and transported into the IMM by carnitine translocase (CAT) (Schönfeld and 
Reiser, 2013). In the IMM, acylcarnitine is converted into acyl-CoA by carnitine palmitoyltransferase 2 
(CPT2) and imported into the matrix where beta oxidation occurs (Schönfeld and Reiser, 2013). Beta-
oxidation produces acetyl-CoA from acyl-CoA for the TCA cycle to use while also making 1 NADH and 1 
FADH2. The amount of ATP produced during the oxidation of fatty acids is about 106 moles of ATP per 
fatty acid (Schönfeld and Reiser, 2013). Finally, the breakdown of proteins into amino acids can be 
converted into seven different metabolites to power the TCA cycle at various steps. Amino acids that 
catabolize into acetyl CoA or acetoacetyl coA are known as ketogenic amino acids since they produce 
ketone bodies or fatty acids (Berg et al., 2002). Other amino acids that are catabolized into pyruvate, alpha 
ketoglutarate, succinyl CoA, fumarate, or oxaloacetate and are termed glucogenic amino acids (Berg et al., 
2002). Alpha ketoglutarate, succinyl CoA, fumarate, and oxaloacetate are all intermediates present in the 
TCA cycle.  
It is important to note that the preference between glucose and fatty acid as precursors of the TCA 
cycle varies in different tissues. For example, the brain primarily consumes glucose whereas the heart 
favors the degradation of fatty acids (Schönfeld and Reiser, 2013). Several factors contribute to the reason 
a certain nutrient is favored over another.  First is that since fatty acid oxidation produces more ATP; tissues 
that require more energy are likely to favor fatty acid oxidation. Another difference is the amount of NADH 
and FADH2 generated (FADH2/NADH). This ratio is important for dictating whether electrons will be 
transferred by complex I or complex II. During glucose oxidation a ratio of 0.2 FADH2/NADH will lead to 
most electrons entering complex I (Schönfeld and Reiser, 2013). Fatty acid oxidation, on the other hand, 
has a slightly higher ratio of 0.5, which allows for complex II to compete with complex I and thus produce 
reactive oxygen species from complex I (Schönfeld and Reiser, 2013). 
 
Mitochondria Complex I 
Compositions of Mitochondrial Complex I (CI) 
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Mitochondrial Complex I (I) is the first and largest complex of the electron transport chain. The size 
of mammalian complex I is about ~1 mDa and has a distinct boot shape, with a peripheral arm extending 
into the mitochondrial matrix and a membrane arm embedded in IMM (Fiedorczuk et al., 2016; Hirst, 2013). 
The structure of CI can be divided into three functional modules based on their roles during OXPHOS: the 
N-module (NADH binding site), the Q module (ubiquinone binding site), and the P module (proton pumping 
site) (Mimaki et al., 2012). At the tip of the peripheral arm, NADH binds to the N-module, donating two 
electrons. These electrons pass through a series of iron-sulfur clusters and bind to ubiquinone in the Q 
module. Concurrently, 4 protons are pumped across the membrane arm from the matrix into the IMS, 
contributing to the proton gradient for ATP to be made (Hirst, 2013).  
Single particle cryo-EM was used to solve the first structural models of mammalian CI (Fiedorczuk 
et al., 2016; Zhu et al., 2016). These models have provided insights to the positions of each subunit in CI 
as well as potential roles in regulating complex I. Mammalian CI is made up of 44 different subunits, 
encoded by both the mitochondrial and nuclear genomes, 7 and 37 subunits respectively (Figure 1.2) (Hirst, 
2013; Zhu et al., 2016). Fourteen of these subunits are known as the core subunits due to their catalytic 
functions being conserved throughout all species, while the rest are referred to as the accessory subunits. 
The 14 core subunits are highly similar structurally to bacteria CI suggesting that the redox mechanism has 
been evolutionarily conserved across species (Berrisford et al., 2016). The core subunits consist of all 7 
mtDNA subunits (ND1-6 and ND4L) and 7 of the nDNA subunits (NDUFS1-3, NDUFS7-NDUFS8, and 
NDUFV1-2) (Hirst, 2013). The crystal structure of CI from Thermus thermophilus identified the positions of 
all 14 core subunits and showed that they form the foundational boot-shaped structure of CI (Baradaran et 
al., 2013; Berrisford et al., 2011; Sazanov and Hinchliffe, 2006). The mtDNA-encoded subunits are 
embedded in the membrane arm and the nDNA-encoded subunits extend into the matrix to make the 
peripheral arm. In addition to the subunits, the peripheral arm includes a flavin mononucleotide at the tip 
for the binding of NADH and 8 iron-sulfur clusters that are involved in electron transfer (Fiedorczuk et al., 
2016; Zhu et al., 2016). The 30 accessory subunits, which are not present in bacteria CI, form a cage-like 
structure wrapping around the core subunits. In addition, one of the accessory subunits, NDUFAB1, was 
found to be present at two different locations to make the total number of subunits in the final complex 45 
6
(Fiedorczuk et al., 2016). The role of these accessory subunits and their requirement for the function of CI 
is still being explored (Garcia et al., 2017; Stroud et al., 2016).  
The roles and the importance of the accessory subunits remain unclear, especially as they seem 
to have co-evolved with higher-order organisms that demand more energy. One hypothesis is that they play 
a role in the stabilization of CI. This hypothesis was tested in HEK293 cells using CRISPR to knock out 
every accessory subunit of CI. Results showed that 25 accessory subunits were strictly required for the 
stabilization of CI and that NDUFAB1 was required for cell viability (Stroud et al., 2016). Our study 
performed in Drosophila flight muscle knocked down 28 of the 30 accessory subunits found in mammals 
using RNAi. All 28 accessory subunits were shown to be required for cell viability and stabilization (Garcia 
et al., 2017). All together, these results have made a strong case that accessory subunits are critical for the 
function and stabilization of CI. 
The characterization of the accessory subunits at atomic resolution have provided great insights to 
their additional role in regulating CI. In particular, a study of ovine CI identified specific cofactors that bind 
to accessory subunits that may be important for regulating redox reactions, oxygen sensing, and fatty acid 
synthesis (Fiedorczuk et al., 2016). Furthermore, in the hydrophobic membrane arm, several lipids, 
including cardiolipin, bound to several core and accessory subunits and were important for the stabilization 
of CI (Fiedorczuk et al., 2016). The mechanism regulating the coupling between electron transfer and proton 
translocation is still a mysterious process, however the CI structure suggests that accessory subunits to 
play a critical role (Hirst, 2013; Sazanov and Hinchliffe, 2006). The binding site of ubiquinone in CI (Q site) 
is thought to be the driver of this process, and thus must be tightly regulated. CI regulates the Q site by 
undergoing a conformational change to block the Q site and prevent ubiquinone from entering (Sazanov, 
2014). This state is known as the deactive state of CI and occurs in the absence of substrates (Babot et 
al., 2014; Blaza et al., 2018). Certain accessory subunits are suggested to flank the Q site during the 
deactive state to prevent the entry of ubiquinone (Fiedorczuk et al., 2016). As future CI structures increase 
the atomic resolution of accessory subunits, it will be interesting to see what additional roles are inferred 
from these structures 
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Biogenesis of Mitochondrial CI 
The assembly of mammalian CI is a step wise process that occurs inside the mitochondria. First, 
subunits of CI bind to each other to form four distinct assembly intermediates. The N-, Q-, and P- modules 
make up the core assembly intermediates with the P module split into two different intermediates: P 
proximal (PP)  (being closer to the membrane arm), and P distal (PD) (being farther away from the membrane 
arm) (Formosa et al., 2018; Signes and Fernandez-Vizarra, 2018). Once these assembly intermediates are 
formed, they integrate in a coordinated sequence to make the final structure. In human 143b osteosarcoma 
cells, researchers performed a pulse-chase experiment using chloramphenicol to inhibit mitochondria 
translation. Once the subunits of CI were not detectable, mitochondria translation was turned back on and 
the assembly of CI was tracked by blue-native PAGE followed by proteomics, the whole process termed 
“complexome profiling” (Guerrero-Castillo et al., 2017). They found that the Q and PP modules bind together 
first, followed by the PD module. The N module was the last to bind to the Q module to complete the 
formation of the CI holoenzyme (Guerrero-Castillo et al., 2017). Most CI subunits form one of the assembly 
intermediates prior to being added to the holoenzyme, but some CI subunits bind the holoenzyme on their 
own. Our lab published the use of D. melanogaster to study CI assembly (Garcia et al., 2017). Using RNAi, 
35 of the 37 nuclear encoded subunits were individually knocked down in the flight muscle of D. 
melanogaster. Mitochondria were isolated, and the assembly intermediates were tracked using blue-native 
PAGE followed by immunoblot analysis. The study showed the steps at which each of these subunits were 
incorporated into the intermediates and/or the holoenzyme. These results complemented those of the 
human studies reporting that several of the nuclear-encoded subunits are critical for the formation of specific 
assembly intermediates. However, interestingly, specific subunits, such as NDUFS5, came in at a later 
point and did not belong to any specific assembly intermediate, suggesting that certain subunits get inserted 
into CI on their own (Garcia et al., 2017).  
 
Models of Complex I Biogenesis 
Research to uncover the mechanisms of how all 44 subunits come together to form CI has had a 
setback due to the lack of genetic models as well as the lack of structural knowledge compared to the other 
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respiratory chain complexes. Saccharomyces cerevisiae, which has been a powerful genetic model 
throughout many areas of scientific research, does not have CI, but has the other four complexes 
(Mileykovskaya et al., 2012). Although this model served as a foundation for understanding the assembly 
of complex II-complex V, a different genetic model is necessary to study that of CI (Meunier et al., 2013; 
Rigby et al., 2007). Therefore, the field turned to other less-known genetic models, such as the fungi 
Neurospora crassa and Yarrowia lipolytica (Guerrero-Castillo et al., 2009; Marques et al., 2005). These 
models were very useful in investigating the core assembly of CI, but were limited due to the lack of certain 
accessory subunits when compared to mammalian CI (Kerscher et al., 1999; Videira, 1998). In the past 
decade, the Drosophila melanogaster flight muscle has been deemed a relevant model for mitochondria 
research  (Owusu-Ansah et al., 2013; Thomas et al., 2014). In recent years it has been used to understand 
mammalian CI, as it contains 42 of the 44 human CI subunits, the closest of all models thus far (Garcia et 
al., 2017). Additionally, recent advancements in genetic tools, such as CRISPR/CAS9, led to the creation 
of knockout cell lines for each CI subunit (Stroud et al., 2016). These models showed that the accessory 
subunits are critical for CI assembly and helped elucidate the process.  
Another reason that our knowledge of the CI subunits and their assembly has lagged compared to 
other respiratory chain complexes has to do with the delay in solving the crystal structure of CI. To put 
things into perspective, the mammalian structures of the other complexes were solved in the late 90s and 
early 2000s compared to the first atomic resolution mammalian CI structure being identified in 2016 
(Abrahams et al., 1994; Fiedorczuk et al., 2016; Iwata et al., 1998; Sun et al., 2005; Tsukihara et al., 1995). 
The large size of CI is the main reason for this delay, however the development of cyro-electron microscopy 
(cryo-EM) technology in the past decade contributed to solving the structure of CI (Baker, 2018).  
 
Regulators of CI Biogenesis 
In addition to CI subunits, several chaperone proteins known as assembly factors are important for 
regulating the biogenesis of CI (Formosa et al., 2018). These proteins are involved in the formation and 
function of CI; however, they are not present in the final holoenzyme. Assembly factors have been shown 
to play specific roles in regulating the assembly of CI, such as stabilization of the assembly intermediates 
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by binding to specific subunits, posttranslational modifications of subunits, or stabilizing the expression 
levels of  subunits or other assembly factors (Andrews et al., 2013; Rhein et al., 2013; Sugiana et al., 2008). 
To date, 15 assembly factors have been identified, with 11 of them shown to have mutations in CI-deficient 
patients (Formosa et al., 2018). More often than not, patients who are diagnosed with CI deficiency do not 
know what the causative gene is after exome sequencing. This can be due to mutations happening de 
novo, mutations occurring in untranslated regions, and difficulty in identifying the exact variant that is 
causing the mutation (Fassone and Rahman, 2012). New technologies, such as RNA sequencing, will be 
important for identifying such mutations (Kremer et al., 2017). Consequently, new CI assembly factors 
remain to be discovered (Pagliarini and Rutter, 2013; Taylor et al., 2014).  
 
Supercomplexes 
Traditionally, the complexes of the ETC were thought to exist only as discrete enzymes, however 
the past decade of research has shown evidence that they can exist as supramolecular structures. Cryo-
EM has revealed that mammalian CI can bind with complexes III and IV to form supercomplexes. This 
includes CI bound to a complex III dimer (I1III2) and CI bound to a complex III dimer and complex IV (I1III2IV1) 
(Letts et al., 2017). Although the function of supercomplexes is not entirely clear, the current hypothesis of 
these structures is to increase the efficiency of electron transfer during OXPHOS (Letts and Sazanov, 2017; 
Milenkovic et al., 2017). Researchers also think that complexes III and IV help stabilize CI and prevent it 
from oxidative stress. Interestingly, the structures of supercomplexes have revealed accessory subunits of 
CI to be the main sites where CIII and CIV subunits bind to form supercomplexes (Fiedorczuk et al., 2016; 
Letts and Sazanov, 2017; Zhu et al., 2016). Such discoveries have proposed an additional role for 
accessory subunits to be involved in stabilizing and forming supercomplexes.  
 
CI as a Regulator of Mitochondrial Function 
As the “front door” for electrons to pass through the ETC and a huge contributor to the proton 
gradient, CI always had the clearly defined role to be the main driver of ATP production. The past two 
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decades of mitochondria research have advanced the role of CI beyond bioenergetics, as a central 
regulator of metabolism. CI is now also implicated in other cellular processes, such as generating reactive 
oxygen species (ROS) for signaling, regulating the levels of NADH/NAD+, calcium signaling, and regulating 
apoptosis (Angell et al., 2000; Robb et al., 2018; Santidrian et al., 2013a; Valsecchi et al., 2009). All of 
these roles that CI is involved in are important for maintaining cellular homeostasis. In pathological states 
of CI, one or more of these processes in the cell will be the underlying cause (Rodenburg, 2016). 
 
Reactive Oxygen Species Signaling 
Mitochondria are key contributors to ROS in the cell (Murphy, 2009). CI is one of the main sites of 
ROS production, providing superoxides that get converted to hydrogen peroxide by superoxide dismutase 
(Kussmaul and Hirst, 2006). Hydrogen peroxide has been shown to be an important signaling molecule, 
regulating metabolic adaptation, cell proliferation and cell differentiation processes (Hamanaka et al., 2013; 
Wheaton et al., 2014). Although the mechanism by which CI produces ROS during electron transfer flow in 
the membrane arm is not fully understood, CI can produce ROS via both forward and reverse electron 
transfer flow (RET) (Hirst et al., 2008; Robb et al., 2018). Forward electron transfer flow is the usual flow of 
electrons that come from NADH binding to FMN, passing through iron-sulfur clusters and being released 
to ubiquinone. Studies have shown that most ROS produced this way occurs from the reduction of flavin 
and an increase of NAD+/NADH ratio (Hirst et al., 2008). Alternatively, RET occurs when there is a high 
ATP/ADP ratio, reduced ubiquinone pool, and high proton motive force. Instead of electrons being passed 
onto complex III, ubiquinone will bring the electrons back to complex I where they proceed back through 
the iron-sulfur clusters and are released to make superoxides due to flavin disassociating from CI (Robb et 
al., 2018; Stepanova et al., 2017). RET is a common phenomenon in ischemia-reperfusion (Chouchani et 
al., 2016; Stepanova et al., 2017). During this process CI makes a large amount of superoxides, causing a 
major oxidative damage in the cell, ultimately leading to damage in the tissue (Chouchani et al., 2016). 
Although RET is generally perceived as pathological, recently it has been shown to be involved in other 
physiological processes, such as improved lifespan and cellular differentiation (Lee et al., 2011; Scialò et 
al., 2016, 2017).  As one of the largest sites of superoxide production in the mitochondria, CI may also play 
11
a role in oxygen sensing. NDUFS2, a CI core subunit, was shown to control hydrogen peroxide generation 
in the carotid body and pulmonary artery smooth muscle cells (PASMCs) during hypoxic conditions 
(Dunham-Snary et al., 2019; Fernández-Agüera et al., 2015). The knockdown of other CI, CIII, and IV 
subunits in this study did not alter the levels of peroxide generation or mimic chronic hypoxic conditions, 
suggesting that this role is unique to NDUFS2 (Dunham-Snary et al., 2019).  
 
NADH metabolism  
NADH is a key player in cellular metabolism as a cofactor for several metabolic pathways, including 
glycolysis and the TCA cycle (Stein and Imai, 2012). For proper mitochondrial function, it is critical to 
maintain an optimal NAD+/NADH ratio (Zhu et al., 2015). CI oxidizes electrons from NADH to NAD+, and 
therefore plays an important role in monitoring this ratio. In most cases of CI dysfunction, NADH 
accumulates in the mitochondria matrix and as a result decreases the NAD+/NADH ratio, eliciting various 
responses by the cell (Lee et al., 2019). For example, in cardiac-specific NDUFS4 (nuclear encoded subunit 
of CI) knockout mice, a decrease in the NAD+/NADH ratio led to the inhibition of sirtuin 3 (SIRT3) activity 
and an increase in protein acetylation, ultimately resulting in an increased sensitivity to cardiac stress 
(Karamanlidis et al., 2013). SIRT3 is a NAD+ dependent deacetylase that localizes primarily to the 
mitochondria, and is implicated to be critical in controlling the energy demands of the mitochondria during 
stress (Ansari et al., 2017)(Ahn et al., 2008). Some CI dysfunction and the consequent decrease of NAD+ 
has been shown to  target SIRT3 activation, leading to an increased level of ROS (Desquiret-Dumas et al., 
2013). On the other hand, SIRT3 has been shown to interact with the CI subunit NDUFA9 to regulate its 
acetylation and thus the CI holoenzyme activity (Ahn et al., 2008). Additionally, while glycolysis favored in 
cancer cells typically leads to an imbalance of  NAD+/NADH ratio, a study showed that increasing CI activity 
in breast cancer cells prevented tumor growth and metastasis by rebalancing the NAD+/NADH ratio, 





In the mitochondria, calcium has been shown to affect metabolism, OXPHOS, and apoptosis 
(Finkel et al., 2015). One driving force for calcium uptake by the mitochondria is the membrane potential 
created by the respiratory electron transport chain (Griffiths and Rutter, 2009). The pumping of protons 
across the IMM creates a negative charge in the matrix which induces cations such as calcium to enter the 
matrix (Griffiths and Rutter, 2009). CI is a critical component to creating this electrochemical proton gradient 
as it contributes about 40% of the protons being pumped across the IMM (Hirst, 2013). Loss of CI activity 
leads to decreased ATP production, decreased ATPase activity, lack of calcium uptake by the ER, and 
finally an accumulation of calcium in the cytoplasm (Valsecchi et al., 2009). The mitochondrial calcium 
uniporter (MCU), discovered in the past decade, has been suggested to be the main route of entry for 
calcium into the mitochondria (Giorgi et al., 2018). This protein complex of approximately 480 kDa (Marchi 
and Pinton, 2014) has been suggested to lead to an accumulation of calcium in the mitochondria in 
cardiomyopathy mouse models with impaired OXPHOS. In a study done on whole-mitoplast HEK293T 
cells, chronic inhibition of CI enhanced the MCU activity, suggesting a relationship between CI and the 
MCU (Balderas-Angeles et al., 2018). As future studies focus on the regulation of the MCU, it will be 
interesting to see if the uniporter or its regulators are directly involved with the activity or assembly of CI.  
 
Apoptosis 
Mitochondria play a key role in activating apoptosis in the cell (Lemarie and Grimm, 2011). Certain 
subunits of CI have been shown to be directly involved in regulating apoptosis. NDUFA13, also known as 
GRIM-19 (gene associated with retinoid-interferon-induced-mortality-19), regulates cell death by binding to 
STAT3 (signal transducer and activator of transcription 3), and inhibiting its ability to bind to DNA (Angell 
et al., 2000; Huang et al., 2004; Zhang et al., 2003). When STAT3 is active, it binds several anti-apoptotic 
genes that are transcribed to promote tumor survival (Zhang et al., 2003). NDUFA6, typically downregulated 
in apoptotic cells, when overexpressed in HIV-infected cells could rescue cells from undergoing 
apoptosis.(Ladha et al., 2005). The core subunits NDUFS1 and NDUFS3 have also been shown to be 
implicated in apoptosis. NDUFS1 is cleaved by caspases which are cysteine proteases that initiate 
apoptosis signaling (Ricci et al., 2004). Similarly, NDUFS3 is cleaved by the protease granzyme A, a 
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protease that induces cell death (Martinvalet et al., 2008). In both of these cases, an increase of 
superoxides and disruption in membrane potential leads to apoptosis. CI subunits have previously unknown 
roles in regulating apoptosis and it will be important to identify any other CI subunits that are involved in 
these processes.  
 
Diseases of CI 
Isolated CI Deficiency 
Dysfunction of mitochondria CI has been shown to be involved in several different diseases 
(Rodenburg, 2016). The most common of these are primary mitochondrial diseases which is a 
heterogeneous group of diseases that mostly affects the tissues with the highest energy demands. 
Mutations inherited in the mitochondria-encoded CI subunits, nuclear-encoded CI subunits, or CI assembly 
factors lead to isolated CI deficiency (Distelmaier et al., 2009). Isolated CI deficiency refers to the severe 
reduction of CI while the activities of other respiratory chain complexes are normal. Compared to other 
respiratory chain complexes, isolated CI deficiency accounts for nearly one-third of all OXPHOS disorders 
(Fassone and Rahman, 2012; Ghezzi and Zeviani, 2018). To date, mutations in all 14 core subunits, 13 of 
the 30 accessory subunits, and 11 of the 15 assembly factors have been described in patients (Frazier et 
al., 2019). To diagnose CI deficiency, the CI redox activity in patient biopsies or fibroblasts are measured 
to be less than 30% compared to the control (Fassone and Rahman, 2012). Most often symptoms involve 
neurological dysfunction, but can also affect other organs, such as the heart and skeletal muscle, causing 
multi-system diseases (Fassone and Rahman, 2012). The most common diseases that result from CI 
deficiency are Leigh Syndrome, fatal infantile lactic acidosis, leukoencephalopathy, mitochondrial 
encephalomyopathy-lactic acidosis-stroke like episodes (MELAS), and hypertrophic cardiomyopathy 
(Fassone and Rahman, 2012; Rodenburg, 2016). Interestingly, the correlation between the mutations 
present in specific CI subunits and their phenotypes did not present any patterns in the clinical outcome 
(Koene et al., 2012). For example, patients with mutations in NDUFS2, a core subunit of CI found in the Q 
module, all displayed Leigh Syndrome, but 3 of 5 of the patients also showed hypertrophic cardiomyopathy 
and the prognosis for these patients varied, with one dying as early as 4 days and another dying at 3 years 
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old (Ngu et al., 2012). One reason for such heterogenous phenotypes would be that, unlike nuclear DNA 
mutations which follow the Mendelian laws of inheritance, mtDNA presents heteroplasmy in the various 
tissues and organs (Alston et al., 2017). These variations have made it difficult for physicians to treat these 
diseases. Identifying any correlations of phenotypes and prognosis based on the location of CI subunits in 
the holoenzyme would be an interesting question to pursue.  
 
Complex I Associated Diseases 
CI dysfunction is present in several chronic- and age-related diseases, including cardiovascular, 
diabetes, cancer, and neurodegenerative diseases (Boudina et al., 2007; Hroudová et al., 2014; Siasos et 
al., 2018; Urra et al., 2017). In most of these diseases CI dysfunction is not due to genetic mutations within 
CI. Therefore, whether CI is the primary or secondary cause of the disease remains to be debated. For 
example, CI has long been thought to be the culprit for Parkinson’s disease (Area-Gomez et al., 2019). This 
hypothesis was first suggested when 1-methyl-4-penyl-1, 2, 3, 6-tetrahydropyridine (MPTP), a CI inhibitor, 
was found to induce parkinsonian syndrome when injected in mice or humans. The resemblance between 
the MPTP-induced model and the clinical Parkinson’s disease led researchers to investigate CI activity in 
patient samples and find deficiencies in the enzyme (Langston, 2017). However, other observations 
reporting deficiencies of other respiratory chain enzymes in the muscle, lymphocytes, and platelets of 
Parkinson’s disease patients propose an overall dysfunction in mitochondria, rather than specific to CI 
(Langston, 2017).  
 
Conclusion 
Recent years have unraveled new and foundational components that are required for the function 
and biogenesis of human CI. In addition, CI has been shown to be involved in other areas of mitochondrial 
regulation, making it a multifaceted unit in the mitochondria rather than limited to bioenergetics in scope. In 
the clinical setting, the diagnosis of CI mitochondria diseases still remains to be a challenge due to poor 
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prognosis and polymorphic phenotypes. Furthermore, CI has been associated with chronic- and age-
related diseases that are traditionally not related to mitochondria, however its role remains a mystery. This 
thesis will be presented in two parts. The first part will focus on the classic assembly process of CI in 
Drosophila and show how the mechanisms are conserved between mammals and flies. The second part 
will further show how the Drosophila model is a powerful genetic model to identify and examine factors that 
regulate CI.  In particular, I will discuss in detail a novel candidate, Fragile X Mental Retardation 1 (FMR1), 
and its potential role in regulating CI biogenesis. Finally, I will conclude with how Drosophila can be used 
























Figure 1.1: The electron transport chain  
Adapted from Sazanov, 2015. The electron transport chain is located in the inner mitochondrial membrane 
and consists of four different complexes: complex I, complex II, complex III, and complex IV. These four 
complexes work together to transfer electrons and establish a proton gradient that complex V uses to 
generate ATP. Complex I or complex II initiate the transfer of electrons when they oxidize NADH or FADH2 
respectively. These electrons are first passed along to complex III by the electron carrier ubiquinone and 
then are passed to complex IV by the electron carrier cytochrome c. These electrons will undergo a reaction 
with oxygen to make water. To generate the proton gradient, complex I and complex III pump four protons 

























































Figure 1.2: Mitochondrial complex I 
The function of complex I in the oxidative phosphorylation system can be broken down into three 
different modules.  The N module, Q module and P Module. During OXPHOS, complex I initiates transfer 
of electrons when NADH binds to a FMN in the N module to donate its electron, these electrons proceeds 
through 8 iron sulfur clusters where it will then bind to ubiquinone so it can pass the electrons on to Complex 
III.  As this is happening, complex I also contributes to the proton gradient that is important for generating 
ATP by pumping 4 protons across the inner membrane of the mitochondria at the P modules.  
Human complex I has 44 different subunits with some of them located in the membrane and some 
of the proteins protruding into the matrix. 7 subunits are encoded by the mitochondria and are all found in 
the inner membrane, while the other 37 subunits are encoded by the nucleus and are found throughout the 
structure. 14 of the subunits are known as the core proteins and are have been shown to be critical for 
functions of complex I as they found in all organisms that have complex I. The other 30 accessory subunits 
found in humans varies between organisms and whether or not they are necessary or required for the 
assembly and stability of complex I remains to be characterized. 
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 Mitochondrial CI (NADH: ubiquinone oxidoreductase) is the first and largest of the electron 
transport chain complexes in the mitochondrion, and has a molecular mass approaching 1 MDa [reviewed 
in (Hirst, 2013)]. Human CI has 44 distinct subunits (Table 2.1); 14 of which are directly involved in 
transferring electrons from NADH to ubiquinone, or in generation of the membrane potential. Because these 
14 subunits are conserved from bacteria to humans, and form the catalytic centers of the enzyme, they are 
referred to as the core or central subunits. The 30 remaining subunits are referred to as accessory subunits, 
because they are not directly involved in catalysis, and are expressed to varying extents among eukaryotes 
(Table 2.1) [reviewed in (Hirst, 2013)]. A current hypothesis is that the accessory subunits regulate ROS 
formation, complex assembly or stability, and cellular homeostasis in vivo. Of note, disease-causing 
mutations in several accessory subunits have been identified (Berger et al., 2008; Budde et al., 2000; Hoefs 
et al., 2008; Hoefs et al., 2011; Kirby et al., 2004; Ostergaard et al., 2011; Scacco et al., 2003); and genetic 
disruption of some accessory subunits in  cell lines impair CI assembly (Guerrero-Castillo et al., 2017; 
Stroud et al., 2016). However, a definitive role for many of the accessory subunits in vivo remains to be 
established. 
CI has two major arms: a hydrophobic membrane arm and a hydrophilic peripheral arm that 
protrudes into the mitochondrial matrix. The two arms are oriented almost perpendicularly to each other 
resulting in a characteristic boot or L-shaped structure (Clason et al., 2010; Efremov et al., 2010; 
Radermacher et al., 2006; Zickermann et al., 2015). Several cryo-electron microscopy density maps and 
higher resolution atomic structures of CI from various eukaryotes have recently been described (Fiedorczuk 
et al., 2016; Vinothkumar et al., 2014; Zhu et al., 2016; Zickermann et al., 2015). The accessory subunits 
were found to form a cage around the core subunits, and were particularly concentrated around the 
membrane domain. These observations lend further credence to the hypothesis that the accessory subunits 
are involved in stabilizing the complex during or after biogenesis in vivo.  
Surprisingly, despite the outstanding genetic capabilities of Drosophila, a systematic genetic 
analysis of CI assembly has not been described in this organism. Instead, previous in vivo genetic analyses 
of the regulation of eukaryotic CI assembly have been performed primarily in the aerobic fungus Neurospora 
crassa (Duarte et al., 1995). Although the N. crassa model of CI assembly is renowned for being the first 
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system for which a model of CI assembly was described, there are notable deviations from the assembly 
pathway in mammalian systems (Nehls et al., 1992; Tuschen et al., 1990). For instance, several accessory 
subunits as well as CI assembly intermediates found in mammalian CI are not conserved in N. crassa (24). 
Similarly, CI in Arabidopsis thaliana has a carbonic anhydrase domain and several additional subunits that 
are not present in the human enzyme (21). Thus, it is important to develop additional genetically tractable 
CI assembly model systems that more closely resemble and recapitulate the human system.  
Importantly, Drosophila has a comparable number of CI subunits (similar to the human and bovine 
enzymes) and over a dozen putative assembly factors, all of which have clear human orthologs, making it 
a suitable model organism for studying CI assembly. Studying CI assembly in Drosophila has the added 
advantage of being in an in vivo context, where the effects of both developmental signals and environmental 
perturbations can be examined. Accordingly, we have analyzed the role of several nuclear-encoded CI 
subunits in CI assembly in Drosophila muscles.  
We describe the mechanism of CI assembly in Drosophila flight muscles. Specifically, we show 
that many of the accessory subunits regulate specific stages of CI biogenesis in vivo, such that, when their 
level of expression is reduced, CI activity is diminished due to impaired CI assembly. We demonstrate that 
CI biogenesis in Drosophila involves the formation of ~315-, ~550-, and ~815-kDa assembly intermediates, 
and that RNAi-mediated knockdown of either dNDUFS2 or dNDUFS3 decreases the amount of the ~315-
kDa assembly intermediate that is formed. Furthermore, we show that a specific accessory subunit – 
dNDUFA5 – is required for the formation and/or stabilization of the ~315-kDa assembly intermediate in vivo. 
Additionally, we define a specific role for another accessory subunit (dNDUFS5); and show that it is required 
for converting a transient CI assembly intermediate (an ~700-kDa assembly intermediate) into the ~815-
kDa assembly intermediate, during one of the terminal steps of CI assembly. Four components of the 
Mitochondrial Complex I Assembly (MCIA) complex (dECSIT, dNDUFAF1, dACAD9 and dTIMMDC1) were 
associated with the ~700-kDa assembly intermediate, further confirming that it is a true assembly 
intermediate in CI biogenesis. Importantly, incorporation of dNDUFS5 into CI is necessary to stabilize or 
promote incorporation of dNDUFA10 into the complex. We also identify several roles for many of the 
dNDUFB subunits. Altogether, our analyses reveal how studies of CI biogenesis in Drosophila can uncover 
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mechanisms of CI assembly in vivo, and establish Drosophila as an important genetically pliable model 
organism for addressing questions relevant to mammalian CI biogenesis. 
 
Results 
Drosophila flight muscles are suitable for studying CI assembly 
 CI consists of a hydrophilic matrix arm and a hydrophobic membrane arm that are oriented almost 
orthogonally to each other (Figure 2.1A). Subunits with the prefix NDUFA (NDUFA1-3 and NDUFA5-13) 
were so named as they were originally thought to be part of the matrix arm, whereas the NDUFB subunits 
(NDUFB1-NDUFB11) are part of the membrane arm. In addition, subunits that are found in the vicinity of 
the 8 Fe-S clusters (NDUFS) or single Flavoprotein (NDUFV) are also localized in the matrix. All the NDUFA 
and NDUFB subunits are accessory subunits (Figure 2.1A). We used the Drosophila RNAi Screening 
Center Integrative Ortholog Prediction Tool (DIOPT) to identify 42 putative orthologs of the 44 human CI 
subunits (Figure 2.1B and Table 2.1) (Hu et al., 2011). To facilitate comparison with their human orthologs, 
in this manuscript we refer to Drosophila orthologs of the human CI subunits as dNDUFS1, dNDUFS2, etc. 
Their designated gene nomenclature in Drosophila are shown in Table 2.1. 
To confirm whether the putative CI orthologs identified by DIOPT were bona fide CI subunits in 
Drosophila flight muscles, we isolated mitochondria from thoraxes of wild-type flies, solubilized their 
membranes in 1% digitonin, and resolved their oxidative phosphorylation (OXPHOS) complexes into 
various bands using blue native polyacrylamide gel electrophoresis (BN-PAGE) (Rera et al., 2011; Wittig 
et al., 2006). We solubilized the mitochondrial membranes in 1% digitonin because we found that 1% 
digitonin was the optimal detergent concentration for isolating and resolving OXPHOS complexes in their 
native state in Drosophila (Figure 2.2), as has been reported previously (Rera et al., 2011; Wittig et al., 
2006). Subsequently, we cut out each of the bands detected by coomassie staining of the gel, and identified 
their composition by mass spectrometry (Figure 2.1C). We confirmed the existence of 37 of the 42 putative 
CI orthologs based on their presence in the band corresponding to the CI holoenzyme (Band B) and/or 
supercomplex (Band A) (Figure 2.1C, Tables 2.1 and 2.2). Notably, the Drosophila ortholog of NDUFA4 
(ND-MNLL) – a protein that was previously considered a CI subunit, but has been reassigned as a complex 
IV (CIV) subunit (Balsa et al., 2012) – co-migrated with the CIV band (Band E) (Figure 2.1C and Table 
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2.2). In addition, 4 of the subunits we were unable to detect are highly hydrophobic membrane-embedded 
core subunits encoded in the mitochondrion (ND2, ND3, ND4L and ND6); thus they may have escaped 
detection due to their highly hydrophobic nature. Interestingly, these subunits were not identified in a 
previous proteomic analysis of CI in mouse cell lines (Balsa et al., 2012).  
Coomassie- or silver-stained native gels containing mitochondrial protein complexes from flies 
expressing RNAi to CI, complex III (CIII), CIV, and complex V (CV) proteins further confirmed the identities 
of the bands cut for mass spectrometry (Figure 2.1D). Because our mass spectrometry data suggested 
that a portion of CI might be co-migrating with CV and possibly CIII, we tested whether this co-migration 
was the result of supercomplex formation. We were unable to find antibodies that cross-react with any of 
the Drosophila CIII proteins, but antibodies that cross-react with dNDUFS3 (a CI protein) and dATPsynß (a 
CV protein) were commercially available, and were used to examine the identity of “band A” via western 
blotting. As is evident in the silver staining gel (Figure 2.1D), immunoblotting revealed that “band A” was 
actually a doublet; and the lower band in the doublet corresponds to a dimer of CV, as has been observed 
in other contexts (Figure 2.1E) (Rera et al., 2011; Wittig et al., 2006). In addition, CI in flight muscles was 
found to exist predominantly as the holoenzyme, with a relatively small portion involved in CI-CIII 
supercomplex formation, which migrates as an upper band in the doublet (Figure 2.1E). Notably, the 
observation that CI in Drosophila flight/skeletal muscles occurs predominantly as the holoenzyme (i.e. free 
CI, not involved in supercomplex formation), contrasts markedly with CI in cardiac or skeletal muscles from 
mice, where a significant portion of CI is trapped in supercomplex formation (Figure 2.1F). Thus, in addition 
to the genetic capabilities of Drosophila and the fact that it has a comparable number of CI subunits as the 
human enzyme, it is a suitable model for studying CI assembly because most of CI in flight muscles exists 
as the holoenzyme. Accordingly, a defect in CI biogenesis can easily be scored and quantified. 
Consequently, we decided to examine the role of the nuclear-encoded CI subunits in CI assembly. 
 
Disruption of several CI subunits in flight muscles impair CI assembly  
We found that loss-of-function alleles for many Drosophila CI genes are lethal (not shown). 
Therefore, to ascertain which CI subunits are required for CI biogenesis in Drosophila, we used the 
Gal4/UAS system to express transgenic RNAi constructs (henceforth referred to as UAS-RNAi lines) to 
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both core and accessory CI subunits (Brand and Perrimon, 1993). We examined the effect of knocking 
down the subunits specifically in muscles (using either Dmef2-Gal4 or mhc-Gal4). Transgenic expression 
of many of the UAS-RNAi constructs using Dmef2-Gal4 – a muscle-restricted Gal4 driver that is expressed 
strongly throughout development – caused lethality (not shown). However, a genetic cross between each 
of the UAS-RNAi lines and mhc-Gal4 produced viable flies, as the mhc-Gal4 driver has a weaker expression 
relative to Dmef2-Gal4 during the initial larval stages (Figure 2.3). Accordingly, we decided to analyze CI 
assembly in mitochondria isolated from thoraxes of mhc-Gal4/UAS-CIRNAi flies (henceforth referred to as 
mhc>CIRNAi flies) using BN-PAGE.  
We observed that, in general, both core and accessory subunits produced CI assembly defects 
whenever the extent of transcript knockdown was more than 50% (Figure 2.4A). To further assess the 
extent of the CI assembly deficit for each subunit, we quantified the amount of CI relative to the amount of 
CV in each lane, and normalized it to the corresponding value in the wild-type lane. Interestingly, this 
revealed that some of the most robust CI assembly deficits were observed when accessory subunits (such 
as dNDUFA10-12 and dNDUFB4-6) were genetically impaired (Figures 2.4A and 2.4B). Similar results 
were obtained with silver staining of the protein complexes in the native gels (Figure 2.4B). Additionally, 
in-gel CI enzyme activity assay revealed that the assembly deficits correlated with a reduction in CI activity 
(Figure 2.4C). Finally, we found that knockdown of most accessory and core subunits impaired the climbing 
ability in these flies (Figure 2.4D). Altogether, these results indicate that many of the core and accessory 
subunits are essential for viability and biogenesis of the CI holoenzyme or supercomplex in flight muscles. 
Accordingly, we turned our attention towards elucidating the mechanism of CI assembly in Drosophila flight 
muscles.  
 
Proteomic analyses and immunoblotting identify assembly intermediates of CI 
Studies from some mammalian cell lines have shown that CI biogenesis proceeds via a series of 
assembly intermediates that combine with each other, or other subunits, to form the ~950-kDa boot-shaped 
holoenzyme. The assembly intermediates generally correspond to partial or complete domains of the 3 
functional modules of CI. The NADH Dehydrogenase module (N module) is located at the tip of the matrix 
arm, and is the site of NADH oxidation. Situated between the N module and the membrane is the Q module, 
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which is responsible for Ubiquinone reduction. The proton-conducting P module in the membrane arm can 
be subdivided into a proximal PP-module (roughly corresponding to the first half of the P-module that 
connects with the Q-module) and a distal PD-module (Figure 2.5A). 
The current model posits that CI assembly in mammalian systems begins with the formation of a 
small assembly intermediate containing NDUFS2 and NDUFS3, that combines with NDUFS7 and NDUFS8 
(Figure 2.5B). This assembly intermediate is the primary component of the Q-module; and ultimately 
combines with ND1 to form an ~315-kDa assembly intermediate that is anchored to the mitochondrial inner 
membrane. The ~315-kDa assembly intermediate combines with an independently-formed ~370-kDa 
assembly intermediate to form an ~550-kDa assembly intermediate (Figure 2.5B). The ~550-kDa assembly 
intermediate, which consists of the complete Q-module and a portion of the P-module, grows by the addition 
of more subunits to form the ~815-kDa assembly intermediate, via mechanisms that are very poorly defined. 
At this point, the ~815-kDa assembly intermediate is generally considered to be composed of the complete 
Q- and P-modules. Finally, an independently-formed assembly intermediate consisting of NDUFS1, 
NDUFV1, NDUFV2, NDUFV3, NDUFS4, NDUFS6 and NDUFA12, which together form the N module, is 
added as a “cap” to the ~815-kDa assembly intermediate to produce the ~950-kDa holoenzyme [Figure 
2.5B; the ~315-, ~370-, ~550-, and ~815-kDa assembly intermediates were previously estimated as ~400-
, ~460-, ~650- and ~830-kDa subcomplexes respectively (Andrews et al., 2013; Vartak et al., 2014)]. 
As some flight muscles are formed by 24 hours after pupal formation (Roy and VijayRaghavan, 
1999), we decided to ascertain the extent of CI biogenesis starting at 48 hours (i.e. 2 days) post-pupariation. 
Specifically, we isolated mitochondria at various time points, and examined CI assembly via western blotting 
of the native complexes. Because current models of mammalian CI assembly postulate that NDUFS3 and 
ND1 are both part of the ~815-kDa, ~550-kDa, and ~315-kDa assembly intermediates, western blot with 
anti-NDUFS3 or anti-ND1 antibodies will be expected to detect these 3 assembly intermediates, and 
possibly lower molecular weight assembly intermediates (if the respective epitopes are not masked when 
the assembly intermediate is formed). In addition, the fully assembled CI and CI-containing supercomplexes 
will be expected to be detected as well. Indeed, immunoblotting with anti-NDUFS3 revealed that a portion 
of CI is assembled during pupal development and continues during the first 48 hours after flies eclose 
(emerge as adults from pupae) (Figure 2.5C). Although we were able to detect the ~315-kDa and ~550-
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kDa assembly intermediates with the anti-ND1 antibody (Figure 2.5C), the higher molecular weight bands 
were only weakly detectable, conceivably because the epitope to which this antibody was raised for this 
hydrophobic subunit becomes less exposed to the aqueous environment during the final stages of CI 
biogenesis (Figure 2.5C). Moreover, while we were able to detect subcomplexes of CV that migrate with 
an apparent mass of about 100 kDa at this stage of development (Figure 2.6), we were unable to detect 
dNDUFS3-containing assembly intermediates with an apparent mass of less than 200 kDa. There are at 
least two possible explanations for this result: (i) the smaller NDUFS3-containing assembly intermediates 
may not be present at this stage; or (ii) the epitope of dNDUFS3 in the smaller assembly intermediates was 
inaccessible to the antibody, perhaps as a result of being masked by bound assembly factors and/or other 
interactors. Therefore, we used proteomic analyses to distinguish between these two possibilities.  
Mitochondria were isolated from thoraxes of wild-type flies that had been aged for 24 hours after 
eclosure, and subjected to BN-PAGE. Subsequently, the region of the gel between ~50 kDa and ~350 kDa, 
was excised and divided into 14 slices (labeled fraction A1 to A14) for in-gel digestion and subsequent 
proteomics analyses (Figure 2.5D). We observed that dNDUFS2, dNDUFS3 and dNDUFS7 co-migrated 
in fractions corresponding to a mass of approximately 280-320 kDa (Figure 2.5D and Table 2.3). 
Interestingly, the CI assembly factor, dNDUFAF4, was also found in these fractions (Figure 2.5D and Table 
2.3). In addition, dNDUFA5 co-migrated with dNDUFS2, dNDUFS3 and dNDUFS7 (Figure 2.5D), 
confirming that it is a component of the ~315-kDa assembly intermediate in vivo. Importantly, although 
several other CI subunits migrated in fractions corresponding to a mass of approximately 50-250 kDa, 
neither dNDUFS2 nor dNDUFS3 were found in these fractions. Thus, it appears that in an in vivo context, 
in Drosophila flight muscles, the constituents of the ~315-kDa assembly intermediate are combined almost 
synchronously. 
 
Specific subunits regulate the biogenesis or stability of specific assembly intermediates of CI  
If the assembly intermediates observed are bona fide intermediates in the pathway of CI assembly 
in Drosophila, then at least some of these assembly intermediates will stall and accumulate, or they may 
disintegrate when specific CI subunits that are required for CI assembly are disrupted (Figure 2.7A). To 
test this hypothesis, we analyzed the CI assembly intermediates from thoraxes of Mhc>CIRNAi flies, 24 hours 
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after eclosure using an anti-NDUFS3 antibody. As expected, the various subunits that produced CI 
assembly deficits in Figure 4 also resulted in a reduction of the level of the holoenzyme or the CI-containing 
supercomplex (Figures 2.7B-F). 
Disruption of dNDUFS1 and dNDUFV1, which are components of the N module of CI, and are thus 
expected to be added as part of the “cap” during the final step in CI assembly, resulted in a stalling and 
accumulation of the ~815-kDa assembly intermediate (Figures 2.7B and 2.7C). However, unexpectedly, 
disruption of dNDUFA6 and dNDUFA12, not known to be part of the N module, also stalled the ~815-kDa 
subcomplex (Figure 2.7C). RNAi-mediated knockdown of dNDUFS2, dNDUFS3, dNDUFS5, dNDUFS7, 
and dNDUFS8 led to a reduction in the amount of the ~815-kDa assembly intermediate (relative to wild 
type), as they impaired some of the initial steps of CI biogenesis (Figures 2.7B and 2.7C). In addition, the 
amount of the ~315-kDa assembly intermediate was drastically reduced when the expression of dNDUFS2, 
dNDUFS3, or dNDUFS7 was impaired (Figure 2.7B); in line with our proteomic results in Figure 2.5D and 
current mammalian CI assembly models that show that the first step in CI biogenesis involves the formation 
of an assembly intermediate consisting of NDUFS2 and NDUFS3 (Figure 2.5B) [reviewed in (Vartak et al., 
2014)]. Notably, we found that RNAi-mediated knockdown of dNDUFA5 depleted the ~315-kDa assembly 
intermediate (Figure 2.7C). Combining this result, with our proteomic data showing that dNDUFA5 co-
migrates with dNDUFS2, dNDUFS3 and dNDUFS7 (Figure 2.5D), we conclude that although dNDUFA5 is 
an accessory subunit, it is a critical component of, and required for formation or stabilization of the ~315-
kDa assembly intermediate (i.e. the Q module) in vivo.  
Disruption of most of the dNDUFB subunits did not markedly alter the stability or extent of accretion 
of the CI assembly intermediates 24 hours after eclosion (Figure 2.7D), but by 48 and 72 hours after 
eclosion some notable and consistent phenotypes between the two time points were observed (Figure 
2.7E and 2.7F). For instance, RNAi-mediated disruption of dNDUFB3 decreased the extent of accumulation 
of all the assembly intermediates; and the 550-kDa assembly intermediate accumulated when dNDUFB1, 
dNDUFB8 and dNDUFB11 were impaired at both time points (i.e. 48 and 72 hours post-eclosion). 
Surprisingly, although none of the NDUFB subunits are known to be part of the 315-kDa assembly 
intermediate, the extent of accumulation of the 315-kDa assembly intermediate was diminished when the 
expression of dNDUFB1, dNDUFB4, dNDUFB5, dNDUFB6 and dNDUFB10 were reduced (Figure 2.7E 
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and 2.7F). Taken together, these results indicate that specific subunits regulate the biogenesis or stability 
of specific CI assembly intermediates during CI assembly in Drosophila thoraxes.  
 
Identification of an ~700-kDa assembly intermediate of CI in Drosophila  
An assembly intermediate that accumulates between the ~550- and ~815-kDa assembly 
intermediates was detected on immunoblots of samples from mhc>dNDUFS5RNAi and mhc>dNDUFC2RNAi 
thoraxes (Figure 2.7B). We estimate its size to be ~700 kDa because it co-migrates with CV, previously 
estimated to be ~700 kDa in blue native gels (Figure 2.8A) (Abdrakhmanova et al., 2006). The 
accumulation of the ~700-kDa assembly intermediate in samples from mhc>dNDUFS5RNAi thoraxes was 
notable, because it suggested that this could be the point of entry of dNDUFS5 during CI assembly. 
NDUFS5 is a membrane-associated accessory subunit that extends into the intermembrane space; it is 
currently unclear at what point it becomes incorporated into CI. In contrast to the ~315-, ~550- and ~815-
kDa assembly intermediates, the ~700-kDa assembly intermediate was not readily perceptible by anti-
NDUFS3 immunoblotting in the wild-type sample or most of the other mutant samples isolated 24 hours 
after eclosure (Figure 2.7B). This raised the possibility that it could simply be a degradation product, 
perhaps derived from the ~815-kDa assembly intermediate.  
To determine whether the ~700-kDa assembly intermediate is a true assembly intermediate, we 
decided to look at earlier time points (6 and 12 hours post-eclosion) to ascertain whether it ever appears in 
wild-type samples. Immunoblotting at these time points revealed that accumulation of the ~700-kDa 
assembly intermediate in mhc>dNDUFS5RNAi thoraxes is present by the 6-hour time point, and gradually 
tapers off afterwards (Figure 2.8B). Importantly, at the 6-hour time point a faint band corresponding to the 
~700-kDa assembly intermediate can be observed in wild-type samples, indicating that the ~700 kDa-
assembly intermediate exists in wild-type samples, and rapidly matures to the ~815-kDa assembly 
intermediate. The stalling of the ~700-kDa assembly intermediate in mhc>dNDUFS5RNAi thoraxes occurred 
concurrently with an accumulation of both the ~550-kDa and ~315-kDa assembly intermediates, and a 
diminution of the ~815-kDa assembly intermediate relative to wild-type levels. Thus, dNDUFS5 may be 
required for converting the ~700-kDa assembly intermediate into the ~815-kDa assembly intermediate, 
such that when this fails, there is a backlog of the ~700-, ~550- and ~315-kDa assembly intermediates. To 
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test this hypothesis, we compared the assembly intermediates that accumulate in 
mhc>dNDUFS5RNAi,dNDUFS1RNAi and mhc>dNDUFS5RNAi,dNDUFV1RNAi thoraxes with that in 
mhc>dNDUFS1RNAi and mhc>dNDUFV1RNAi thoraxes respectively. We reasoned that because the ~815-
kDa assembly intermediate accumulates in mhc>dNDUFS1RNAi and mhc>dNDUFV1RNAi thoraxes (Figure 
2.7B), if dNDUFS5 is required for converting the ~700-kDa assembly intermediate into the ~815-kDa 
assembly intermediate, then the extent of accumulation of the ~815-kDa assembly intermediate in either 
mhc>dNDUFS5RNAi,dNDUFS1RNAi and/or mhc>dNDUFS5RNAi,dNDUFV1RNAi thoraxes should be reduced 
relative to mhc>dNDUFS1RNAi and mhc>dNDUFV1RNAi respectively. In agreement with this proposition, we 
observed that the accumulation of the ~815-kDa assembly intermediate was significantly attenuated in 
mhc>dNDUFS5RNAi, dNDUFS1RNAi thoraxes relative to mhc>dNDUFS1RNAi thoraxes (Figure 2.8C). This 
was also accompanied by an accumulation of the ~700-kDa assembly intermediate (Figure 2.8C). Similar 
results were obtained by comparing mhc>dNDUFS5RNAi,dNDUFV1RNAi and mhc>dNDUFV1RNAi thoraxes 
(Figure 2.8C). Accordingly, we deduce from these results that when dNDUFS5 expression levels are 
impaired, the transient ~700-kDa assembly intermediate stalls and accumulates, impeding progression of 
CI biogenesis and ultimately resulting in a bottleneck of the ~550-kDa and ~315-kDa assembly 
intermediates as well.  
To gain further insight into the identity of the ~700-kDa assembly intermediate, a single gel slice 
encompassing the region shown in Figure 2.8A was excised from native gels containing samples from 
wildtype and mhc>dNDUFS5RNAi thoraxes. Proteins from the gel slice were digested and analyzed by LC 
mass spectrometry; and a label-free spectral counting approach was used to generate a heat map for some 
of the proteins that showed altered expression levels between the samples. In agreement with our results 
showing a stalling and accumulation of the ~700-kDa assembly intermediate in this portion of the gel, we 
observed that several CI subunits were upregulated in the mhc>dNDUFS5RNAi sample relative to wildtype 
(Figure 2.8D). However, in stark contrast to the other CI subunits, we consistently observed (in 6 biological 
replicates taken at different time points of the day to control for circadian regulation) that dNDUFA10 was 
downregulated in the mhc>dNDUFS5RNAi sample; indicating that incorporation of dNDUFS5 into CI is 
necessary to stabilize or promote incorporation of dNDUFA10 into the complex (Figure 2.8D). In 
mammalian systems, at least five CI assembly factors – ECSIT, TMEM126B, NDUFAF1, ACAD9 and 
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TIMMDC1  – are typically found associated with CI assembly intermediates, and have been dubbed the 
Mitochondrial Complex I Assembly (MCIA) complex (Guarani et al., 2014; Heide et al., 2012; Nouws et al., 
2010; Vogel et al., 2007). We found four of these assembly factors (dECSIT, dNDUFAF1, dACAD9 and 
dTIMMDC1), associated with the 700-kDa assembly intermediate that were upregulated in the 
mhc>dNDUFS5RNAi samples, further confirming that it is a true assembly intermediate in CI biogenesis 
(Figure 2.8D and Table 2.4).  
 
The distal portion of the membrane arm of CI is assembled independently of the matrix arm 
We noticed that in some instances where CI assembly was impaired, an additional band 
accumulated between the CIII and CIV bands in both the coomassie- and silver-stained gels (arrows in 
Figures 2.4A and 2.4B). A closer examination revealed that the accumulation of this intermediate was 
more readily evident in samples where subunits localized to the hydrophilic matrix domain were disrupted 
(i.e. the dNDUFS, dNDUFV and dNDUFA subunits) (Figure 2.1A). In line with our observations described 
in Figures 2.5, 2.7 and 2.8, we hypothesized that this band was likely another CI assembly intermediate 
that had stalled and accumulated as a result of a block in CI biogenesis. We decided to identify the 
constituents of this putative assembly intermediate via mass spectrometry. 
We cut out the region of the gel corresponding to the stalled assembly intermediate in the wildtype, 
mhc>dNDUFS5RNAi and mhc>dNDUFV1RNAi  thoraxes (Figure 2.9A), and used label-free quantification of 
peptides to ascertain which subunits and possibly assembly factors were altered between the two samples. 
Several components of the ETC machinery were downregulated; but there was a dramatic increase in CI 
subunits that are part of the distal membrane domain (i.e. all the dNDUFB subunits as well as dNDUFAB1, 
dNDUFC2, ND4 and ND5) (Figures 2.9B and 2.9C; Table 2.5). We note that there was no obvious 
accumulation of this assembly intermediate in blue native or silver-stained gels when any of these subunits 
(i.e. the dNDUFB subunits, or NDUFAB1 and NDUFC2 subunits) were disrupted (Figures 2.4A and 2.4B). 
Notably, many of these membrane-associated subunits were present in the corresponding gel slice from 
the wild-type samples (although at lower levels). All the components of the MCIA complex (i.e. dECSIT, 
dNDUFAF1, dACAD9, dTMEM126B and dTIMMDC1) were also found associated with this assembly 
intermediate. Based on current assignments of the various CI subunits, this assembly intermediate is clearly 
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the distal portion of the membrane arm (Fiedorczuk et al., 2016; Vinothkumar et al., 2014; Zhu et al., 2016; 
Zickermann et al., 2015).  
 
Proposed model of CI assembly in Drosophila muscle 
We propose a model for CI assembly in Drosophila flight muscles where dNDUFS2, dNDUFS3, 
dNDUFS7, dNDUFS8 and dNDUFA5 are combined in essentially one step to form the Q module, which is 
anchored to the membrane by dND1 (Figure 2.10). This assembly intermediate corresponds to the 
assembly intermediate in mammalian systems that was previously referred to as the ~400-kDa subcomplex, 
but has recently been re-estimated as the ~315-kDa subcomplex (Andrews et al., 2013; Vartak et al., 2014). 
This is consistent with the observation that assembly intermediates containing dNDUFS2, dNDUFS3, 
dNDUFS7, dNDUFS8 and dNDUFA5 co-migrate in blue native gels (Table 2.2), and that immunoblotting 
with both anti-ND1 and anti-NDUFS3 detect the ~315-kDa assembly intermediate (Figure 2.5C).  
Subsequently, another assembly intermediate consisting of some of the subunits in the membrane 
domain is formed. This assembly intermediate comprises part of the P-module (i.e. Partial P1), and is 
conjugated to the Q-module to form an assembly intermediate that corresponds to the ~550-kDa (formerly 
~650-kDa) assembly intermediate previously described in mammalian systems (Figure 7). Although 
proteomic analyses of the assembly intermediate that accumulates in mhc>dNDUFS5RNAi and 
mhc>dNDUFV1RNAi  thoraxes shows that all the dNDUFB subunits as well as dNDUFC1, dNDUFAB1, ND4 
and ND5 subunits are present in the subcomplex (see Table 2.5), it is unlikely that all the membrane 
subunits are incorporated into the complex at this stage under normal (wild-type) conditions. We 
hypothesize that the accumulation of the membrane accessory subunits in response to genetic disruption 
of the matrix subunits may be a compensatory mitochondrial stress signaling mechanism impinging on the 
nucleus, and resulting in a system that is poised to rapidly resume CI biogenesis if and when the missing 
matrix subunit becomes available. The accretion of the Partial P-module under conditions where other 
components of the CI assembly machinery are impaired provides further evidence that the various modules 
of the complex (i.e. the Q-, P- and N-modules) are assembled largely independently of each other in vivo.  
The ~550-kDa assembly intermediate grows by the addition of more subunits to form a transient 
assembly intermediate of ~700-kDa (Figure 7); we postulate that dNDUFS5 is then incorporated at or just 
40
  
prior to this stage together with possibly dNDUFA10 to rapidly convert the ~700-kDa assembly intermediate 
to the ~815-kDa assembly intermediate, consisting of the complete P- and Q-modules (Figure 7). Finally, 
the N-module is added to produce the CI holoenzyme (Figure 7). 
 
Discussion 
We have exploited the genetic capabilities of Drosophila to uncover the mechanism of CI assembly 
in vivo, in Drosophila flight muscles. Our immunoblotting and proteomic analyses reveal that during CI 
assembly in Drosophila, the first membrane-bound major assembly intermediate that forms contains at least 
the following six subunits: dND1, dNDUFS2, dNDUFS3, dNDUFS7, dNDUFS8 and dNDUFA5. Based on 
its constituents and migration pattern in native PAGE, we conclude that this assembly intermediate is the 
same assembly intermediate traditionally referred to as the ~315-kDa assembly intermediate from studies 
on mammalian CI assembly; and corresponds to the Q module of CI (Andrews et al., 2013; Vartak et al., 
2014). Consistent with their roles in regulating formation of the Q module, we found that genetic disruption 
of dNDUFS2, dNDUFS3, dNDUFA5, and dNDUFS7 attenuated the amount of the ~315-kDa assembly 
intermediate formed.  
Unexpectedly, we found an ~700-kDa assembly intermediate that is short-lived (at least relative to 
the ~315-, ~550- and ~815-kDa assembly intermediates), as it is rapidly converted into the ~815-kDa 
assembly intermediate. Importantly, our proteomic analyses revealed that incorporation of dNDUFS5 into 
CI around this stage is necessary to stabilize or promote incorporation of dNDUFA10 into the complex. 
Similar to the ~315-, ~550-, and ~815-kDa assembly intermediates, the ~700-kDa subcomplex is a true 
assembly intermediate as it can be detected in wild-type muscles as well. Additionally, components of the 
MCIA complex are associated with the ~700-kDa assembly intermediate, as has been reported for other 
assembly intermediates observed in mammalian systems. RNAi-mediated disruption of dNDUFS5 led to a 
stalling and accumulation of this otherwise transient assembly intermediate, to a point where it is readily 
detectable by western blots; most likely because this is the stage at or around which dNDUFS5 is 
incorporated into the complex.  
It is possible that mutations in some accessory subunits will have both primary and secondary 
effects. As a case in point, dNDUFS5 disruption may first impair conversion of the ~700-kDa assembly 
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intermediate to the ~815-kDa assembly intermediate, and consequently, impair CI assembly (as we have 
shown); but ultimately, the accumulation of the ~700-kDa assembly intermediate can activate the 
mitochondrial unfolded protein response as well as other stress signaling cascades with far-reaching 
consequences (Haynes et al., 2013; Jensen and Jasper, 2014; Owusu-Ansah and Banerjee, 2009; Owusu-
Ansah et al., 2013; Owusu-Ansah et al., 2008). As another example, when dNDUFB3 was disrupted no 
specific assembly intermediates were stalled or disintegrated. Instead, there was a general reduction in the 
level of expression of all assembly intermediates. It is possible that disruption of dNDUFB3 activates stress 
signaling pathways that induce apoptosis or culminate in a general reduction of protein synthesis, leading 
to a reduction in CI assembly.  
We find that at least 42 of the 44 distinct human CI proteins are conserved in Drosophila. The two 
human CI proteins for which a clear ortholog was not readily identified in Drosophila by DIOPT are NDUFA3 
(9 kDa) and NDUFC1 (6 kDa), which are two of the smallest subunits of the complex. Interestingly, obvious 
orthologs of NDUFC1 are not found in C. elegans or Yarrowia lipolytica; and the orthologs in vertebrates 
such as Zebrafish and Xenopus have very weak homology (DIOPT score of 1) to the human protein. 
Therefore it is possible that this subunit has significant sequence divergence in Drosophila, and although 
present, was not recognized by DIOPT. For most of the CI subunits where multiple paralogs were identified 
by DIOPT (i.e. NDUFS2, NDUFS7, NDUFV2, NDUFA7 and NDUFB2), only one of the paralogs was 
detected as a bona fide CI subunit in flight muscles. However, as an exception to this general rule, two of 
the three paralogs of NDUFV1 were detected as part of CI in skeletal muscles via mass spectrometry. ND-
51 (CG9140) appears to be the authentic ortholog of human NDUFV1 as it is highly expressed in skeletal 
muscles relative to ND-51L (CG11423), and is comparable in size to the human ortholog (both are about 
51 kDa). ND-51L is a 77 kDa protein with a stretch of about 200 amino acids at the N-terminus that is not 
present in either the Drosophila paralog (ND-51) or human ortholog (NDUFV1). It remains to be determined 
whether the expression of the subunits with multiple paralogs are regulated in a tissue-specific manner to 
generate mitochondria with varied CI activities; or whether they are regulated in the same tissue in response 
to different environmental conditions to fine-tune the activity of CI. 
In summary, we have described the mechanism of CI assembly in Drosophila flight muscles, and 
defined specific roles for some of the accessory subunits in CI assembly. Importantly, although CI 
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dysfunction has been implicated in a large number of pathologies, we find that knocking down the 
expression of various antioxidant enzymes or mitochondrial protein quality control genes does not solely 
impair CI assembly, indicating that destabilization of CI may not be the sole underlying factor in many 
mitochondrial disorders (Figure 2.11). In addition, our proteomic analyses established that incorporation of 
dNDUFS5 into CI is necessary to stabilize or promote incorporation of dNDUFA10 into the complex. We 
note that our analyses of CI assembly in an in vivo setting, where CI biogenesis is subject to both 
developmental and environmental cues, revealed that many of the accessory subunits are required for both 
assembly and viability. Moreover, several NDUFB subunits (dNDUFB1, dNDUFB4, dNDUFB5, dNDUFB6 
and dNDUFB10) seem to regulate the stability of the 315-kDa assembly intermediate, in apparent deviation 
from what will be expected from current models of mammalian CI assembly. However, the mechanism of 
CI biogenesis in Drosophila flight muscles is remarkably similar to what has been described in mammalian 
systems; and the differences observed here may be due to the fact that we have analyzed CI assembly in 
an in vivo setting. Accordingly, Drosophila is a suitable organism for addressing questions relevant to 
mammalian CI biogenesis. We anticipate that future studies using the full repertoire of genetic tools and 















Materials and Methods 
Drosophila Strains and Genetics.  
The following fly stocks were used: y w; Dmef2-Gal4 and w; mhc-Gal4 were the Gal4 transgenic lines used 
to express RNAi lines in muscles. w1118/mhc-Gal4 flies were used as wildtype (wt) controls. Other fly 
stocks used were: y1 sc*v1 ; P{TRiP.HMS00854}attP2 (Bloomington, #33911), y1 v1 ; 
P{TRiP.HMS05059}attP2 (Bloomington, #28573), y1 v1 ; P{TRiP.HMC02929}attP40 (Bloomington, 
#44535), y1 v1 ; P{TRiP.HMC03554}attP40 (Bloomington, #53325), y1 sc*v1 ; P{TRiP.HMC03861}attP40 
(Bloomington, #55180), y1 sc*v1 ; P{TRiP.HM05229}attP2 (Bloomington, #30487), y1 sc*v1 ; 
P{TRiP.HMS01590}attP2 (Bloomington, #36701), y1 v1 ; P{TRiP.HMC03429}attP40 (Bloomington, 
#51855), y1 sc*v1 ; P{TRiP.HMC03653}attP40 (Bloomington, #52913), y1 sc*v1 ; P{TRiP.GLC01699}attP2 
(Bloomington, #50577),y1 sc*v1 ; P{TRiP.HMC03662}attP40 (Bloomington, #52922), y1 sc*v1 ; 
P{TRiP.HMS00798}attP2 (Bloomington, #32998), y1 sc*v1 ; P{TRiP.HMS01584}attP2 (Bloomington, 
#36695), y1 sc*v1 ; P{TRiP.HMC02678}attP2/ TM3, Sb1 (Bloomington, #43279), y1 v1 ; 
P{TRiP.HM05206}attP2 (Bloomington, #29528), y1 v1 ; P{TRiP.HM22452}attP40 (Bloomington, #58322), 
y1 v1 ; P{TRiP.GLC01422}attP2 (Bloomington, #43235), y1 v1 ; P{TRiP.HMJ23156}attP40 (Bloomington, 
#61321), y1 sc*v1 ; P{TRiP.HM05255}attP2/TM3, Sb1 (Bloomington, #30511), y1 sc*v1 ; 
P{TRiP.HMC03242}attP2 (Bloomington, #51357), y1 v1 ; P{TRiP.HMJ22367}attP40 (Bloomington, 
#58282), y1 sc*v1 ; P{TRiP.HMS00815}attP2 (Bloomington, #33878), y1 v1 ; P{TRiP.JF02892}attP2 
(Bloomington, #28056), y1 v1 ; P{TRiP.JF02899}attP2 (Bloomington, #28062) and y1 sc*v1 ; 
P{TRiP.HMS01560}attP2 (Bloomington, #36672). Transgenic RNAi stocks for disrupting CG8680 (8680R-
3), CG9172 (9172R-2), CG6463 (6463R-1), CG9350 (9350R-2), CG9762 (9762R-3), CG13240 (13240R-
2), CG3283 (3283R-1) and CG3192 (3192R-3) were from the National Institute of Genetics (NIG, Japan) 
Drosophila Stock Center. RNAi stocks for disrupting CG12400 (v102590), CG7712 (v100616), CG12859 
(v8786), CG4169 (v26405) and CG9306 (v23088) were from the Vienna Drosophila Resource Center.  
 
Mitochondria Purification.  
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Mitochondrial purification was performed essentially as described by Rera et al 2012 (Rera et al., 2011). 
Thoraxes were dissected and gently crushed with a pestle homogenizer in 500µl of pre-chilled mitochondrial 
isolation buffer containing 250 mM sucrose and 0.15 mM MgCl2 in 10 mM Tris.HCl, pH 7.4, on ice. After 
two rounds of centrifugation at 500g for 5 minutes at 4°C to remove insoluble material, the supernatant was 
recovered and centrifuged at 5000g for 5 minutes at 4°C. The pellet which is enriched for mitochondria was 
washed twice in the mitochondrial isolation buffer and stored at -80°C until further processing.  
 
Blue Native Polyacrylamide Gel Electrophoresis (BN-PAGE).  
BN-PAGE was performed using NativePAGE gels from Life Technologies, following the manufacturer’s 
instructions. Essentially, mitochondria were suspended in native PAGE sample buffer (Life Technologies) 
supplemented with 1% digitonin and protease inhibitors, and incubated on ice for 20 minutes. Following 
centrifugation at 20,000g for 30 minutes, the supernatant was recovered, mixed with the G-250 sample 
additive (Life Technologies) and Native PAGE Sample Buffer (Life Technologies), and loaded onto 3–12% 
pre-cast Bis–Tris Native PAGE gels (Life Technologies). The NativeMark Protein standard (Life 
Technologies), run together with the samples, was used to estimate the molecular weight of the protein 
complexes. Electrophoreses was performed using the Native PAGE Running buffer (as anode buffer, from 
Life technologies) and the Native PAGE Running buffer containing 0.4% Coomassie G-250 (cathode 
buffer). Gels were stained with the Novex Colloidal Blue staining kit (Life Technologies) to reveal the protein 
complexes.  
 
Silver Staining.  
Silver staining of native gels was performed with the SilverXpress staining kit from Life Technologies, 
following the manufacturer’s protocol.  
 
In-gel Complex I Activity. 
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 Complex I activity in native gels was performed by incubating the native gels in 0.1 mg/ml NADH, 2.5 mg/ml 
Nitrotetrazolium Blue Chloride, 5 mM Tris-HCl (pH 7.4) overnight at room temperature.  
 
Climbing Assay 
20 flies were collected in a vial for each CI subunit that was knocked down. Flies were tapped lightly to the 
bottom of the vial and were allowed 15 seconds to past the midway line in the vial (target line). The 
percentage of flies to cross the target line was calculated. 
 
Immunoblotting 
For immunoblotting of samples in native gels, protein complexes from native gels were transferred to PVDF 
membranes (BIORAD). For immunoblotting of samples in whole tissue lysates, thoraxes were homogenized 
in RIPA buffer (150 mM NaCl, 1% Triton X-100, 0.5% Sodium Deoxycholate, 0.1% SDS, 50mM Tris HCl, 
pH 8) supplemented with Halt protease inhibitors (Pierce), resolved on mini-PROTEAN TGX stain-free gels 
from BIO-RAD, and transferred to PVDF membranes. In both instances (native and non-native gels), the 
membrane was subsequently blocked in 5% (w/v) non-fat dry milk in Tris-buffered saline (TBS) for 
30minutes, and incubated in the appropriate primary antibody dissolved in 2% BSA, 0.1% Tween 20 in TBS 
(TBST) overnight at 4°C. Following the overnight incubation, the blot was rinsed 4X10 minutes in 
0.1%TBST, blocked for 30 minutes in 5% (w/v) non-fat dry milk in TBST and incubated for two hours with 
the appropriate HRP-conjugated secondary antibody dissolved in 2% BSA, 0.1% Tween 20 in TBS (TBST). 
After incubation in the secondary antibody, samples were rinsed 4X10 minutes in 0.1%TBST. 
Immunoreactivity was detected by enhanced chemiluminescence (ECL) and analyzed by a ChemiDoc Gel 
imaging system from BIO-RAD. Antibodies used were anti-NDUFS3 (abcam, ab14711), anti-ND1 (abcam, 
ab74257), anti ATPsynß (Life technologies, A21351) anti-GFP (Life technologies, A6455) and anti-actin 
(EMD Millipore, MAB1501).  
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In-Gel Protein Digestion  
The dried gel pieces were rehydrated and digested in 80 µL of 12.5 ng/µL Trypsin Gold/50 mM ammonium 
bicarbonate at 37°C overnight. Following the digestion, condensed evaporated water was collected from 
tube walls by brief centrifugation using benchtop microcentrifuge (Eppendorf, Hauppauge, NY). The gel 
pieces and digestion reaction were mixed with 50 µL 2.5% Trifluoroacetic acid (TFA) and rigorously mixed 
for 15 minutes. The solution with extracted peptides was transferred into a fresh tube, and the remaining 
peptides were extracted with 80µl of 70% Acetonitrile (ACN)/5% TFA mixture using by rigorously mixing for 
15 minutes. The extracts were pooled and dried to completion (1.5–2 hours) in a SpeedVac. The dried 
peptides were reconstituted in 30 µl of 0.1% TFA by mixing for 5 minutes and stored on ice or at −20 °C 
prior to analysis.  
 
LC-MS/MS Analysis  
The concentrated peptide mix was reconstituted in a solution of 2 % ACN, 2 % Formic acid (FA) for MS 
analysis. Peptides were eluted from the column using a Dionex Ultimate 3000 Nano LC system with a 10 
min gradient from 2% buffer B to 35 % buffer B (100 % ACN, 0.1 % FA). The gradient was switched from 
35 % to 85 % buffer B over 1 min and held constant for 2 min. Finally, the gradient was changed from 85 
% buffer B to 98 % buffer A (100% water, 0.1% FA) over 1 min, and then held constant at 98 % buffer A for 
5 more minutes. The application of a 2.0 kV distal voltage electrosprayed the eluting peptides directly into 
the Thermo Fusion Tribrid mass spectrometer equipped with an EASY-Spray source (Thermo Scientific). 
Mass spectrometer-scanning functions and HPLC gradients were controlled by the Xcalibur data system 
(Thermo Finnigan, San Jose, CA).  
 
Database Search And Interpretation Of MS/MS Data  
Tandem mass spectra from raw files were searched against a Drosophila protein database using the 
Proteome Discoverer 1.4 software (Thermo Finnigan, San Jose, CA). The Proteome Discoverer application 
extracts relevant MS/MS spectra from the .raw file and determines the precursor charge state and the 
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quality of the fragmentation spectrum. The Proteome Discoverer probability-based scoring system rates 
the relevance of the best matches found by the SEQUEST algorithm. The Drosophila protein database was 
downloaded as FASTA-formatted sequences from Uniprot protein database (database released in May, 
2015). The peptide mass search tolerance was set to 10ppm. A minimum sequence length of 7 amino acids 
residues was required. Only fully tryptic peptides were considered. To calculate confidence levels and false 
positive rates (FDR), Proteome Discoverer generates a decoy database containing reverse sequences of 
the non-decoy protein database and performs the search against this concatenated database (non-decoy 
+ decoy). Scaffold (Proteome Software) was used to visualize searched results. The discriminant score 
was set at less than 1% FDR determined based on the number of accepted decoy database peptides to 
generate protein lists for this study. Spectral counts were used for estimation of relative protein abundance 
between samples. 
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Figure 2.1: Drosophila flight muscles are suitable for studying complex I assembly. 
(A) Schematic representation of how the 44 distinct subunits of bovine or ovine CI are arranged to produce 
the L-shaped topology; based on recent CI structures described (Fiedorczuk et al., 2016; Vinothkumar et 
al., 2014; Zhu et al., 2016; Zickermann et al., 2015). The asterisk denotes subunits for which an ortholog 
was not identified in Drosophila by DIOPT. NDUFAB1 occurs twice in the complex, giving rise to a total of 
45 subunits. 
(B) Summary of the experimental procedure for studying CI assembly in Drosophila. Transgenic RNAi 
constructs to the nuclear-encoded subunits were expressed specifically in thoracic muscles using the mhc-
Gal4 driver. Mitochondria were isolated from thoraxes of 1 week-old flies, solubilized in 1% digitonin, and 
analyzed by blue native polyacrylamide gel electrophoresis (BN-PAGE). 
(C) The constituents of each of the six major bands observed during BN-PAGE was analyzed by mass 
spectrometry. 38 subunits of Drosophila CI were confirmed by mass spectrometry. The 38 subunits 
correspond to 37 different orthologs of human CI. Two paralogs of human NDUFV1 were confirmed by 
mass spectrometry (see Table 2.1). See Table 2.2 for all the peptides identified in the six major bands 
shown. 
(D) BN-PAGE (left panel) and Silver staining (right panel) of samples from thoraxes following RNAi-
mediated knockdown of complex I (CI), complex III (CIII), complex IV (CIV) and complex V (CV) proteins to 
confirm the identities of the bands. SupCI and CV2 denote a supercomplex of CI and a dimer of CV 
respectively. The exact RNAi constructs expressed starting from left to right were to the white gene 
(wildtype, WT), dNDUFV1 (CI), dNDUFS1 (CI), dUQCRC-2 (CIII), dUQCRC-Q (CIII), dCox5A (CIV), 
cyclope (CIV), dATPsyn-β (CV), and ATPsyn-b (CV). 
(E) Immunoblotting with anti-NDUFS3 and anti-ATPsynβ antibodies of native gels to detect CI and CV 
respectively. Note that band A is a doublet consisting predominantly of a dimer of CV, and a supercomplex 
of CI. 
(F) BN-PAGE (top panel) and CI in-gel enzyme activity (lower panel) indicate that most of CI exists as the 
holoenzyme in Drosophila melanogaster (DM) skeletal muscles, in contrast to cardiac, soleus, EDL and 
tibia muscles from mice where a significant portion of CI exists as a supercomplex.  
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Figure 2.2: 1% digitonin is the optimum detergent concentration for resolving OXPHOS complexes 
in Drosophila thoraxes. 
Related to Figure 2.1.  
Mitochondrial protein complexes from wild-type thoraxes were solubilized in various concentrations of 
detergents as shown  
(A) Digitonin at 0.25%, 0.5%, 1% and 2%  
(B) 1% digitonin, and Triton X-100 concentrations of 0.25%, 0.5%, 1% and 2%  
(C) 1% digitonin, and n-Dodecyl β-D-maltoside (DDM) concentrations of 0.25%, 0.5%, 1% and 2%  
(D) NP-40 concentrations of 0.25%, 0.5%, 1% and 2%, and  





















Figure 2.3: Strong expression of dmef2-gal4 during development. 
Related to Figure 2  
Western blot showing extent of GFP expression in Dmef2-Gal4; UAS-GFP and mhc-Gal4; UAS-GFP larval 
somatic and adult thoracic muscles respectively. Expression of β-actin serves as a loading control. Note 

























Figure 2.4: Disruption of several CI core and supernumerary subunits impair CI assembly In 
Drosophila. 
BN-PAGE (A), Silver staining (B), and CI in-gel enzyme activity (C) of mitochondria isolated from thoraxes 
following RNAi-mediated knockdown of the CI proteins indicated (mhc-Gal4>dNDUFXRNAi ). The values 
listed below each lane indicate the residual amount of CI normalized to the amount in the wild-type (mhc-
Gal4>w1118) lane.  
(D) Climbing phenotype after the knockdown of CI subunits. Flies were aged from 0-3 days. Climbing 
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Figure 2.5: Proteomic analyses and immunoblotting identify assembly intermediates of CI. 
(A) Schematic of CI showing the three modules of the enzyme. The NADH Dehydrogenase module (N 
module) is located at the tip of the matrix arm, and is the site of NADH oxidation. Situated between the N 
module and the membrane arm, is the Q module, which is responsible for Ubiquinone reduction. The 
proton-conducting P module is in the membrane arm. 
(B) The current model of CI assembly in mammalian systems (reviewed in (Vartak et al., 2014). The 
assembly process begins with the formation of an assembly intermediate containing NDUFS2 and 
NDUFS3, which combines with NDUFS7 and NDUFS8. The subcomplex of NDUFS2, NDUFS3, NDUFS7 
and NDUFS8 ultimately combines with ND1 to form the ~315 kDa assembly intermediate that is anchored 
to the membrane. The ~315 kDa subcomplex (also called the Q module) combines with an independently-
formed ~370 kDa assembly intermediate to form an ~550 kDa assembly intermediate. This assembly 
intermediate which consists of the Q module and part of the P module grows by the addition of more 
subunits to form the ~815 kDa assembly intermediate, via mechanisms that are very poorly defined. The 
~815 kDa assembly intermediate now consists of the complete Q and P modules. Finally, the N module is 
added to produce the 950kDa fully-assembled complex. Assembly factors or chaperones that assist in this 
process, but are not present in the fully assembled complex, have been omitted for clarity.  
(C) Western blot of samples obtained from thoraxes from pupae aged between 2 and 4 days after 
pupariation, and of flies from 0.5 hours to 48 hours post-eclosure to detect the assembly intermediates, 
fully assembled CI, and a supercomplex containing complex I (supCI) after BN-PAGE. The anti-NDUFS3 
antibody strongly detects CI and supCI; and weakly detects the ~315 kDa, ~550 kDa and ~815 kDa 
assembly intermediates after a short exposure. However, after a longer exposure, the ~315 and ~550 kDa 
assembly intermediates can clearly be seen. In the right panel, the membrane was stripped and re-probed 
with anti-NDI. Anti-ND1 detects the ~315 kDa and ~550 kDa assembly intermediates, and a very faint band 
corresponding to CI.  
(D) Proteomic analyses of assembly intermediates that form in the native gel sized between ~50 kDa and 






























CI Subunits and Assembly Factors Identified 
In Each Fraction
A1 (400-450) dNDUFS3
A2 (350-400) dNDUFAF4, dNDUFS3, dNDUFA5, dNDUFS7
A3 (300-350) dNDUFAF4, dNDUFS2, dNDUFS3, dNDUFA5, dNDUFS7
A4 (260-300) dNDUFAF4, dNDUFS2, dNDUFS3, dNDUFA5, dNDUFS7, dACAD9
A5 (220-260) dNDUFA7, dNDUFS2, dNDUFS3, dNDUFA5, dNDUFS1, dACAD9
A6 (200-220) dNDUFA7, dNDUFS1, dACAD9
A7 (180-200) dNDUFA7, dNDUFS1, dACAD9
A8 (160-180) dNDUFA7, dNDUFS1, dACAD9
A9 (140-160) dNDUFA10, dNDUFA7, dNDUFA11, dNDUFS1, dACAD9
A10 (120-140) dNDUFA10, dNDUFA7, dNDUFA11
A11 (100-120) dNDUFA10, dNDUFA7, dNDUFA12
A12 (85-100) dNDUFA10, dNDUFA7, dNDUFA12, dNDUFA11
A13 (70-85) dNDUFA10, dNDUFA7, dNDUFA12, dNDUFA11
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Figure 2.6: Detection of smaller subcomplexes of CV. 
Related to Figure 2.5  
Immunoblots of samples obtained from wildtype, mhc>dNDUFS8RNAi and mhc>dNDUFV1RNAi thoraxes 
of flies aged for 24 hours after eclosure to detect CI and CV assembly intermediates. In the left and right 
panels, anti-ND1 and anti-NDUFS3 antibodies detect the CI holoenzyme and supercomplex, and the ~315 
kDa, ~550 kDa and ~815 kDa CI assembly intermediates; but no assembly intermediates less than about 
300 kDa are detected by these antibodies. However, in the middle panel, anti-ATPsynβ detects the CV 






















Figure 2.7: Specific subunits regulate the biogenesis or stability of specific assembly intermediates 
of CI. 
(A) The left panel depicts a schematic of the distribution of assembly intermediates on immunoblots as a 
result of RNAi-mediated disruption of various CI subunits. The right panel describes how various results 
can be interpreted. 
(B-D) Distribution of assembly intermediates in thoraxes dissected 24 hours after eclosion with transgenic 
RNAi expression of the CI subunits shown. In panels labeled long exposure, the region of the membrane 
just at or below CI was cut and imaged. 
(B) The ~815 kDa assembly intermediate accumulates in thoraxes expressing transgenic RNAi to 
dNDUFS1 and dNDUFV1; and the ~315 kDa assembly intermediate is decreased in thoraxes expressing 
transgenic RNAi of dNDUFS2, dNDUFS3 and dNDUFS7. In addition, another assembly intermediate 
accumulates in thoraxes expressing RNAi to dNDUFS5 and dNDUFC2 (denoted by *). (C) The ~815 kDa 
assembly intermediate stalls in thoraxes expressing transgenic RNAi to dNDUFA6 and dNDUFA12; and 
the ~315 kDa assembly intermediate is attenuated in thoraxes expressing transgenic RNAi of dNDUFA5. 
(D) There were no overt alterations in assembly intermediates at this time point when the dNDUFB subunits 
were disrupted. 
(E and F) Distribution of assembly intermediates in thoraxes dissected 48 hours (E) and 72 hours (F) after 
eclosion with transgenic RNAi expression of the NDUFB subunits shown. RNAi-mediated knockdown of 
the expression of dNDUFB3 decreased the extent of accumulation of all the assembly intermediates; and 
the 550 kDa assembly intermediate accumulated when the expression of dNDUFB1, dNDUFB8 and 
dNDUFB11 were reduced. In addition, the extent of accumulation of the 315 kDa assembly intermediate 
was diminished following RNAi-mediated disruption of dNDUFB1, dNDUFB4, dNDUFB5, dNDUFB6 and 










I : wild-type; normal expression of CI holoenzyme, supercomplex of CI
(supCI) and the 815-, 550- and 315 kDa subcomplexes
II : mutant; reduced expression of CI holoenzyme and supCI; 815 kDa
subcomplex stalls and accumulates.
III : mutant; reduced expression of CI holoenzyme and supCI; 315 kDa
subcomplex is also reduced.
IV : mutant; reduced expression of CI holoenzyme, supCI, and all the
subcomplexes
V : mutant; reduced expression of CI holoenzyme and supCI; a new
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Figure 2.8: Identification of an ~700 kDa assembly intermediate of CI in Drosophila.  
(A) Top Panel: Immunoblots of samples obtained from wildtype and mhc>dNDUFS5RNAi   thoraxes of flies 
aged for 6 hours after eclosure depicting co-migration of the ~700 kDa intermediate and CV. In the left and 
middle panels, anti-NDUFS3 antibodies detect the fully assembled CI, the ~700 kDa subcomplex, as well 
as other assembly intermediates in dNDUFS5RNAi  thoraxes. Note that in the middle panel, the region of the 
membrane just below CI was cut and imaged. In the right panel, anti-ATPsynβ detects the CV monomer 
(700kDa) and dimer as shown. Lower Panel: Mitochondrial protein complexes from wildtype and 
mhc>dNDUFS5RNAi thoraxes were resolved by BN-PAGE and the region corresponding to the ~700 kDa 
assembly intermediate (i.e. CV, demarcated) was cut out, subjected to tryptic digestion, and analyzed by 
label-free quantitative LC-MS/MS.  
(B) Immunoblots from samples obtained after 6 hours, 12 hours and 24 hours post eclosure from thoraxes 
where NDUFS1, NDUFS3, NDUFS5 and NDUFV1 were knocked down as a result of transgenic RNAi 
exression. Note that the ~815 kDa assembly intermediate accumulates as a result of disruption of NDUFS1 
and NDUFV1, and the ~700 kDa assembly intermediate stalls and accumulates in NDUFS5 mutants at all 
time points. Importantly, upon prolonged exposure of the immunoblot, a band corresponding to the ~700 
kDa assembly intermediate can also be observed in wild-type samples (denoted with the * in the lower 
panel), which confirms that it is an authentic, albeit transient assembly intermediate. 
(C) The accumulation of the ~815 kDa assembly intermediate was significantly attenuated in 
mhc>dNDUFS5RNAi,dNDUFS1RNAi thoraxes relative to mhc>dNDUFS1RNAi thoraxes; instead there is an 
accumulation of the ~700 kDa assembly intermediate. Similar results were obtained when samples from 
mhc>dNDUFS5RNAi,dNDUFV1RNAi thoraxes were compared to samples from mhc>dNDUFV1RNAi thoraxes. 
(D) Proteomic changes in the gel slice sample from wildtype and mhc>dNDUFS5RNAi thoraxes 
corresponding to the ~700 kDa assembly intermediate. Relative protein abundance among biological 
samples is expressed by spectral counts on a log scale. Several CI subunits and CIAFs, most notably 
components of the MCIA complex are upregulated in the ~700 kDa assembly intermediate. However, the 
amount of dNDUFA10 (denoted with an asterisk) is reduced in mhc>dNDUFS5RNAi thoraxes relative to wild 
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Figure 2.9: CI assembly In Drosophila involves an assembly intermediate containing several 
membrane-associated accessory subunits. 
(A) Mitochondrial protein complexes from wildtype, mhc>dNDUFS5RNAi and mhc>dNDUFV1RNAi  thoraxes 
were separated by BN-PAGE and the region corresponding to the accumulated assembly intermediate 
(demarcated) was cut out, subjected to tryptic digestion, and analyzed by label-free quantitative LC-MS/MS.  
(B) Proteomic changes in the gel slice samples from wildtype, mhc>dNDUFS5RNAi and mhc>dNDUFV1RNAi  
thoraxes. Relative protein abundance among biological samples is expressed by spectral counts on a log 
scale. The color scale bar indicates the range of protein expression levels. See additional information in 
Table 2.5. 
(C) Schematic representation highlighting the membrane subunits that are upregulated in the gel slice 
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Figure 2.10: Proposed model of CI assembly in Drosophila flight muscle. 
An assembly intermediate consisting of dNDUFS2, dNDUS3, dNDUFS7, dNDUFS8 and dNDUFA5 are 
combined in essentially one step to form the Q module, which is anchored to the membrane by ND1. 
Subsequently, an independently-formed subcomplex comprising of membrane-associated subunits (Partial 
P1) is conjugated to the Q module, and possibly other subunits, to form an assembly intermediate 
comprised of the Q module and part of the P module (Q + Partial P2). This grows by the addition of more 
subunits to form a transient assembly intermediate of ~700kDa (Q + Partial P3). We propose that dNDUFS5 
is then incorporated at this step, to promote incorporation or stabilization of dNDUFA10. Subsequently, the 
transient ~700 kDa assembly intermediate is rapidly converted to the ~815 kDa assembly intermediate, 





































Figure 2.11: Destabilization of CI is not specifically linked to stress. 
Related to Figure 2.4A  
(A) Silver-stained gels containing OXPHOS complexes isolated from wildtype, Dmef2Gal4>PINK1RNAi, 
Dmef2Gal4>ParkRNAi, Dmef2Gal4>GSTS1RNAi, Dmef2Gal4>Trxr-1RNAi, Dmef2Gal4>Sod1RNAi, 
Dmef2Gal4>Sod2RNAi and Dmef2Gal4>catalaseRNAi thoraxes of flies aged for 72 hours after eclosure to 
determine the integrity of the OXPHOS complexes. Lanes marked with an asterisk denote instances where 
assembly of several OXPHOS complexes were impaired.  
(B) BN-PAGE showing mitochondrial protein complexes from mhc>w1118 (wild-type) thoraxes of flies aged 
for 24 hours; and starved or maintained at 25C, 30C or 37C for 18 or 36 hours. Note that there were no 





















Table 2.1 There are at least 42 orthologs of the 44 human complex I subunits in Drosophila, related 
to Figure 2.1. 
 *Shows which protein in a set of paralogs was confirmed by mass spectrometry. Core subunits are shown 



























Table 2.2: Proteins Identified via mass spectrometry of OXPHOS complexes in Drosophila, related 
to Figure 2.1. 
The constituents of each of the six major bands observed during BN-PAGE was analyzed by mass 
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Abdrakhmanova, A., Zwicker, K., Kerscher, S., Zickermann, V., and Brandt, U. (2006). Tight binding of 
NADPH to the 39-kDa subunit of complex I is not required for catalytic activity but stabilizes the multiprotein 
complex. Biochim Biophys Acta 1757, 1676-1682. 
 
Andrews, B., Carroll, J., Ding, S., Fearnley, I.M., and Walker, J.E. (2013). Assembly factors for the 
membrane arm of human complex I. Proc Natl Acad Sci U S A 110, 18934-18939. 
 
Balsa, E., Marco, R., Perales-Clemente, E., Szklarczyk, R., Calvo, E., Landazuri, M.O., and Enriquez, J.A. 
(2012). NDUFA4 is a subunit of complex IV of the mammalian electron transport chain. Cell Metab 16, 378-
386. 
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Mitochondrial Complex I (CI) from bovine heart mitochondria has 44 distinct subunits; 14 are 
referred to as core subunits, as they are directly required for electron transfer from NADH to ubiquinone, or 
for generation of the membrane potential (Hirst, 2013). The other 30 nuclear-encoded subunits are referred 
to as accessory subunits, because they are not directly required for catalysis (Fiedorczuk et al., 2016). CI 
consists of a hydrophilic matrix arm and a hydrophobic membrane arm that project into the mitochondrial 
matrix and inner membrane respectively; and are oriented almost orthogonally to each other, resulting in a 
boot-shaped structure (Blaza et al., 2018; Zhu et al., 2016). The mechanistic assembly of the 44 distinct 
subunits occurs via a step-wise process. First, the subunits come together to form four assembly 
intermediates which then bind to each other to complete the assembly of the holoenzyme (Garcia et al., 
2017; Guerrero-Castillo et al., 2017). The four assembly intermediates are named after the functional 
modules of the enzyme. They are the NADH binding site module (N-module), ubiquinone binding site 
module (Q-module) and the proton pumping module which is split into two assembly intermediates (P 
proximal-module (PP) and P distal-module (PD)).  
CI assembly factors (CIAFs) are proteins that assist with the assembly process but are not found 
in the fully assembled complex (Formosa et al., 2018). Fifteen CIAFs have been described thus far 
(Formosa et al., 2018). Some CIAFs function as chaperones to stabilize specific CI assembly intermediates, 
or assist with the combination of two assembly intermediates to form a larger assembly intermediate 
(Andrews et al., 2013; Sugiana et al., 2008). Others have more specific roles, such as the posttranslational 
modifications of subunits (Rhein et al., 2013). The need to identify novel regulators of CI assembly is 
underscored by the fact that about half of CI disorders observed in patients cannot be traced to mutations 
in any of the 44 human CI subunits or known CIAFs (Pagliarini and Rutter, 2013; Taylor et al., 2014). This 
may be due to mutations happening de novo, occurring on sites of untranslated regions, and missing the 
exact variant that causes the disease after sequencing (Fassone and Rahman, 2012; Rodenburg, 2016). 
New sequencing technologies, such as RNA sequencing, are being used to complement the initial approach 
of whole exome and whole genome sequencing. One study used RNA sequencing to diagnose a patient’s 
CI deficiency due to a mutation in a known assembly factor TIMMDC1; the expression of TIMMDC1 was 
120
reduced due to a new exon in intron 5 which produced a frameshift introducing a premature stop codon 
(Kremer et al., 2017). Although RNA sequencing seems like a promising method to identify new regulators 
of CI, the challenge lies in the vast amount of data generated, and the dearth of genes of interest known to 
cause CI deficiency. As a proof of this challenge, only 10% of cases in the previous study were diagnosed 
using RNA sequencing. Therefore, identifying more nuclear genes that affect CI assembly is warranted for 
a more efficient genetic diagnosis of CI deficiency. 
Here, we have utilized Drosophila melanogaster as a model system to study the CIAFs and their 
roles in CI assembly (Figure 3.1). We hypothesized that some of the proteins that interact with NDUFS3, 
an integral core subunit of the Q-module, may serve as CIAFs. We identified 175 different interacting 
proteins of NDUFS3 and knocked them down individually in Drosophila using RNAi. Blue-native PAGE was 
performed to analyze the respiratory chain complexes of the knockdown flight muscle mitochondria. We 
discovered that knockdown of the Drosophila Fragile X Mental Retardation Protein (dFMRP) destabilized 
the structure of CI. Accordingly, we further analyzed the lifespan and in-gel activity, and characterized the 
assembly process, of flies lacking dFMRP. We report here that knockdown of dFMRP leads to a 
misassembly of CI. We further demonstrate the stalling of 815-kDa assembly intermediate and the 
accumulation of lower assembly intermediates. Finally, we conclude that the misassembly of CI is due to 
the destabilization of the PP- or PD-module. 
 
Results 
Complex I-interacting proteins were identified in Drosophila flight muscles 
To identify interactors of CI, we genetically tagged the C-terminus of Drosophila NDUFS3 
(dNDUFS3) with HA and expressed it in the fly flight muscles using Mhc-Gal4 (Figure 3.2A). The C-
terminus was used given that the mitochondria targeting sequence for dNDUFS3 is located at the N-
terminus (Loeffen et al., 1998). This was achieved in offspring produced from a cross between two 
transgenic flies: one carrying the dNDUFS3-HA linked to an upstream activating sequence (i.e. UAS-
dNDUFS3-HA, the Gal4 protein binds to the UAS sequence and drives expression of the dNDUFS3-HA 
construct), and the other with the muscle-specific Gal4 driver (e.g. Mhc-Gal4) (Figure 3.2A). We found that 
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Mhc-Gal4<UAS-dNDUFS3-HA flies are viable and have no overt phenotypic differences from wild-type 
flies. The expression of dNDUFS3-HA was confirmed by SDS-PAGE and probing with an anti-HA antibody 
(Figure 3.2C). We also confirmed that dNDUFS3-HA gets incorporated into CI using blue-native PAGE 
(BN-PAGE) followed by immunoblot analysis (Figure 3.2D). We probed with an HA antibody and found that 
dNDUFS3-HA gets incorporated into the holoenzyme of CI and several assembly intermediates. These 
results demonstrated successful tagging of dNDUFS3 with HA and that the tagging did not alter the 
holoenzyme of CI and its assembly intermediates. 
To identify the proteins interacting with dNDUFS3, we first isolated whole thorax lysates by 
permeabilizing the cellular membranes with buffer containing either 1% NP-40 or Digitonin (4g Digitonin: 
1g Protein) from Mhc-Gal4<UAS-dNDUFS3-HA flies aged to 24 hours after eclosing (Figure 3.2A). We 
chose 24 hours because CI biogenesis is active in Drosophila during the first 48 hours (Garcia et al., 2017). 
Samples were placed on ice for 30 minutes and then centrifuged at high speed to clear lysates before 
proceeding with co-immunoprecipitation (co-IP) (Figure 3.2A). For co-IP, samples were first rotated with 
control agarose beads for 1 hour to control for any non-specific binding proteins. Next, the supernatant was 
transferred to agarose beads containing an anti-HA antibody and rotated overnight. Control agarose beads 
and anti-HA beads were sent for mass spectrometry to identify interacting proteins. We found a total of 385 
proteins between the NP-40- and digitonin-permeabilized samples; 60% of the proteins identified were 
found with both buffers (Figure 3.2A and Table 3.1). We identified known interactors such as dNDUFS2, 
dNDUFS7 and dNDUFS8 which form the 315-kDa CI assembly intermediate (Figure 3.2B). We also 
identified other CI subunits such as dNDUFA9, dNDUFA10, dNDUFS1, dNDUFV1, and dNDUFV2 (Figure 
3.2B). dNDUFA9 and dNDUFA10 are found in the Q-module of CI and are known to interact closely with 
dNDUFS3. While dNDUFS1, dNDUFV1, and dNDUFV2 are not known to interact with dNDUFS3, they were 
also identified (Figure 3.2B). 
 
dFMRP was identified as a regulator for CI biogenesis by screening NDUFS3-interacting proteins 
We chose to screen 175 of the proteins that interacted with dNDUFS3 after eliminating ribosomal 
proteins, mitochondria proteins that are known to be involved with the respiratory chain complexes, and 
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proteins that did not have RNA interference’s (RNAi’s) readily available at the time (Table 3.1). The RNAi’s 
to target these proteins were ordered from the Bloomington Drosophila Stock Center (BDSC) at 
http://flystocks.bio.indiana.edu/. If available, more than one RNAi for each protein were ordered. In total, 
we obtained 292 transgenic UAS-RNAi lines and tested their effect on CI assembly (Table 3.2). Each UAS-
RNAi line was crossed to the Drosophila muscle enhancing factor (Dmef2) gal4, which is known to express 
gal4 in flight muscles. Dmef2-Gal4<UAS-RNAi offspring were aged for 5-7 days at 25°C. If the flies died 
before the 5 days, they were re-crossed and dissected at an earlier time point. If offspring did not eclose to 
adults due to embryonic or pupae lethality, they were re-crossed to the myosin heavy chain (Mhc) gal4 
which has been shown to reduce the expression of the RNAi compared to Dmef2-Gal4 (Garcia et al., 2017). 
In total, 53 of the UAS-RNAi lines were crossed with Mhc-Gal4. For each cross, we isolated mitochondria 
from 10 thoraxes, solubilized their membranes with 4g of digitonin to 1g of protein and performed BN-PAGE 
to resolve the oxidative phosphorylation (OXPHOS) complexes. The gels were subjected to either 
coomassie- or silver staining to show the effect of the RNAi on CI (Figure 3.3A-BB). We focused on UAS-
RNAi lines that specifically destabilized CI rather than generally affecting the other complexes, since 
knockdown of known CIAFs only reduce CI (Figure 3.1E). After screening 292 UAS-RNAi lines, we 
identified three hits that destabilized CI: Cora (Figure 3.3M Lane 107), CG10543 (Figure 3.3Q Lane 166), 
and Drosophila Fragile Mental Retardation 1 Protein (dFMRP) (Figure 3.3AA Lane 279). However, other 
RNAi’s targeting the same proteins did not produce similar phenotypes. We speculate that this could be 
due to the RNAi’s not effectively knocking down the protein levels.  
To confirm the knockdown at protein levels, we crossed the three RNAi’s that target FMR1 
(Bloomington Stock #’s: 27484, 35200, and 34944) to their respective Gal4’s and performed a western blot 
on whole cell lysates of fly thoraxes (Figure 3.3CC). Before dissecting the flies, we aged them for 72 hours 
as the offspring of the RNAi that produced the CI phenotype died before 4 days. The RNAi that causes CI 
deficiency, Bloomington Stock #34944, showed a 90% knockdown efficiency in comparison to the other 
RNAi’s which showed a 50% knockdown efficiency (Figure 3.3CC). We also looked at dNDUFS3 protein 
levels in these flies and found it to be absent in the #34944 stock (Figure 3.3CC). We were not able to find 
antibodies that cross-react with Cora or CG10543, therefore from here on we focused on dFMRP.  
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Because we were not able to confirm the CI phenotype with an alternative RNAi, we decided to try 
CRISPR interference (CRISPRi) in Drosophila flight muscles to decrease the protein levels of dFMRP. The 
sgRNA was designed for dead CAS9 (dCAS9) to target the first intron of dFMRP and silence transcription 
levels. However, protein levels of dFMRP were not significantly reduced and no CI phenotype was present 
(Figure 3.4A-3.4D). Additionally, efforts were made to knockdown the mammalian orthologues of dFMRP 
(FMRP and FXR1) in cell lines, but an efficient knockdown could not be achieved for any of the proteins to 
observe a CI deficiency (Figure 3.4E-3.4O). Ongoing collaboration with Dr. Richard Kitsis will test the 
mouse orthologues in vivo.  
To confirm the mass spectrometry results that dFMRP interacts with NDUFS3, we followed the 
same co-IP protocol that was initially used to identify NDUFS3 interactors. We isolated whole tissue lysates 
from thoraxes of Mhc-Gal4<UAS-NDUFS3-HA offspring aged to 24 hours and 48 hours after eclosing and 
performed co-IP. We hypothesized that dFMRP also interacts with dNDUFS3 at 48 hours since early 
biogenesis of CI happens from 0 to 48 hours in adult flies (Garcia et al., 2017). Anti-HA-beads were digested 
with SDS-buffer, subjected to immunoblot analysis and probed with anti-dFMRP. A band between the 75 
and 100 kDa marker was identified in both 24 and 48 hour time points (Figure 3.3DD). The size of this 
band corresponds with the mass spectrometry results which identified a dFMRP isoform whose size is 81 
kDa.  
 
Knockdown of dFMRP destabilizes CI and reduces fly lifespan 
MhcGal4<UAS-dFMRPRNAi(BL#34944) (Henceforth referred to as Mhc<dFMRPRNAi) offspring died 
within four days when incubated at 25°C. To track the exact lifespan of these flies, we monitored their 
survival rates after eclosing into adults. Every 12 hours, we checked the vials and recorded the percentage 
of flies that were still alive. At 48 hours, we began to see the survival rate decrease. By 60 hours, 50% of 
the offspring were dead and by 84 hours 100% of the flies had died (Figure 3.5A). To assess the protein 
expression levels of dFMRP throughout its lifespan, cell lysates from whole thorax tissues aged to 6, 24, 
and 48 hours were subjected to western blot and probed with anti-dFMRP (Figure 3.5B). At 6 hours, ~25% 
of dFMRP was present, followed by ~20% at 24 hours and ~10% at 48 hours. Next, we checked if 
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Mhc<dFMRPRNAi offspring have a reduction in the structure of CI at an earlier timepoint where ~20% of the 
protein is still present. We isolated mitochondria from Mhc<dFMRPRNAi thoraxes aged to 24 hours, 
solubilized their membranes in 4g of digitonin to 1g of protein, and performed BN-PAGE. Coomassie- and 
silver-stained native gels showed a significant reduction in CI. To further assess the extent of the CI 
deficiency, in-gel activity assay was performed, and revealed a reduction in CI activity in Mhc<dFMRPRNAi 
flies aged to 6, 24 and 48 hours (Figure 3.5E). Altogether, these results indicate that dFMRP is essential 
for the viability of the flies and is important for the stability of the CI holoenzyme. Accordingly, we decided 
to elucidate the mechanisms of CI assembly in Mhc<dFMRPRNAi offspring. 
 
Disruption of dFMRP in flight muscles impairs CI assembly 
We have established a Drosophila model system to study the assembly of CI, where we showed 
the four assembly intermediates, the N-, Q-, P proximal- (PP), and P distal-(PD) modules, come together in 
a step-by-step procedure (Garcia et al., 2017). We generated individual knockdown strains of Drosophila 
for each subunit of CI and determined at which assembly step the subunit is indispensable. An antibody 
against NDUFS3, an early component of the Q-module, was used to track the Q-module building up from 
the 315-kDa assembly intermediate (Q-module) to 550-kDa (Q + PP -modules) and then 815-kDa (Q + PP 
+ PD -modules) on BN-PAGE. The stalling or accumulation of the assembly process at one of these 
milestones indicated that the subunit being knocked down is essential to advance to the next step. We also 
reported a new 700-kDa assembly intermediate in the process between 550- and 815-kDa, where we 
speculate individual subunits rather than an entire module bound the 550-kDa before the PD was added. 
Using this model, we examined whether dFMRP is an assembly factor required for the CI assembly. 
To test, we isolated mitochondria from Mhc<dFMRPRNAi offspring at the 24 hour timepoint and examined 
CI assembly via western blotting of native complexes. We used an antibody to NDUFS3 to track the Q-
module (Figure 3.6A). As expected, the protein levels of both holoenzyme CI and the CI-Complex III (CI-
CIII) supercomplex were reduced in flies when dFMRP was disrupted (Figure 3.6B). At a longer exposure, 
a reduction in the 815-kDa assembly intermediate and an increase in the 550- and 700-kDa assembly 
intermediates were observed, suggesting that dFMRP was the key component to achieve the 815 kDa from 
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the 550- and 700-kDa assembly intermediates (Figure 3.6B). To better understand the misassembly of CI 
in dFMRP knockdown flies, we used antibodies to other CI subunits to analyze the other modules. We used 
an antibody to dND3, a mitochondria-encoded subunit and a part of the PP-module assembly, to track the 
PP-module (Figure 3.6A) (Guerrero-Castillo et al., 2017). Anti-dND3 did not detect the CI-CIII supercomplex 
but showed a strong reduction of the CI holoenzyme in dFMR1 knockdown flies aged to 24 hours (Figure 
3.6C). In a longer exposure, the 815-kDa assembly intermediate was reduced but the smaller assembly 
intermediates including the 700- and 550-kDa were accumulated, in agreement with the observation with 
anti-NDUFS3 (Figure 3.6C). Additionally, anti-dND3 detected additional bands below the 550-kDa 
assembly intermediate that also were increased (Figure 3.6C). We believe these bands are assembly 
intermediates that contain portions of the PP-module. Because the exact subunits that make up these bands 
have not been characterized, we termed them as lower assembly intermediates (L.A.I).  
The assembly intermediates for the PD- and N-modules have not been well characterized in 
Drosophila. Therefore, we aged Mhc<dFMRPRNAi offspring to various times (6, 24, and 48 hours) to track 
bona fide assembly intermediates of these modules. To identify assembly intermediates of the PD-module 
we used antibodies against the mitochondria-encoded subunit dND5 and the nuclear-encoded CI subunit 
dNDUFB5, previously shown to initiate the biogenesis of the PD-module in mammalian system (Figure 
3.6A) (Guerrero-Castillo et al., 2017). The holoenzyme CI and the CI-CIII supercomplex were reduced in 
Mhc<dFMRPRNAi offsprings when probed with these antibodies (Figure 3.6D and 3.6E). Interestingly, the 
48 hour time point showed the strongest reduction of CI which coincides with the time point at which these 
flies begin to die. Contrary to the expectation, none of the antibodies detected the 815-kDa assembly 
intermediate in wild-type (W1118) or dFMRPRNAi samples, although the PD-module is known to be a part of 
it. One explanation could be that the epitopes for dND5 and dNDUFB5 were not accessible to the antibodies 
within the 815-kDa assembly intermediate. Alternatively, the assembly is stalled before the formation of the 
815-kDa assembly intermediate due to the disruption of dFMRP. Similar to the immunoblot against dND3, 
several L.A.I. below the 815-kDa assembly intermediate were observed. It is possible that some or all of 
the L.A.I are degraded products of a larger assembly intermediate, especially when we don’t observe the 
same size proteins in the wildtype. However, this question remains to be further investigated. 
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To track assembly intermediates of the N-module, we used an antibody against dNDUFV1, a CI 
nuclear-encoded core subunit part of the N-module (Figure 3.6A). As expected, both CI and CI-CIII 
supercomplex were reduced in Mhc<dFMRPRNAi offspring (Figure 3.6F). The N-module is the last piece to 
be added to CI to form the holoenzyme, therefore we don’t expect to detect the 815-kDa assembly 
intermediate with this antibody. In dFMR1 knockdown flies we observed an L.A.I band at the 6 and 24 hour 
and faintly at 48 hour time points that were not present in wild-type flies (Figure 3.6F). Again, this L.A.I may 
indicate that due to dFMRP disruption the N-module assembly is stalled; alternatively, there is a possibility 
that this L.A.I is also a degradation product, Taken together, these results indicate that dFMR1 regulates 
the biogenesis of CI assembly intermediates at the level of Q-, PP-, PD- and N-modules during CI assembly 
in Drosophila flight muscles. 
 
The PD-module regulator, Foxred1, is downregulated in Mhc<dFMRPRNAi offspring 
We have previously shown that in Drosophila, the knockdown of CI subunits that form the N-module 
leads to an accumulation of the 815-kDa assembly intermediate vs. a reduction which has been shown in 
both Q- and P-modules (Garcia et al., 2017). Given that information, a reduction of the 815-kDa assembly 
intermediate suggested that the misregulation of CI was occurring at the Q- or P-modules in flies as a result 
of dFMRP disruption rather than the N-module. To identify the module that is being misregulated, we 
measured the protein expression levels of known CI assembly factors (CIAFs) that regulate the Q- and P-
modules (Figure 3.7A). We chose to test CIAFs based on the finding that the knockout of certain CIAFs in 
mammalian cells led to the downregulation of CI subunits that belong to the specific modules those CIAFs 
interact with (Stroud et al., 2016). Therefore, we hypothesized that if any assembly factor is downregulated, 
then the module it regulates would be affected. We aged Mhc<dFMRPRNAi offspring to 6, 24, and 48 hour 
time points, collected cell lysates from thoraxes, and performed western blot. We probed for dNDUFAF5, 
known to regulate the Q-module, and found a slight increase of expression at 48 hours (Figure 3.7B). We 
also assessed the protein expression of dACAD9, dECSIT, dNDUFAF1, and dTIMMDC1, known to regulate 
the PP-module. Minimal changes in protein levels was detected in dACAD9, dECSIT, and dNDUFAF1, 
however at 48 hours dTIMMDC1 was substantially reduced (Figure 3.7C). Finally, the protein expression 
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of dFOXRED1, a regulator of the PD-module, was measured. To our surprise, dFoxred1 was reduced at 6 
and 24 hours and undetectable at 48 hours (Figure 3.7D). These results indicate that the disruption of 
dFMRP leads to the misassembly of CI by the reduction of TIMMDC1 or Foxred1, located in either PP- or 
PD-module respectively. However, further confirmation is necessary, especially to rule out the possibility of 
RNAi off-target effect. 
 
Discussion 
In this chapter, we screened the interactors of NDUFS3, a Q module core subunit, to identify novel 
CIAFs of CI assembly. The existing models of CI assembly have considerable weaknesses especially when 
trying to identify novel regulators of CI biogenesis such as CIAF. For instance, CIAFs and several CI 
assembly intermediates found in mammalian CI are not conserved in N. crassa and Arabidopsis thaliana 
(Duarte et al., 1995) (Clark et al., 2006; Yun et al., 2014) (Park et al., 2006) (Hu et al., 2011).  
Here we demonstrate that Drosophila melanogaster is an ideal model to study the regulators of CI 
biogenesis. (i) The flight muscles of Drosophila are highly enriched with mitochondria (Figure 3.1B). (ii) 
The widely available genetic tools, relatively short lifespan and high fertility of Drosophila allow both loss- 
and gain-of function experiments to be performed rather easily (Figure 3.1C and 3.1D). (iii) CI assembly 
can be analyzed in vivo in the flight muscles. (iv) CI assembly in Drosophila is conserved with mammalian 
CI assembly and contains 42 of the 44 subunits (Figure 3.1A) and (v) several of the CIAFs are present in 
Drosophila and have been shown have a conserved function (Figure 3.1E). Thus, we used the Drosophila 
model system to identify regulators of CI assembly.  
Our approach of identifying interactors of the CI subunit NDUFS3 in Drosophila involved a screen 
of 175 proteins via RNAi knockdowns, through which we identified three potential hits that regulate the 
stability of CI: Cora, CG10543, and dFMRP. We followed up with dFMRP for the fact that all isoforms of 
dFMRP were knocked down in the Mhc<dFMRPRNAi thoraxes, as well as the availability of a cross-reacting 
antibody.  
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While the primary method of dFMRP knockdown in our model was RNAi, RNAi methods pose a 
limitation of off-target effect (OTEs), warranting confirmation of the observed phenotypes using additional 
RNAi of the same target or alternative knockdown methods (Mohr et al., 2014). While we tested three 
different RNAi against dFMRP (Bloomington Stock #’s: 27484, 35200, and 34944), only one (BI# 34944) 
showed a robust knockdown. (Figure 3.3CC). To check for OTEs of BI#34944 RNAi, the following software 
(https://www.flyrnai.org/up-torr/) from the Harvard Medical School DRSC/TRIP functional genomics 
resources was used. The Bl #34944 RNAi is short hairpin with 21 base pairs in length. When we matched 
for sequences 15 base pairs in length or greater, no OTEs were reported. Alternatively, a query with the 
RNAi nucleotide sequence in NCBI Nucleotide Blast resulted in 100% match to the Fmr1, whereas any 
other matches were less than 70% and not assembly subunits.  
Unfortunately, our alternative knockdown attempts using CRISPRi and loss-of-function mutation in 
Drosophila did not reproduce the reduced CI and the lethal phenotypes we saw in Mhc<dFMRPRNAi 
offspring. In Drosophila, there are 11 different isoforms of dFMRP with the most cited one to have 10 exons 
and to be approximately 81 kDa (Mila et al., 2018; Oostra and Willemsen, 2009; Weisz et al., 2018). Some 
CRISPRi did result in the complete absence of the 81 kDa isoform as detected by western blot, but 
accumulations of lower bands were observed (Figure 3.4B). Considering that the sgRNA was designed to 
target only the first exon of dFmr1, it is possible that these lower bands are isoforms of dFMRP without the 
first exon of dFmr1, and are able to compensate for the lost isoform during CI assembly. The results from 
the loss-of-function dFmr1 mutant flies exhibited similar pattern as the CRISPRi flies; no reduction of CI by 
BN-PAGE and smaller isoforms of dFMRP detected by western blot, which could be the reason they are 
able to survive as opposed to the Mhc<dFMRPRNAi offsprings that die within three days (Dockendorff et al., 
2002). The limitations of the CRISPRi and the mutant fly inherently lies in that the dFMRP has so many 
isoforms. One way to combat this limitation would be to generate knockout lines using CRISPR-Cas9 or 
TALENs to ensure that the all isoforms of FMRP are knocked out. However, I expect that these flies would 
not eclose into adults since a strong knockdown of FMRP results in lethality shortly after hatching. 
Alternatively, advances in CRISPRi technology have allowed for multiple sgRNA’s to be used concurrently 
(up to 5) to target different nucleotide sequences on a gene. In the case where the knockout results in 
lethality, this method could prove to be a better option given that CRISPRi can be inducible in flies. On the 
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other hand, exogenous Drosophila FMRP or its respective mammalian orthologues can be overexpressed 
in Mhc<dFMRPRNAi offspring to see if it rescues the CI deficit. This could also help predict which mammalian 
orthologue is important for CI function. 
In addition, we used shRNA in mammalian cell culture to test the effect of knockdown in mammalian 
CI assembly. dFMRP has three mammalian orthologues: fragile X mental retardation 1 protein (FMRP) and 
the fragile X-related proteins 1 and 2 (FXR1 and FXR2) (Oostra and Willemsen, 2009).  We did not observe 
a CI reduction phenotype, which could be due to the fact that a strong enough knockdown could not be 
achieved in any of the orthologs. An alternate method would be to assess the CI assembly in mice, as 
whole body knockout mice are readily available for FMRP and FXR2 (Spencer et al., 2006). Additionally, 
creating a double knockout of FMRP and FXR2 might be necessary if a CI phenotype is not seen in the 
single knockout mice, since compensation mechanisms between these two proteins have been 
characterized (Spencer et al., 2006). For FXR1, another mammalian orthologue of dFMRP, the whole body 
knockout mouse is embryonic lethal; however, mice with loxP sites targeting FXR1 are available and can 
be crossed to Cre mice to create tissue specific knockouts (Mientjes et al., 2004). Since FXR1 is highly 
expressed in the muscle and heart, FXR1 should be knocked out in these tissues and CI should be analyzed 
by BN-PAGE (Mientjes et al., 2004). Overall, these future experiments will be crucial for confirming whether 
FMRP regulates CI function.   
 The observation of Foxred1 being absent from 6 to 48 hours was unexpected. Foxred1, an 
assembly factor, has been hypothesized to regulate the PD-module as revealed by complexome profiling 
(Guerrero-Castillo et al., 2017). The subunits that Foxred1 interacts with are NDUFB6, NDUFB5, 
NDUFB10, NDUFB11, NDUFB1 and the mitochondria-encoded subunit ND4. Interestingly, knockdown of 
each of these subunits by RNAi in flies revealed a similar pattern of assembly intermediates compared to 
that of Mhc<dFMRPRNAi offspring when tracking the CI assembly via NDUFS3. In Mhc<dFMRPRNAi 
offspring, BN-PAGE followed by immunoblot analysis with anti-NDUFS3 showed a stalling at the 815-kDa 
assembly intermediate which led to the accumulation of the 700-, 550-, and 315-kDa assembly 
intermediates (Garcia et al., 2017). In addition, in patients mutations in Foxred1, a decrease in the 815-kDa 
assembly intermediate and an accumulation of L.A.I has been shown, similar to the pattern of 
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Mhc<dFMRPRNAi offspring (Formosa et al., 2015). These results overall have suggested that the 
destabilization of CI in Mhc<dFMRPRNAi offspring is due to the mis-assembly of the PD-module. To further 
characterize this, it would be interesting to see if dFMRP interacts with Foxred1 or any other subunits that 
Foxred1 makes an assembly intermediate with. If it does, one could hypothesize that dFMRP forms an 
assembly intermediate with Foxred1 and the subunits that interact with Foxred1. This could be tested by 
performing complexome profiling to check if dFMRP co-migrates with the PD-module. Alternatively, it would 
be interesting to test if FMRP binds to and regulates the transcripts of the PD-module subunits, given that 
FMRP is an RNA binding protein.   
In summary, we have identified three potential new regulators of CI assembly in Drosophila flight 
muscles, and described the mis-assembly process for dFMRP. To fully characterize the role of dFMRP, it 
will be important to analyze whether it directly interacts with CI in the mitochondria or it regulates its subunits 
from the outside of the mitochondria. In conclusion, it will be important to confirm that each of these hits are 






Materials and Methods 
Drosophila Strains and Genetics.  
The following fly stocks were used: y w; Dmef2-Gal4 and w; mhc-Gal4 were the Gal4 transgenic lines used 
to express RNAi lines in muscles. w1118/mhc-Gal4 flies were used as wildtype (wt) controls. To test CI 
assembly factors, the following fly stocks were ordered from the Bloomington Drosophila Stock Center 
(https://bdsc.indiana.edu/): 55660 (dNDUFAF1RNAi), 31160 (dNDUFAF2RNAi), 51894 (dNDUFAF3RNAi), 
51879 (dNDUFAF4RNAi), 55332 (dNDUFAF6RNAi), 51873 (dNUBPLRNAi), and 42608 (dFoxred1RNAi). Other 
assembly factors were ordered from the National Institute of Genetics (NIG, Japan) Drosophila Stock 
Center https://shigen.nig.ac.jp/fly/nigfly/: 17726R-3 (dNDUFAF5RNAi), 9852R-1 (dTIMMDC1RNAi). The UAS-
NDUFS3-HA stock was ordered from FLYORF at 
https://www.flyorf.ch/imlskonakart/SelectProd.do;jsessionid=43121D3655A6E110BCEAE6AC49E7C416?
prodId=4620&manufacturer=IMLS&category=all&name=F003000&model=Fruitfly. Stocks that were 
screened were ordered from the Bloomington Drosophila Stock Center (https://bdsc.indiana.edu/). The 
Bloomington stock number can be found in table 3.2 for each respective protein.  
 
Mitochondria Purification.  
Mitochondrial purification was performed essentially as described by Rera et al 2012 (Rera et al., 2011). 
Thoraxes were dissected and gently crushed with a pestle homogenizer in 500µl of pre-chilled mitochondrial 
isolation buffer containing 250 mM sucrose and 0.15 mM MgCl2 in 10 mM Tris.HCl, pH 7.4, on ice. After 
two rounds of centrifugation at 500g for 5 minutes at 4°C to remove insoluble material, the supernatant was 
recovered and centrifuged at 5000g for 5 minutes at 4°C. The pellet which is enriched for mitochondria was 
washed twice in the mitochondrial isolation buffer and stored at -80°C until further processing.  
 
Blue Native Polyacrylamide Gel Electrophoresis (BN-PAGE).  
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BN-PAGE was performed using NativePAGE gels from Life Technologies, following the manufacturer’s 
instructions. Essentially, mitochondria were suspended in native PAGE sample buffer (Life Technologies) 
supplemented with 1% digitonin and protease inhibitors, and incubated on ice for 20 minutes. Following 
centrifugation at 20,000g for 30 minutes, the supernatant was recovered, mixed with the G-250 sample 
additive (Life Technologies) and Native PAGE Sample Buffer (Life Technologies), and loaded onto 3–12% 
pre-cast Bis–Tris Native PAGE gels (Life Technologies). The NativeMark Protein standard (Life 
Technologies), run together with the samples, was used to estimate the molecular weight of the protein 
complexes. Electrophoreses was performed using the Native PAGE Running buffer (as anode buffer, from 
Life technologies) and the Native PAGE Running buffer containing 0.4% Coomassie G-250 (cathode 
buffer). Gels were stained with the Novex Colloidal Blue staining kit (Life Technologies) to reveal the protein 
complexes.  
 
Silver Staining.  
Silver staining of native gels was performed with the SilverXpress staining kit from Life Technologies, 
following the manufacturer’s protocol.  
 
In-gel Complex I Activity. 
Complex I activity in native gels was performed by incubating the native gels in 0.1 mg/ml NADH, 2.5 mg/ml 
Nitrotetrazolium Blue Chloride, 5 mM Tris-HCl (pH 7.4) overnight at room temperature.  
 
In-gel Complex II Activity. 
Complex II activity in native gels was performed by incubating the native gels in 50 mM sodium 





For immunoblotting of samples in native gels, protein complexes from native gels were transferred to PVDF 
membranes (BIORAD). For immunoblotting of samples in whole tissue lysates, thoraxes were homogenized 
in RIPA buffer (150 mM NaCl, 1% Triton X-100, 0.5% Sodium Deoxycholate, 0.1% SDS, 50mM Tris HCl, 
pH 8) supplemented with Halt protease inhibitors (Pierce), resolved on mini-PROTEAN TGX stain-free gels 
from BIO-RAD, and transferred to PVDF membranes. In both instances (native and non-native gels), the 
membrane was subsequently blocked in 5% (w/v) non-fat dry milk in Tris-buffered saline (TBS) for 
30minutes, and incubated in the appropriate primary antibody dissolved in 2% BSA, 0.1% Tween 20 in TBS 
(TBST) overnight at 4°C. Following the overnight incubation, the blot was rinsed 4X10 minutes in 
0.1%TBST, blocked for 30 minutes in 5% (w/v) non-fat dry milk in TBST and incubated for two hours with 
the appropriate HRP-conjugated secondary antibody dissolved in 2% BSA, 0.1% Tween 20 in TBS (TBST). 
After incubation in the secondary antibody, samples were rinsed 4X10 minutes in 0.1%TBST. 
Immunoreactivity was detected by enhanced chemiluminescence (ECL) and analyzed by a ChemiDoc Gel 
imaging system from BIO-RAD. Antibodies used were anti-NDUFS3 (abcam, ab14711), anti-ND1 (abcam, 
ab74257), anti-HA (Thermofisher PA1-985), anti-dFMRP (abcam, ab10299), and anti-actin (EMD Millipore, 
MAB1501). Additional antibodies used were anti-dSDHA, anti-dND5, anti-dNDUFB5, anti-dNDUFV1, anti-
dTIMMDC1, anti-dNDUFAF1, anti-dECSIT, anti-dACAD9, anti-dNDUFAF5, and anti-dFoxred1 which were 
generated by the Edward Owusu-Ansah lab. 
 
LC-MS/MS Analysis  
The concentrated peptide mix was reconstituted in a solution of 2 % ACN, 2 % Formic acid (FA) for MS 
analysis. Peptides were eluted from the column using a Dionex Ultimate 3000 Nano LC system with a 10 
min gradient from 2% buffer B to 35 % buffer B (100 % ACN, 0.1 % FA). The gradient was switched from 
35 % to 85 % buffer B over 1 min and held constant for 2 min. Finally, the gradient was changed from 85 
% buffer B to 98 % buffer A (100% water, 0.1% FA) over 1 min, and then held constant at 98 % buffer A for 
5 more minutes. The application of a 2.0 kV distal voltage electrosprayed the eluting peptides directly into 
the Thermo Fusion Tribrid mass spectrometer equipped with an EASY-Spray source (Thermo Scientific). 
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Mass spectrometer-scanning functions and HPLC gradients were controlled by the Xcalibur data system 
(Thermo Finnigan, San Jose, CA).  
 
Database Search And Interpretation Of MS/MS Data  
Tandem mass spectra from raw files were searched against a Drosophila protein database using the 
Proteome Discoverer 1.4 software (Thermo Finnigan, San Jose, CA). The Proteome Discoverer application 
extracts relevant MS/MS spectra from the .raw file and determines the precursor charge state and the 
quality of the fragmentation spectrum. The Proteome Discoverer probability-based scoring system rates 
the relevance of the best matches found by the SEQUEST algorithm. The Drosophila protein database was 
downloaded as FASTA-formatted sequences from Uniprot protein database (database released in May, 
2015). The peptide mass search tolerance was set to 10ppm. A minimum sequence length of 7 amino acids 
residues was required. Only fully tryptic peptides were considered. To calculate confidence levels and false 
positive rates (FDR), Proteome Discoverer generates a decoy database containing reverse sequences of 
the non-decoy protein database and performs the search against this concatenated database (non-decoy 
+ decoy). Scaffold (Proteome Software) was used to visualize searched results. The discriminant score 
was set at less than 1% FDR determined based on the number of accepted decoy database peptides to 




60 flies per genotype were collected and placed in 3 vials of food with approximately 20 flies each. The 
amount of flies alive was recorded for in each vial every 12 hours. The survival rate was calculated by (the 
amount of flies alive in each vial / 20 (initial amount of flies in the vial)). The average was taken from the 3 
vials at each time point for each genotype and was plotted using GraphPad Prism software. 
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Co-Immunoprecipitation (co-IP) Analysis 
20 whole fly thoraxes were blended in  200 ul of NP-40 lysis buffer (25 mM Tris-HCL [pH 7.5], 150 mM 
NaCl, 5 mM EDTA, 1% (v/v) NP-40, 5% (v/v) Glycerol, 1 mM DTT supplemented with protease inhibitors 
[Thermofisher]) or 200 ul of digitonin lysis buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 4g:1g (digitonin 
: protein ratio) supplemented with protease inhibitors [Thermofisher]). Tubes were placed on ice for 30 
minutes. Cell lysate was centrifuged at 20,000 x g for 10 min at 4°C. The supernatant was transferred to a 
a new tube and 300 ul of dilution buffer ([NP-40: 25 mM Tris-HCL [pH 7.5], 150 mM NaCl, 5 mM EDTA, 5% 
(v/v) Glycerol, 1 mM DTT]; [Digitonin 50 mM Tris-HCl [pH 7.5], 150 mM NaCl]) was added to the 
supernatant. 50 ul of control agarose beads were added and rotated for 1 hour at 4°C. Samples were 
centrifuged at 2500g for 2 minutes to collect control agarose beads. Lysates were pipetted into 50 ul of anti-
HA beads and rotated overnight in the 4°C. The beads were washed three times with 1000ul of lysis buffer 
at 4°C. Control and anti-HA agarose beads were sent for mass spectrometry to identify interactors of 
NDUFS3-HA. To check the binding of dFMRP, samples were eluted using 60 ul of 1X SDS-loading sample 
buffer and heated to 95°C for 10 minutes. Samples were then subjected to immunoblot analysis and probed 
with anti-dFMRP. 
 
Transfection of shRNA plasmids 
shRNA plasmids were ordered from Origene (FMR1 sRNA plasmid # 312955; FXR1 shRNA plasmid 
#312890). Origene transfection protocol was followed step-by-step. To check transfection efficiency, cells 




Figure 3.1: Drosophila flight muscles are suitable for identifying novel regulators of complex I 
biogenesis. 
(A) Drosophila complex I is comparable to mammalian complex as it contains 42 of the 44 subunits. 
Schematic representation of how the 44 distinct subunits of bovine or ovine CI are arranged to produce the 
L-shaped topology; based on recent CI structures described (Fiedorczuk et al., 2016; Vinothkumar et al., 
2014; Zhu et al., 2016; Zickermann et al., 2015). The asterisk denotes subunits for which an ortholog was 
not identified in Drosophila by DIOPT. NDUFAB1 occurs twice in the complex, giving rise to a total of 45 
subunits. 
(B) Drosophila flight muscles are rich in mitochondria. Drosophila flight muscles from wildtype flies stained 
with phalloidin (red) to mark the sarcomeres, and expressing GFP tagged with a nuclear localization signal 
in (A) or GFP with a mitochondrial targeting signal in (B). (C) Adult fly showing position of flight muscles 
(thorax) in region demarcated.  
(C) Drosophila have a short life cycle. Schematic representation showing the life cycle of flies. Flies take 
10 days from egg to eclose into adult flies. The survival span of flies is approximately 3 months.   
(D) Several advanced genetic tools have been established by the Drosophila community. This includes 
access to 1000s of RNAi’s available from stock centers around the world, easy manipulation of genes using 
the Gal4/UAS system, as well as cost efficiency compared to mammalian models.  
(E) Several assembly factors in mammalian systems are functionally conserved in Drosophila. BN-PAGE 
(left panel) and Silver staining (right panel) of samples from thoraxes following RNAi-mediated knockdown 
of assembly factor proteins, dNDUFAF1, dNDUFAF2, dNDUFAF3, dNDUFAF4, dNDUFAF5, dNDUFAF6, 
dNUBPL, dTIMMDC1, dFoxred1. CI-CIII denotes the complex I-complex III supecomplex, CV2 denotes a 
dimer of complex V respectively, CI denotes complex I, CV denotes complex V, CIII denotes complex III, 
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Figure 3.2: Identifying interactors of CI in Drosophila flight muscles. 
(A) Summary of the experimental procedure for identifying interactors of the CI nuclear-encoded subunit 
dNDUFS3. (1) dNDUFS3-HA flies were generated using the Gal4-UAS system. (2) dNDUFS3-HA was 
expressed in the Drosophila thoraxes and dissected for co-immunoprecipitation (Co-IP). (3) Co-IP was 
performed with anti-HA agarose beads to identify interactors to NDUFS3. (4) Two different lysis buffers 
(NP-40 and digitonin) identified a total of 385 putative interactors. 237 were identified in both buffers, 68 
were found in NP-40 buffer and 80 were present in the digitonin buffer. (5) Of these 385, 175 proteins were 
selected to be screened. (6) In total 292 RNAi’s were ordered from the Bloomington Drosophila Stock 
Center. More than 1 RNAi was ordered for each protein if available. 
(B) Schematic representation of mammalian CI representing the CI subunits that interacted with NDUFS3 
after mass spectrometry analysis. The subunits in red indicate that they interacted with NDUFS3. They are 
NDUFV1, NDUFV2, NDUFS1, NDUFA9, NDUFS7, NDUFS2, NDUFS8, and NDUFA10. NDUFS3 is 
encoded in yellow.  
(C) To check the expression of HA in Mhc-Gal4<UAS-dNDUFS3-HA flies aged to 24 hours, 10 thoraxes 
were lysed in SDS-PAGE buffer and subjected to western blot and probed with an HA antibody. 
(D) To check to see if NDUFS3-HA gets incorporated into the holoenzyme of CI during CI biogenesis, we 
isolated mitochondria from 10 Mhc-Gal4<UAS-dNDUFS3-HA thoraxes aged to 6 or 24 hours, 
permeabilized their membranes in 1% digitonin and performed a BN-PAGE. To track the assembly of CI 
we performed a western blot and probed with anti-ND1 (middle panel) and anti-NDUFS3 (right panel) to 
track the CI-CIII supercomplex, CI, 815 kDa-, 550 kDa- and 315 kDa assembly intermediates respectively. 
To see if NDUFS3-HA gets incorporated into the complex, we probed with anti-HA (left panel) and 
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Figure 3.3: Screening interactors of the dNDUFS3 CI subunit identifies dFMRP as a regulator for CI 
biogenesis. 
(A-BB) 292 RNAi’s to interacting proteins of dNDUFS3 were expressed in flight thoraxes using either the 
Dmef2- or Mhc- Gal4 and aged for 5-7 days. We isolated mitochondria from 10 thoraxes, permeabilized 
their membranes in 1% digitonin and performed BN-PAGE. The complexes were resolved by either 
coomassie- or silver staining. Each lane is numbered and corresponds to the RNAi’s ordered from the 
Bloomington Stock Center found in Table 3.2. CI-CIII denotes the complex I-complex III supecomplex, CV2 
denotes a dimer of complex V respectively, CI denotes complex I, CV denotes complex V, CIII denotes 
complex III, CIV denotes complex IV, and CII denotes complex II. 
(CC) Western blot showing the protein levels of FMRP in flies expressing RNAi’s that target FMRP in the 
flight muscles. All flies were aged for 72 hours. The protein expression levels of dNDUFS3 and the complex 
II subunit dSDHA were also analyzed in these flies. 
(DD) The interaction between dNDUFS3-HA and dFMRP was confirmed via western blot analysis. Co-IP 
was performed using anti-HA agarose beads in NP-40 lysis buffer on thoraxes from Mhc-Gal4<UAS-
dNDUFS3-HA aged to 24 hours and 48 hours. Beads were lysed in SDS-PAGE buffer, subjected to 
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Figure 3.4: Alternative methods used to disrupt dFMRP and mammalian orthologues to confirm CI 
phenotype. 
(A) Table of the lane number of each genotype to be used as reference for Figures 3.7B-3.7D. 
MhcGal4<UAS-cas9 was used as control. 
(B) SDS-PAGE of whole lysates to check FMRP expression. Note lane 4 shows a reduction in the 81 kDa 
isoform of dFMRP that causes an increase in lower isoforms. Actin was used as a loading control. 
(C) Natve PAGE followed by silver-staining of mitochondria isolated from thoraxes in 4g:1g protein to 
digitonin ratio (protein:digitonin) to analyze respiratory chain complexes 
(D) Native PAGE followed by western blot probed with anti-NDUFS3 to analyze holoenzyme CI and 
assembly intermediates. Anti-SDHA (CII) is used as a loading control 
(E-F) Knockdown of FXR1 after a transfection of 48 and 72 hours in HeLa cell lines. SC=scrambled shRNA; 
A,B,C,D= different shRNA plasmids targeting FXR1; Mix = 1:1:1:1 ratio of A-D shRNAs; NT = cells not 
treated with any shRNA. Actin was used as a loading control. 
(G-H) Knockdown of FXR1 after a transfection of 48 and 72 hours in C2C12 cell lines. SC=scrambled 
shRNA; A,B,C,D= different shRNA plasmids targeting FXR1; NT = cells not treated with any shRNA. Actin 
was used as a loading control. 
(I-K) Knockdown of FMR1 after a transfection of 24, 48, and 72 hours hours in C2C12 Cell lines. 
SC=scrambled shRNA; A,B,C,D= different shRNA plasmids targeting FXR1; Mix = 1:1:1:1 ratio of A-D 
shRNAs; NT = cells not treated with any shRNA. Actin was used as a loading control. 
(L-M) Knockdown of FMR1 after a transfection of 48 and 72 hours in HeLa cell lines. SC=scrambled shRNA; 
A,B,C,D= different shRNA plasmids targeting FXR1; Mix = 1:1:1:1 ratio of A-D shRNAs; NT = cells not 
treated with any shRNA. Actin was used as a loading control. 
(N-O) Knockdown of FMR1 after a transfection of 48 and 72 hours in C2C12 cell lines. SC=scrambled 
shRNA; A,B,C,D= different shRNA plasmids targeting FXR1; NT = cells not treated with any shRNA. Actin 
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Figure 3.5: Knockdown of dFMRP destabilizes CI and reduces lifespan. 
(A) Survival curve showing the percentage of flies surviving per hours. The blue bar indicates 
Mhc<dFMRPRNAi and the green bar indicates Mhc<W1118. 
(B) Western blot showing the protein levels of Mhc<dFMRPRNAi flies aged to 6, 24, and 48 hours compared 
to Mhc<W1118. Anti-dFMRP was used to detect dFMRP. Anti-actin was used as a loading control. 
(C) BN-PAGE of Mhc<W1118 and Mhc<dFMRPRNAi flies aged to 24 hours. CI-CIII denotes the complex I-
complex III supecomplex, CV2 denotes a dimer of complex V respectively, CI denotes complex I, CV 
denotes complex V, CIII denotes complex III, CIV denotes complex IV, and CII denotes complex II. 
(D) Silver Stainining of Mhc<W1118 and Mhc<dFMRPRNAi flies aged to 24 hours. CI-CIII denotes the 
complex I-complex III supecomplex, CV2 denotes a dimer of complex V respectively, CI denotes complex 
I, CV denotes complex V, CIII denotes complex III, CIV denotes complex IV, and CII denotes complex II. 
(E) CI in-gel activity of Mhc<W1118 and Mhc<dFMRPRNAi aged to 6, 24, and 48 hours. CII in-gel activity 
was also detected for loading control. CI-CIII denotes the complex I-complex III supecomplex, , CI 
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Figure 3.6: Disruption of dFMRP in flight muscles impairs CI assembly. 
(A) Schematic representation of mammalian CI representing the antibodies to CI subunits (depicted in red) 
used to track the assembly of the modules of CI. dNDUFV1 was used to detect the N-module, dNDUFS3 
was used to detect the Q-module, dND3 was used to detect the PP-module, and dNDUFB5 and dND5 were 
used to detect the PD-module. 
(B) Immunoblots probed with anti-NDUFS3 of samples obtained from wildtype and mhc>dFMRPRNAi   
thoraxes of flies aged for 24 hours after eclosure. Left panel shows short exposure timepoint. Note a 
decrease in the CI-CIII supercomplex and holoenzyme of CI in mhc>dFMRPRNAi thoraxes. Right panel 
shows long exposure timepoint to reveal assembly intermediates. 815-, 700-, 550-, and 315 kDa assembly 
intermediates were detected. Note a decrease in the 815 kDa assembly intermediate and increase in the 
700- and 550 kDa assembly intermediates in mhc>dFMRPRNAi thoraxes. Anti-SDHA was used as a loading 
control. 
(C) Immunoblots probed with anti-dND3 of samples obtained from wildtype and mhc>dFMRPRNAi   thoraxes 
of flies aged for 24 hours after eclosure. Left panel shows short exposure time point. Note a decrease in 
the holoenzyme of CI in mhc>dFMRPRNAi thoraxes. Right panel shows long exposure time point to reveal 
assembly intermediates. 815-, 700-, and 550 kDa assembly intermediates were detected. Note a decrease 
in the 815 kDa assembly intermediate and increase in the 700- and 550 kDa assembly intermediates in 
mhc>dFMRPRNAi thoraxes. Also, additional assembly intermediates were detected and termed lower 
assembly intermediates (L.A.I.). Anti-SDHA was used as a loading control. 
(D) Immunoblots probed with anti-dND5 of samples obtained from wildtype and mhc>dFMRPRNAi   thoraxes 
of flies aged for 6, 24, and 48 hours after eclosure. Left panel shows short exposure time point. Note a 
decrease in the holoenzyme of CI and CI-CIII supercomplex in mhc>dFMRPRNAi thoraxes. Right panel 
shows long exposure time point to reveal lower assembly intermediates (L.A.I.). Note an overall increase 
in L.A.I. along with additional bands that may be degradation products from L.A.I. Anti-SDHA was used as 
a loading control. 
(E) Immunoblots probed with anti-dNDUFB5 of samples obtained from wildtype and mhc>dFMRPRNAi   
thoraxes of flies aged for 6, 24, and 48 hours after eclosure. Left panel shows short exposure time point. 
Note a decrease in the holoenzyme of CI and CI-CIII supercomplex in mhc>dFMRPRNAi thoraxes. Right 
157
panel shows long exposure time point to reveal lower assembly intermediates (L.A.I.). Note an overall 
increase in L.A.I. along with additional bands that may be degradation products from L.A.I. Anti-SDHA was 
used as a loading control. 
(F) Immunoblots probed with anti-dNDUFV1 of samples obtained from wildtype and mhc>dFMRPRNAi   
thoraxes of flies aged for 6, 24, and 48 hours after eclosure. Left panel shows short exposure time point. 
Note a decrease in the holoenzyme of CI and CI-CIII supercomplex in mhc>dFMRPRNAi thoraxes. Right 
panel shows long exposure time point to reveal lower assembly intermediates (L.A.I.). Note an overall 
















































































































































































































































































































































Figure 3.7: The PD-module regulator, Foxred1, is downregulated in Mhc<dFMRPRNAi offspring. 
(A) Schematic representation of the assembly of mammalian CI. The Q module binds to the PP-module 
followed by the addition of the PD-module. Finally, the N-module binds to the Q+P module to form the fully 
assembled holoenzyme of CI. Red dots depict the modules that known CIAFs are predicted to bind and 
regulate. 
(B) SDS-PAGE Immunoblots probed with known CIAFs that bind to the PP-module (anti-dTIMMDC1, anti-
dNDUFAF1, anti-dECSIT, and anti-dACAD9) of samples obtained from wildtype and mhc>dFMRPRNAi   
thoraxes of flies aged for 6, 24, and 48 hours after eclosure. Note a slight decrease in dTIMMDC1 at 48 
hours. 
(C) SDS-PAGE Immunoblots probed with known CIAFs that bind to the Q-module (anti-dNDUFAF5) of 
samples obtained from wildtype and mhc>dFMRPRNAi   thoraxes of flies aged for 6, 24, and 48 hours after 
eclosure.  
(D) SDS-PAGE Immunoblots probed with known CIAFs that bind to the PD-module (anti-dFoxred1) of 
samples obtained from wildtype and mhc>dFMRPRNAi   thoraxes of flies aged for 6, 24, and 48 hours after 
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Table 3.1: Proteins identified by mass spectrometry after co-IP with dNDUFS3-HA. 
The table shows all the peptides identified after co-IP with dNDUFS3-HA. Peptides highlighted in blue are 



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 3.2: Table for figure 3.3 listing the RNAi’s that were screened.  
Column 1: The number that corresponds with the lane numbered in figure 3.3. 
Column 2: The Bloomington Stock ordered 
Column 3: The Drosophila gene that is being knocked down by RNAi 




Number Bloomington Stock # Drosophila Gene Gal4 
1 28071 Laminin subunit alpha Dmef2
2 28542 Trailer Hitch Dmef2
3 28790 Limpet Dmef2
4 28895 Nocte Dmef2
5 28920 Polychaetoid Dmef2
6 28930 FASN1 Dmef2
7 30506 isoform B CAP Dmef2
8 31078 Bicoid Stability Factor Dmef2
9 31148 Mical Dmef2
10 31558 Muscle LIM protein Mlp84B Dmef2
11 31560 CG43897 Dmef2
12 31683 LD35640p Psi Dmef2
13 31712 ATP-dependent helicase brm Dmef2
14 32388 CG10077 Dmef2
15 32503 Brahma-associated protein 60 kDa Dmef2
16 32884 CG8036 Dmef2
17 32981 CG10077 Dmef2
18 33386 Polychaetoid Dmef2
19 33392 AT27578p rin Dmef2
20 33668 AT27789p glo Dmef2
21 35003 Cora Dmef2
22 34825 LD35640p Psi Dmef2
23 34550 Bicoid Stability Factor Dmef2
24 35630 Brahma associated protein 155 kDa mor Dmef2
25 35684 Heat schock 70 kDa protein cognate 4 Hsc70-4 Dmef2
26 36066 AT27789p glo Dmef2
27 38967 GH17761p Ubi-p5E Dmef2
28 40922 CG5261 Dmef2
29 41697 Arginine Kinase Dmef2
30 41708 Isocitrate Dehydrogenase Dmef2
31 42783 Terribly reduced obtic lobes Dmef2
32 42826 Thin Dmef2
33 43172 Proline Dehydrogenase 1, mitochondrial slgA Dmef2
34 44012 Ataxin-2 homolog Dmef2
35 44475 CG6439 Dmef2
36 34546 Thiolase Dmef2
37 34520 ATP-dependent helicase brm Dmef2
38 33727 Argonaute-1 Dmef2
39 35185 Belle Dmef2
40 35211 ATP-dependent helicase brm Dmef2
41 35221 Arginine Kinase Dmef2
42 35302 Belle Dmef2
43 35447 Osa Dmef2
44 35775 FASN1 Dmef2
45 38285 Osa Dmef2
173
46 38283 Hts Dmef2
47 38198 Guanine nucleotide-binding protein subunit beta-like protein Rack1Dmef2
48 36663 isoform B CAP Dmef2
49 43245 CG6455 Dmef2
50 38909 Trailer Hitch Dmef2
51 50524 CG6512 Dmef2
52 50650 CG5214 Dmef2
53 51811 Proline Dehydrogenase 1, mitochondrial slgA Dmef2
54 51845 Cora Dmef2
55 52933 nonA Dmef2
56 52937 Hrb87F Dmef2
57 53293 Ago1 Dmef2
58 53917 Sec16 Dmef2
59 53961 Trailer Hitch Dmef2
60 53971 Amphiphysin Dmef2
61 55908 Darkener of Apricot Dmef2
62 55929 Glutactin Dmef2
63 56883 Pyruvate Carboxylase PCB Dmef2
64 56944 Protein no-on-transient A nonA Dmef2
65 57820 CG30069 Dmef2
66 58201 CG11505 Dmef2
67 58278 CG34417 Dmef2
68 58313 CG9485 Dmef2
69 42509 CG11504 Dmef2
70 60371 CG8036 Dmef2
71 61279 Protein no-on-transient A nonA Dmef2
72 61857 Lingerer Dmef2
73 61925 CG30069 Dmef2
74 62002 Laminin subunit gamma-1 Dmef2
75 62945 CG34417 Dmef2
76 63994 CG6455 Dmef2
77 32872 Dodeca-satellite-binding protein 1 Dmef2
78 55201 LD30155p lost Dmef2
79 55168 Succinyl-CoA ligase subunit beta skap Dmef2
80 55388 Laminin subunit gamma-1 Dmef2
81 55619 CG11876 Dmef2
82 42774 RpS19a Dmef2
83 42888 Vha68-1 Dmef2
84 43965 Ank Dmef2
85 44100 Rbp1-like Dmef2
86 44533 CG8520 Dmef2
87 50553 GatA Dmef2
88 50574 Rbp1-like Dmef2
89 50610 RpL8 Dmef2
90 29422 Gat Dmef2
91 30810 yps Dmef2
174
92 31115 Ank Dmef2
93 57464 smr Dmef2
94 56970 med23 Dmef2
95 62167 ssdp Dmef2
96 8390 ebi Dmef2
97 24760 DCTN1 Dmef2
98 24761 DCTN1 Dmef2
99 26037 cyp4d2 Dmef2
100 26305 lasp Dmef2
101 27484 FMR1 Dmef2
102 27565 Eukaryotic translation inititation factor 3 subunit A Dmef2
103 27721 DCTN1 Dmef2
104 27729 Acsl Dmef2
105 28885 Gsts1 Dmef2
106 28896 GYF Dmef2
107 28933 Cora Dmef2
108 31049 Chi Dmef2
109 31244 Hrb87F Dmef2
110 31247 stau Dmef2
111 31301 LD35640p Psi Dmef2
112 31472 Hrb87F Dmef2
113 31570 Tig Dmef2
114 31700 Argonaute-1 Dmef2
115 31708 bap55 Dmef2
116 31728 nej Dmef2
117 31957 scp1 Dmef2
118 31964 CG10543 Dmef2
119 32402 Hsc70-3 Dmef2
120 32990 caz Dmef2
121 33417 AliX Dmef2
122 33996 shep Dmef2
123 34333 CG9485 Dmef2
124 34528 smr Dmef2
125 34571 mask Dmef2
126 34630 Skuld Dmef2
127 34658 med23 Dmef2
128 34662 Med1 Dmef2
129 34694 Guanine nucleotide-binding protein subunit beta-like protein Rack1Dmef2
130 34729 HSP60 Dmef2
131 34839 caz Dmef2
132 35200 FMR1 Dmef2
133 25225 Chi Dmef2
134 35435 Chi Dmef2
135 35690 Stau Dmef2
136 36613 isoform B CAP Dmef2
137 36682 Nej Dmef2
175
138 36721 Klar Dmef2
139 36897 Nrg Dmef2
140 38215 Nrg Dmef2
141 38218 Shep Dmef2
142 40833 Flo2 Dmef2
143 40903 Neurochondrin Dmef2
144 41833 P5CDh1 Dmef2
145 41854 Fas1 Dmef2
146 42510 CG7766 Dmef2
147 42616 lanB1 Dmef2
148 42797 enc Dmef2
149 42887 Fas1 Dmef2
150 42890 cg7766 Dmef2
151 43146 tcp-1zeta Dmef2
152 43187 Stau Dmef2
153 43268 Acsl Dmef2
154 43545 Shep Dmef2
155 44439 CG5261 Dmef2
156 44443 Ebi Dmef2
157 44495 CG9090 Dmef2
158 50525 Med1 Dmef2
159 50904 AliX Dmef2
160 51153 Med23 Dmef2
161 51406 Scp1 Dmef2
162 51433 CG7409 Dmef2
163 51911 CG7470 Dmef2
164 52871 Med23 Dmef2
165 53238 GstS1 Dmef2
166 54816 CG10543 Dmef2
167 55146 FeCh Dmef2
168 55209 CG30122 Dmef2
169 55212 Flo2 Dmef2
170 34039 Zormin Dmef2
171 38298 Terribly reduced obtic lobes Dmef2
172 38931 LD30155p lost Dmef2
173 40924 Koi Dmef2
174 27286 A2bp1 Dmef2
175 27302 NAT1 Dmef2
176 28327 14-3-3zeta Dmef2
177 27487 Stam Dmef2
178 28026 Hrs Dmef2
179 29422 Gat Dmef2
180 30810 yps Dmef2
181 31115 Ank Dmef2
182 31498 14-3-3zeta Dmef2
183 31713 cact Dmef2
176
184 31756 CG8963 Dmef2
185 31917 CG11504 Dmef2
186 32357 NAT1 Dmef2
187 32422 Rpt5 Dmef2
188 32476 A2bp1 Dmef2
189 32496 sod2 Dmef2
190 32930 CG8108 Dmef2
191 33007 hsp27 Dmef2
192 33010 capt Dmef2
193 33741 betaCOP Dmef2
194 33755 med24 Dmef2
195 33900 hrs Dmef2
196 33922 hsp27 Dmef2
197 34086 hrs Dmef2
198 34592 lilli Dmef2
199 34664 Med17 Dmef2
200 34670 Rab1 Dmef2
201 34775 cact Dmef2
202 34978 eIF3i Dmef2
203 35016 Stam Dmef2
204 36076 Rpl28 Dmef2
205 26304 Tpi Dmef2
206 26314 lilli Dmef2
207 33742 HSC70Cb Dmef2
208 34586 Lon Dmef2
209 37484 cact Dmef2
210 37519 B52 Dmef2
211 42888 Vha68-1 Dmef2
212 42881 Ssx Dmef2
213 42501 MED25 Dmef2
214 43310 CG1544 Dmef2
215 50637 Hsp68 Dmef2
216 50726 Vha68-1 Dmef2
217 51157 Cht5 Dmef2
218 51749 CG8520 Dmef2
219 51785 CG10932 Dmef2
220 51820 Aldh-III Dmef2
221 51829 Tpi Dmef2
222 52886 CG17597 Dmef2
223 53298 CG4461 Dmef2
224 53728 HSC70Cb Dmef2
225 54048 RpL17 Dmef2
226 55323 CG17896 Dmef2
227 55362 Rbp1-like Dmef2
228 56880 CG3902 Dmef2
229 57845 CPR100A Dmef2
177
230 58150 Rm62 Dmef2
231 58340 CG9572 Dmef2
232 55381 Idgf4 Dmef2
233 56497 HSC70Cb Dmef2
234 23236 Rab1 Dmef2
235 28923 cont Dmef2
236 32468 Sec13 Dmef2
237 33595 MED25 Dmef2
238 34867 cont Dmef2
239 36871 sod2 Dmef2
240 38250 yps Dmef2
241 38984 Cht5 Dmef2
242 42774 RpS19a Dmef2
243 42656 RpS17 Dmef2
244 31588 Thin Mhc
245 32351 Hrb98DE Mhc
246 34919 Brahma associated protein 155 kDa mor Mhc
247 33686 Nc73EF Mhc
248 34353 Eukaryotic translation inititation factor 3 subunit A Mhc
249 34836 Heat schock 70 kDa protein cognate 4 Hsc70-4 Mhc
250 34343 CG6512 Mhc
251 36921 Shibire Mhc
252 26218 dalao Mhc
253 27068 smr Mhc
254 27724 nej Mhc
255 31337 Brahma-associated protein 60 kDa Mhc
256 31885 CG43143 Mhc
257 32358 Opa1 Mhc
258 32866 AP-2alpha Mhc
259 33954 Brahma-associated protein 60 kDa Mhc
260 34087 smr Mhc
261 34575 Med14 Mhc
262 34981 ebi Mhc
263 35194 CG43143 Mhc
264 35242 dalao Mhc
265 35662 Brahma associated protein 155 kDa mor Mhc
266 41885 Acsl Mhc
267 50895 Viking Mhc
268 9757 rab1 Mhc
269 25969 sod2 Mhc
270 31572 Calcium-Transporting ATPase PMCA Mhc
271 32999 Rhea Mhc
272 32912 l(2)37Cc Mhc
273 39015 Amphiphysin Mhc
274 41983 bcl9 Mhc
275 51746 RpL32 Mhc
178
276 53300 RpL23 Mhc
277 53886 Rpt5 Mhc
278 57503 pglym78 Mhc
279 34944 FMR1 Mhc
280 28513 Shibire Mhc
281 33913 Rhea Mhc
282 34588 kto Mhc
283 37496 Nrg Mhc
284 26303 Pglym78 Mhc
285 27299 Rab1 Mhc
286 27562 CG8108 Mhc
287 28594 l(2)tid Mhc
288 29385 Rpn6 Mhc
289 31395 Rm62 Mhc
290 31709 betaCOP Mhc
291 32983 sod2 Mhc
292 33930 rpt1 Mhc
293 34348 rpn1 Mhc
294 34710 nup358 Mhc
295 34712 Rpt6 Mhc
296 34829 Rm62 Mhc
297 50903 Doa Mhc
179
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 The Drosophila model has proven to be valuable for understanding the regulation of CI biogenesis. 
In this body of work, we have established the mechanism of CI assembly in Drosophila to help delineate 
the assembly process of CI in mammals. We also utilized our model to identify new regulators of CI 
biogenesis that led to the identification of dFMRP playing a role in the stabilization and activity of CI. In this 
chapter, I will summarize our findings and discuss the results collectively, as well as suggest future 
directions. 
 
New roles for accessory subunits 
From our studies, we were able to address a big question in the CI field: whether the accessory 
subunits are required for the biogenesis of CI. We demonstrated that the knockdown of each CI accessory 
subunit in the fly by RNAi resulted in CI misassembly and loss of activity (Garcia et al., 2017). Additionally, 
when these RNAi lines targeting the accessory subunits were crossed to a Gal4 that increases the 
expression of the RNAi during the pupae stage none of the flies’ eclosed to adults suggesting that these 
accessory subunits are critical for CI activity and subsequently the survival of the flies. Our results were in 
agreement with those of studies in mammalian cells that have also shown that knockout of these subunits 
resulted in dysfunctional CI (Stroud et al., 2016). All together, these findings provided strong evidence that 
these accessory subunits are indispensable for CI biogenesis and activity. Given the importance of the 
accessory subunits, it is worth questioning why these subunits are not a part of the core subunits, and the 
evolutionary purpose to understand their roles. One hypothesis could be that they evolved to act as sensors 
for CI in higher-order organisms to respond to the changes in environment. Recent cyro-EM structures have 
uncovered cofactor binding sites on accessory subunits, which enable direct regulation of redox reactions, 
fatty acid synthesis and oxygen sensing. it would be interesting to investigate how these sites are regulated 
during different environmental stresses such as high fat diet, hypoxia, or aging (Dunham-Snary et al., 2019; 
Fiedorczuk et al., 2016; Letts et al., 2017; Zhu et al., 2016). In other words, understanding these binding 
sites may link how CI and the accessory subunits adjust to environmental pressures. Another hypothesis 
is that the accessory subunits tightly regulate the catalytic core subunits. Cryo-EM structures in the ovine 
model have revealed that the coupling between electron transfer and proton translocation is tightly 
183
controlled by accessory subunits, by regulating ubiquinone entry to the Q site (Fiedorczuk et al., 2016). 
Whether the accessory subunits play a role in regulation of NADH binding to FMN, proton pumping across 
the IMM, or the transition between active and inactive state of CI, are all questions of interest. Although the 
mechanism of CI activity has been studied for several decades, the accessory subunits have remained 
largely elusive. New technologies such as cryo-EM allow us to define the accessory subunits at the atomic 
resolution, and combining the new tools with a strong genetic model such as Drosophila we will be able to 
address these questions and further elucidate our understanding of the accessory subunits. To do this, the 
structure of CI in the fly would need to be solved. Given the abundance of mitochondria in fly thoraxes and 
the availability of mammalian structures for reference this would be a simple but vital task to be resolved in 
the near future. Undoubtedly, the Drosophila model will shed light on the roles of the accessory subunits. 
 
Using Drosophila to study human CI diseases 
CI in Drosophila is an attractive model to understand human CI diseases as it contains 42 of the 
44 human CI subunits and the assembly mechanism is very similar (Garcia et al., 2017). In vivo models 
that recapitulate the phenotypes of patients with mitochondria CI deficiency are scarce due to the lethality 
in many CI subunit knockout mice (Lee et al., 2019; Mimaki et al., 2012). Recently, models of CI deficiency 
in the Drosophila were generated using the Gal4-UAS system to knockdown specific CI proteins 
ubiquitously (Foriel et al., 2019). A broad range of phenotypes in the flies were scored, similar to the 
polymorphic phenotypes found in CI deficiency patients (Foriel et al., 2019). This work is the first to arise 
from our foundational work from 2017 and would be the first of many Drosophila models to study the CI 
deficiency in humans. The available genetic information and the advancing gene editing technology such 
as CRISPR/Cas9 will allow researchers to replicate the mutations found in patients and to simulate the 
phenotypes in Drosophila. Moreover, Drosophila models can be used to screen candidate drug molecules 
in a time- and cost-effective manner. While patient samples can be scarce, these models could foster our 
insight of the mitochondrial functions such as ATP production, oxygen consumption, OXPHOS activity 
assays, mitochondria morphology, and assembly of CI.  
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Defining the mechanisms of discovered regulators of CI biogenesis 
 Finding novel regulators of CI or novel CI-regulating roles of known proteins are important tasks to 
improve diagnosis of CI deficiency in patients. To identify target proteins, we have developed a strategy to 
screen those that interact with the NDUFS3 subunit of CI. In addition, I also screened proteins that 
interacted with other subunits of CI or assembly factors. These screens identified the fly proteins Sterol 
Carrier Protein X-related thiolase (Scpx) and Malic Enzyme b (Men-b) as potential regulators of CI (Figure 
4.1L Lane 98 and Figure 4.1I Lane 56). Scpx is localized in the peroxisome and is important for 
peroxisomal beta oxidation by converting 3-ketoacyl-CoA into acyl-CoA, which can then be made into acyl-
carnitine for the mitochondria to use (Faust et al., 2012; Ruiz-Ramírez et al., 2015). One hypothesis linking 
Scpx to CI is through the alterations in the NAD+/NADH ratio. NAD+ is required for converting 3-
hydroxyacyl-CoA into 3-ketocyl-CoA. Therefore, if Scpx is absent, an accumulation of 3-ketoacyl-CoA 
would stall several reactions before the conversion of 3-hydroxyacyl-CoA into 3-ketocyl-CoA. The increased 
NAD+ would then lead to the mitochondria shutting down CI. On another note, to my knowledge, this is the 
first time a link has been made between peroxisomal beta oxidation and CI (Fransen et al., 2017). Thus, it 
would be interesting to follow up what other parts along the pathway are involved with CI deficiency. Men-
b is a protein localized in the mitochondria matrix that converts malate into pyruvate using the cofactor 
NAD+ (Hasan et al., 2015; Weeda, 1981). Similar to Scpx, the CI deficiency phenotype we see in flies 
without men-b is presumably due to a change in the NAD+/NADH ratio, and possibly its downstream effects 
on the TCA cycle.  
Another screen I took part of in the lab was to test proteins found in the MitoCarta list to see if they 
regulate CI. The Mitocarta is a list of proteins that have been identified to localize to the mitochondria (Calvo 
et al., 2016; Pagliarini et al., 2008). In our screen, I identified that disrupting the NFU1 gene by RNAi causes 
a destabilization of the holoenzyme CI (Figure 4.1A Lane 5). NFU1 is an iron-sulfur cluster scaffold protein 
for CI, and this result suggests that iron-sulfur cluster may also contribute to the regulation of CI biogenesis 
(Navarro-Sastre et al., 2011). Future studies analyzing other iron sulfur cluster scaffold proteins may help 
to us to elucidate the mechanism of when and how iron sulfur cluster affects the CI biogenesis.  
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Calcium accumulation in the mitochondria is an essential part of cell activity. We tested if proteins 
known to regulate calcium signaling in the cell have any effect on CI. Mitochondrial calcium uptake 1 
(Micu1), a protein that regulates the calcium uptake into the matrix and a part of the mitochondria calcium 
uniporter complex (MCUC), caused CI deficiency when knocked down by RNAi (Figure 4.1S Lane 98) 
(Antony et al., 2016; Marchi and Pinton, 2014). Interestingly, knocking down other subunits that are part of 
the MCUC did not result in a reduction or loss of activity of CI. Future studies will be necessary to analyze 
the relationship of MICU1 and the regulation of CI.  
Overall, I screened over ~500 different proteins to analyze their effects on CI biogenesis. These 
included knocking down or overexpressing proteins that interact with CI subunits or CIAFs, proteins from 
the MitoCarta, and calcium signaling proteins (Figure 4.1). As more and more proteins are identified to 
regulate CI in the fly system, it will be important to test if the mammalian orthologues produce the same 
phenotype. All in all, these findings have allowed us to broaden our perspective on how the regulation of 
CI is not confined to CI, let alone the mitochondria, in terms of the genes involved (mtDNA and nDNA) and 
the space it takes place in (mitochondria and cytoplasm). 
 
Alternative methods to identifying novel regulators of CI biogenesis 
 Assembly factors are transient interactors to CI subunits and assembly intermediates that assist 
with the assembly of the holoenzyme. As a first approach, we tagged the CI subunits or CIAFs and 
cataloged their interacting proteins to test if they are potential assembly factors. Although this method 
provided a decent list of proteins to screen, transient interactors are overlooked. In the past decade, a 
method known as BioID has proven to be reliable for the identification of transient protein-protein 
interactions (Roux et al., 2013). This method works by tagging a protein of interest to a biotin ligase, that 
when expressed in cells biotinylate any proteins in close proximity. In flies, this method is applied in the 
Gal4-UAS system by expressing the biotin ligase (BirA) enzyme from E. Coli with the protein of interest 
(Ramirez et al., 2015) (Figure 4.2). Another method to identify transient interactors with the CI subunits 
and assembly intermediates would be to trap the assembly intermediates themselves and analyze the 
proteins bound to it. We have shown that disrupting the subunits of CI can result in the accumulation of 
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assembly intermediates (Garcia et al., 2017). It would be interesting to isolate these accumulating assembly 
intermediate and visualize it by cryo-EM to grasp the bound and interacting proteins, and to test their 
potentials as regulators of CI biogenesis.  
 
Elucidating mechanisms of supercomplexes in Drosophila 
 . A growing body of literature in supercomplexes reflect the interest and the importance to elucidate 
the physiological function of these massive complexes as well as their regulation (Greggio et al., 2017; 
Letts and Sazanov, 2017; Letts et al., 2017, 2019; Signes and Fernandez-Vizarra, 2018). Several studies 
have suggested that they are involved in stabilizing the individual complexes, providing a more efficient 
transfer of electrons between the complexes, and preventing ROS formation (Milenkovic et al., 2017). 
Mammalian CI is primarily found in supercomplexes with either complex III (CIII) or CIII-complex IV. In flies, 
we have shown that the CI-CIII supercomplex is present and can be analyzed by BN-PAGE. We have also 
confirmed that NDUFA11 is important for the stabilization of the CI-CIII supercomplex, as reported in 
mammalian models (Letts and Sazanov, 2017; Letts et al., 2017). Future studies should test the different 
components of CI and CIII under different physiological conditions in the context of supercomplex 
stabilization. Thus far, only one regulator of supercomplexes, super complex assembly factor 1 (SCAF1), 
has been discovered (Cogliati et al., 2016). From our screens, we identified that knockdown of CP1 causes 
a reduction in the CI-CIII supercomplex (Figure 4.1L Lane 103). CP1 is a cysteine proteinase that is 
involved in the degradation of proteins. Future studies to elucidate how CP1 regulates the CI-CIII 
supercomplex will be needed. Lastly, studies have revealed that changes in physiological conditions such 
as exercise can alter supercomplex formation in in human skeletal muscle (Greggio et al., 2017). Drosophila 
model is suitable for testing various conditions (i.e. diet, aging) and would be useful in understanding the 




 In conclusion, recent advancements in technology and the addition of new models will help further 
our knowledge of CI. As the field moves forward in understanding the formation and function of the 
holoenzyme, it is now an exciting time to start exploring the possibility of CI beyond the main contributor of 
OXPHOS but as a central mediator of the metabolic processes in general, happening inside and outside 
the mitochondria. This not only includes advancing our knowledge of CI as one enzyme, but also as a 
structure that is made up 44 different pieces, with each piece potentially serving as a signaling molecule. 
Additionally, it will be important to increase our understanding of the transient interactors of CI and address 
how CI is regulated under different environmental pressures. In closing, as we begin to shed light on the 
role of CI as a regulator of metabolism in the mitochondria, this will hopefully help to delineate the role of 





















Materials and Methods 
Drosophila Strains and Genetics.  
The following fly stocks were used: y w; Dmef2-Gal4 ; w; mhc-Gal4 ; w; Ubi-Gal4 and w; myo1a-Gal4. 
W1118 were used as wildtype (wt) controls. Stocks that were screened were ordered from the Bloomington 
Drosophila Stock Center (https://bdsc.indiana.edu/). The Bloomington stock number can be found in table 
4.1 for each respective protein. UAS-BirA and UAS-Ubi6-BirA were ordered from the Bloomington 
Drosophila Stock Center (https://bdsc.indiana.edu/. 
 
Mitochondria Purification.  
Mitochondrial purification was performed essentially as described by Rera et al 2012 (Rera et al., 2011). 
Thoraxes were dissected and gently crushed with a pestle homogenizer in 500µl of pre-chilled mitochondrial 
isolation buffer containing 250 mM sucrose and 0.15 mM MgCl2 in 10 mM Tris.HCl, pH 7.4, on ice. After 
two rounds of centrifugation at 500g for 5 minutes at 4°C to remove insoluble material, the supernatant was 
recovered and centrifuged at 5000g for 5 minutes at 4°C. The pellet which is enriched for mitochondria was 
washed twice in the mitochondrial isolation buffer and stored at -80°C until further processing.  
 
Blue Native Polyacrylamide Gel Electrophoresis (BN-PAGE).  
BN-PAGE was performed using NativePAGE gels from Life Technologies, following the manufacturer’s 
instructions. Essentially, mitochondria were suspended in native PAGE sample buffer (Life Technologies) 
supplemented with 1% digitonin and protease inhibitors, and incubated on ice for 20 minutes. Following 
centrifugation at 20,000g for 30 minutes, the supernatant was recovered, mixed with the G-250 sample 
additive (Life Technologies) and Native PAGE Sample Buffer (Life Technologies), and loaded onto 3–12% 
pre-cast Bis–Tris Native PAGE gels (Life Technologies). The NativeMark Protein standard (Life 
Technologies), run together with the samples, was used to estimate the molecular weight of the protein 
complexes. Electrophoreses was performed using the Native PAGE Running buffer (as anode buffer, from 
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Life technologies) and the Native PAGE Running buffer containing 0.4% Coomassie G-250 (cathode 
buffer). Gels were stained with the Novex Colloidal Blue staining kit (Life Technologies) to reveal the protein 
complexes.  
 
Silver Staining.  
Silver staining of native gels was performed with the SilverXpress staining kit from Life Technologies, 
following the manufacturer’s protocol.  
 
Immunoblotting 
For immunoblotting of samples in native gels, protein complexes from native gels were transferred to PVDF 
membranes (BIORAD). For immunoblotting of samples in whole tissue lysates, thoraxes were homogenized 
in RIPA buffer (150 mM NaCl, 1% Triton X-100, 0.5% Sodium Deoxycholate, 0.1% SDS, 50mM Tris HCl, 
pH 8) supplemented with Halt protease inhibitors (Pierce), resolved on mini-PROTEAN TGX stain-free gels 
from BIO-RAD, and transferred to PVDF membranes. In both instances (native and non-native gels), the 
membrane was subsequently blocked in 5% (w/v) non-fat dry milk in Tris-buffered saline (TBS) for 
30minutes, and incubated in the appropriate primary antibody dissolved in 2% BSA, 0.1% Tween 20 in TBS 
(TBST) overnight at 4°C. Following the overnight incubation, the blot was rinsed 4X10 minutes in 
0.1%TBST, blocked for 30 minutes in 5% (w/v) non-fat dry milk in TBST and incubated for two hours with 
the appropriate HRP-conjugated secondary antibody dissolved in 2% BSA, 0.1% Tween 20 in TBS (TBST). 
After incubation in the secondary antibody, samples were rinsed 4X10 minutes in 0.1%TBST. 
Immunoreactivity was detected by enhanced chemiluminescence (ECL) and analyzed by a ChemiDoc Gel 




Figure 4.1: Screens performed to Identify Novel Regulators of Complex I Biogenesis 
(A-E) RNAi Knockdown of MitoCarta Proteins Screen; (F-L) RNAi Knockdown of Proteins that interacted 
with dNDUFS3, dFoxred1, and dNDUFAF7 after knockdown of dNDUFS5 and lon protease Screen; (M-U) 
RNAi knockdown of Calcium Signaling Proteins Screen; (V-GG) UAS-Protein Overexpression Screen. We 
isolated mitochondria from 10 thoraxes, permeabilized their membranes in 1% digitonin and performed BN-
PAGE. The complexes were resolved by either coomassie- or silver staining. Each lane is numbered and 
corresponds to the RNAi’s ordered from the Bloomington Stock Center found in Table 4.1. CI-CIII denotes 
the complex I-complex III supecomplex, CV2 denotes a dimer of complex V respectively, CI denotes 
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RNAi Knockdown of Proteins that interacted with dNDUFS3, dFoxred1, 
and dNDUFAF7 after knockdown of dNDUFS5 and lon protease 










RNAi Knockdown of Calcium Signaling Proteins
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Figure 4.2: The potential to use BioID in the Drosophila gut and thorax. 
(A) SDS-PAGE of Drosophila gut samples to measure the amount of biotinylated proteins. 
Myo1aGal4<W1118 was used as a control. Two different UAS-BirA lines were used to control expressed 
under the gut driver Myo1aGal4 for non-specific proteins that BirA may biotinylate. Myo1aGal4<UAS-Ubi6-
BirA is used to identify proteins that were biotinylated by BirA since they came in close proximity to Ubi6.  
(B) SDS-PAGE of Drosophila flight thoraxes to measure the amount of biotinylated proteins. 
Myo1aGal4<W1118 was used as a control. Two different UAS-BirA lines were used to control expressed 
under the gut driver Myo1aGal4 for non-specific proteins that BirA may biotinylate. Myo1aGal4<UAS-Ubi6-




































































































Table 4.1: Table for Figure 4.1 listing the RNAi’s that were screened 
Column 1: The screen type for each RNAi 
Column 2: The number that corresponds with the lane numbered in figure 3.3. 
Column 3: The Bloomington Stock ordered. 
Column 4: The Gal4 used to express the UAS-RNAi lines in Drosophila flight muscles. 
Column 5: X denotes if it is a hit 
Column 6: Protein name is listed if identified as a hit. 
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Screen Type Lane Number Bloomington Stock # Gal4 Hit Protein
MitoCarta 1 42595 Dmef2
MitoCarta 2 43155 Dmef2
MitoCarta 3 52922 Dmef2
MitoCarta 4 42591 Dmef2
MitoCarta 5 52907 Dmef2 X NFU1
MitoCarta 6 52920 Dmef2
MitoCarta 7 64025 Dmef2
MitoCarta 8 57572 Dmef2
MitoCarta 9 43245 Dmef2
MitoCarta 10 36671 Dmef2
MitoCarta 11 64489 Dmef2
MitoCarta 12 64564 Dmef2
MitoCarta 13 67030 Dmef2
MitoCarta 14 57557 Dmef2
MitoCarta 15 67425 Dmef2
MitoCarta 16 67585 Dmef2
MitoCarta 17 43297 Dmef2
MitoCarta 18 43278 Dmef2
MitoCarta 19 60133 Dmef2
MitoCarta 20 60360 Dmef2
MitoCarta 21 60404 Dmef2
MitoCarta 22 60475 Dmef2
MitoCarta 23 60873 Dmef2 X NDUFV2 (internal control)
MitoCarta 24 62272 Dmef2
MitoCarta 25 62373 Dmef2
MitoCarta 26 62455 Dmef2
MitoCarta 27 56864 Dmef2
MitoCarta 28 63035 Dmef2 X NDUFV2
MitoCarta 29 56880 Dmef2
MitoCarta 30 56885 Dmef2
MitoCarta 31 34971 Dmef2 X PRDX2
MitoCarta 32 44037 Dmef2 X NFS1
MitoCarta 33 44429 Dmef2
MitoCarta 34 34974 Dmef2
MitoCarta 35 26007 Dmef2
MitoCarta 36 41857 Dmef2
MitoCarta 37 26007 Dmef2
MitoCarta 38 40936 Dmef2
MitoCarta 39 44475 Dmef2
MitoCarta 40 36871 Dmef2
MitoCarta 41 36740 Dmef2
MitoCarta 42 36911 Dmef2 X COQ10A
MitoCarta 43 34588 Dmef2 X MED12L
MitoCarta 44 25886 Dmef2
MitoCarta 45 28664 Dmef2
MitoCarta 46 34028 Dmef2
MitoCarta 47 31157 Dmef2 X MFN2
MitoCarta 48 31074 Dmef2 X BCS1L
MitoCarta 49 38332 Dmef2
MitoCarta 50 31075 Dmef2 X BCS1L
MitoCarta 51 29573 Dmef2
MitoCarta 52 52917 Dmef2
MitoCarta 53 30500 Dmef2
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MitoCarta 54 31077 Dmef2
MitoCarta 55 58074 Dmef2
MitoCarta 56 28294 Dmef2 X MTCH2
MitoCarta 57 58148 Dmef2
MitoCarta 58 60107 Dmef2
MitoCarta 59 58084 Dmef2
MitoCarta 60 28635 Dmef2
MitoCarta 61 56043 Dmef2
MitoCarta 62 27725 Dmef2
MitoCarta 63 31076 Dmef2
MitoCarta 64 51900 Dmef2
MitoCarta 65 52989 Dmef2
MitoCarta 66 44512 Dmef2
MitoCarta 67 51876 Dmef2
MitoCarta 68 55146 Dmef2 X FECH
MitoCarta 69 51798 Dmef2
MitoCarta 70 53355 Dmef2
MitoCarta 71 53287 Dmef2
MitoCarta 72 50939 Dmef2 X SUCLG2
MitoCarta 73 53325 Dmef2
MitoCarta 74 54465 Dmef2
MitoCarta 75 56858 Dmef2 X ACAT2
FS5/Lon KD Interactors 1 52913 Dmef2
FS5/Lon KD Interactors 2 55168 Dmef2
FS5/Lon KD Interactors 3 18121 Dmef2
FS5/Lon KD Interactors 4 40874 Dmef2
FS5/Lon KD Interactors 5 38926 Dmef2
FS5/Lon KD Interactors 6 35608 Dmef2
FS5/Lon KD Interactors 7 36071 Dmef2
FS5/Lon KD Interactors 8 35348 Dmef2
FS5/Lon KD Interactors 9 35486 Dmef2
FS5/Lon KD Interactors 10 33765 Dmef2
FS5/Lon KD Interactors 11 33696 Dmef2
FS5/Lon KD Interactors 12 33950 Dmef2
FS5/Lon KD Interactors 13 31100 Dmef2
FS5/Lon KD Interactors 14 34936 Dmef2
FS5/Lon KD Interactors 15 52907 Dmef2 X NFU1
FS5/Lon KD Interactors 16 31237 Dmef2
FS5/Lon KD Interactors 17 31223 Dmef2
FS5/Lon KD Interactors 18 36775 Dmef2
FS5/Lon KD Interactors 19 36072 Dmef2
FS5/Lon KD Interactors 20 38256 Dmef2
FS5/Lon KD Interactors 21 36820 Dmef2
FS5/Lon KD Interactors 22 34729 Dmef2
FS5/Lon KD Interactors 23 34554 Dmef2
FS5/Lon KD Interactors 24 33976 Dmef2
FS5/Lon KD Interactors 25 31240 Dmef2 X NDUFAF5
FS5/Lon KD Interactors 26 32405 Dmef2
FS5/Lon KD Interactors 27 31222 Dmef2
FS5/Lon KD Interactors 28 31102 Dmef2 X NDUFAF5
FS5/Lon KD Interactors 29 33001 Dmef2
FS5/Lon KD Interactors 30 35034 Dmef2
FS5/Lon KD Interactors 31 51807 Dmef2
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FS5/Lon KD Interactors 32 51797 Dmef2
FS5/Lon KD Interactors 33 51785 Dmef2
FS5/Lon KD Interactors 34 51783 Dmef2
FS5/Lon KD Interactors 35 51749 Dmef2
FS5/Lon KD Interactors 36 51714 Dmef2
FS5/Lon KD Interactors 37 51359 Dmef2
FS5/Lon KD Interactors 38 44512 Dmef2
FS5/Lon KD Interactors 39 44475 Dmef2
FS5/Lon KD Interactors 40 51899 Dmef2
FS5/Lon KD Interactors 41 53894 Dmef2
FS5/Lon KD Interactors 42 53334 Dmef2
FS5/Lon KD Interactors 43 51879 Dmef2 X NDUFAF5
FS5/Lon KD Interactors 44 50555 Dmef2
FS5/Lon KD Interactors 45 51157 Dmef2 X CHCHD3
FS5/Lon KD Interactors 46 57843 Dmef2
FS5/Lon KD Interactors 47 55323 Dmef2
FS5/Lon KD Interactors 48 38332 Dmef2
FS5/Lon KD Interactors 49 40874 Dmef2
FS5/Lon KD Interactors 50 41625 Dmef2
FS5/Lon KD Interactors 51 57252 Dmef2
FS5/Lon KD Interactors 52 55347 Dmef2
FS5/Lon KD Interactors 53 41698 Dmef2
FS5/Lon KD Interactors 54 42007 Dmef2
FS5/Lon KD Interactors 55 57407 Dmef2
FS5/Lon KD Interactors 56 57489 Dmef2 X Men-b
FS5/Lon KD Interactors 57 42005 Dmef2
FS5/Lon KD Interactors 58 43172 Dmef2
FS5/Lon KD Interactors 59 35142 Dmef2
FS5/Lon KD Interactors 60 57736 Dmef2
FS5/Lon KD Interactors 61 61183 Dmef2
FS5/Lon KD Interactors 62 62362 Dmef2 X MARS2
FS5/Lon KD Interactors 63 64489 Dmef2
FS5/Lon KD Interactors 64 64614 Dmef2
FS5/Lon KD Interactors 65 64919 Dmef2
FS5/Lon KD Interactors 66 65243 Dmef2
FS5/Lon KD Interactors 67 66328 Dmef2
FS5/Lon KD Interactors 68 65215 Dmef2
FS5/Lon KD Interactors 69 66929 Dmef2
FS5/Lon KD Interactors 70 28968 Dmef2
FS5/Lon KD Interactors 71 28930 Dmef2
FS5/Lon KD Interactors 72 28749 Dmef2
FS5/Lon KD Interactors 73 28317 Dmef2
FS5/Lon KD Interactors 74 27682 Dmef2
FS5/Lon KD Interactors 75 27650 Dmef2
FS5/Lon KD Interactors 76 25953 Dmef2
FS5/Lon KD Interactors 77 67601 Dmef2
FS5/Lon KD Interactors 78 67003 Dmef2
FS5/Lon KD Interactors 79 29399 Dmef2
FS5/Lon KD Interactors 80 31150 Dmef2
FS5/Lon KD Interactors 81 31205 Dmef2
FS5/Lon KD Interactors 82 31660 Dmef2
FS5/Lon KD Interactors 83 31470 Dmef2
FS5/Lon KD Interactors 84 31666 Dmef2
FS5/Lon KD Interactors 85 31661 Dmef2
204
FS5/Lon KD Interactors 86 32934 Dmef2 X RELA
FS5/Lon KD Interactors 87 31966 Dmef2
FS5/Lon KD Interactors 88 34347 Dmef2 X ADSL
FS5/Lon KD Interactors 89 34346 Dmef2
FS5/Lon KD Interactors 90 34913 Dmef2
FS5/Lon KD Interactors 91 53894 Dmef2
FS5/Lon KD Interactors 92 31660 Dmef2
FS5/Lon KD Interactors 93 51479 Dmef2 X ScpX
FS5/Lon KD Interactors 94 31205 Dmef2
FS5/Lon KD Interactors 95 28317 Dmef2
FS5/Lon KD Interactors 96 43172 Dmef2
FS5/Lon KD Interactors 97 38332 Dmef2
FS5/Lon KD Interactors 98 36691 Dmef2 X Dumpy
FS5/Lon KD Interactors 99 51899 Dmef2
FS5/Lon KD Interactors 100 31100 Dmef2
FS5/Lon KD Interactors 101 52913 Dmef2
FS5/Lon KD Interactors 102 31666 Dmef2
FS5/Lon KD Interactors 103 41939 Dmef2 X Cp1
Calcium Signaling Proteins 1 W1118 Mhc
Calcium Signaling Proteins 2 25830 Mhc
Calcium Signaling Proteins 3 25928 Mhc
Calcium Signaling Proteins 4 26012 Mhc
Calcium Signaling Proteins 5 26172 Mhc
Calcium Signaling Proteins 6 26251 Mhc
Calcium Signaling Proteins 7 27053 Mhc
Calcium Signaling Proteins 8 58971 Mhc
Calcium Signaling Proteins 9 27244 Mhc
Calcium Signaling Proteins 10 35362 Mhc
Calcium Signaling Proteins 11 37502 Mhc
Calcium Signaling Proteins 12 39029 Mhc
Calcium Signaling Proteins 13 28919 Mhc
Calcium Signaling Proteins 14 29401 Mhc
Calcium Signaling Proteins 15 29445 Mhc
Calcium Signaling Proteins 16 W1118 Mhc
Calcium Signaling Proteins 17 29662 Mhc
Calcium Signaling Proteins 18 29663 Mhc
Calcium Signaling Proteins 19 29665 Mhc
Calcium Signaling Proteins 20 29666 Mhc
Calcium Signaling Proteins 21 58972 Mhc
Calcium Signaling Proteins 22 31540 Mhc
Calcium Signaling Proteins 23 58973 Mhc
Calcium Signaling Proteins 24 31695 Mhc
Calcium Signaling Proteins 25 44581 Mhc
Calcium Signaling Proteins 26 64003 Mhc
Calcium Signaling Proteins 27 58974 Mhc
Calcium Signaling Proteins 28 34609 Mhc
Calcium Signaling Proteins 29 35330 Mhc
Calcium Signaling Proteins 30 41900 Mhc
Calcium Signaling Proteins 31 W1118 Mhc
Calcium Signaling Proteins 32 25830 Mhc
Calcium Signaling Proteins 33 25928 Mhc
Calcium Signaling Proteins 34 26012 Mhc
Calcium Signaling Proteins 35 26172 Mhc
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Calcium Signaling Proteins 36 26251 Mhc
Calcium Signaling Proteins 37 27053 Mhc
Calcium Signaling Proteins 38 58971 Mhc
Calcium Signaling Proteins 39 27244 Mhc
Calcium Signaling Proteins 40 35362 Mhc
Calcium Signaling Proteins 41 37502 Mhc
Calcium Signaling Proteins 42 39029 Mhc
Calcium Signaling Proteins 43 28918 Mhc
Calcium Signaling Proteins 44 29401 Mhc
Calcium Signaling Proteins 45 29445 Mhc
Calcium Signaling Proteins 46 29662 Mhc
Calcium Signaling Proteins 47 29663 Mhc
Calcium Signaling Proteins 48 29665 Mhc
Calcium Signaling Proteins 49 29666 Mhc
Calcium Signaling Proteins 50 58972 Mhc
Calcium Signaling Proteins 51 31540 Mhc
Calcium Signaling Proteins 52 58973 Mhc
Calcium Signaling Proteins 53 31695 Mhc
Calcium Signaling Proteins 54 44581 Mhc
Calcium Signaling Proteins 55 64003 Mhc
Calcium Signaling Proteins 56 58974 Mhc
Calcium Signaling Proteins 57 34609 Mhc
Calcium Signaling Proteins 58 35330 Mhc
Calcium Signaling Proteins 59 41900 Mhc
Calcium Signaling Proteins 60 W1118 Mhc
Calcium Signaling Proteins 61 53893 Mhc
Calcium Signaling Proteins 62 63021 Mhc
Calcium Signaling Proteins 63 33923 Mhc
Calcium Signaling Proteins 64 41909 Mhc
Calcium Signaling Proteins 65 31676 Mhc
Calcium Signaling Proteins 66 26726 Mhc
Calcium Signaling Proteins 67 33413 Mhc
Calcium Signaling Proteins 68 63025 Mhc
Calcium Signaling Proteins 69 40835 Mhc
Calcium Signaling Proteins 70 32404 Mhc
Calcium Signaling Proteins 71 41900 Mhc
Calcium Signaling Proteins 72 31471 Mhc
Calcium Signaling Proteins 73 W1118 Dmef2
Calcium Signaling Proteins 74 26172 Dmef2
Calcium Signaling Proteins 75 26251 Dmef2
Calcium Signaling Proteins 76 39029 Dmef2
Calcium Signaling Proteins 77 29401 Dmef2
Calcium Signaling Proteins 78 35330 Dmef2
Calcium Signaling Proteins 79 58974 Dmef2
Calcium Signaling Proteins 80 41900 Dmef2
Calcium Signaling Proteins 81 42580 Dmef2
Calcium Signaling Proteins 82 26726 Dmef2
Calcium Signaling Proteins 83 31676 Dmef2
Calcium Signaling Proteins 84 31471 Dmef2
Calcium Signaling Proteins 85 63021 Dmef2
Calcium Signaling Proteins 86 W1118 Dmef2
Calcium Signaling Proteins 87 26012 Dmef2
Calcium Signaling Proteins 88 29662 Dmef2
Calcium Signaling Proteins 89 29663 Dmef2
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Calcium Signaling Proteins 90 27053 Dmef2
Calcium Signaling Proteins 91 27244 Dmef2
Calcium Signaling Proteins 92 35362 Dmef2
Calcium Signaling Proteins 93 29666 Dmef2
Calcium Signaling Proteins 94 58972 Dmef2
Calcium Signaling Proteins 95 58973 Dmef2
Calcium Signaling Proteins 96 63025 Dmef2
Calcium Signaling Proteins 97 53893 Dmef2
Calcium Signaling Proteins 98 41909 Dmef2 X Micu1
Calcium Signaling Proteins 99 W1118 Daughterless
Calcium Signaling Proteins 100 29665 Daughterless
Calcium Signaling Proteins 101 25839 Daughterless
Calcium Signaling Proteins 102 28919 Daughterless
Calcium Signaling Proteins 103 25928 Daughterless
Calcium Signaling Proteins 104 33413 Daughterless
Calcium Signaling Proteins 105 31549 Daughterless
Calcium Signaling Proteins 106 31695 Daughterless
Calcium Signaling Proteins 107 29445 Daughterless
Calcium Signaling Proteins 108 W1118 Dmef2;tub80
Calcium Signaling Proteins 109 38919 Dmef2;tub80
Calcium Signaling Proteins 110 W1118 Dmef2
Calcium Signaling Proteins 111 41909 Dmef2 X Micu1
Calcium Signaling Proteins 112 CG4495 Dmef2
Calcium Signaling Proteins 113 W1118 Dmef2;tub80
Calcium Signaling Proteins 114 31540 Dmef2;tub80
Calcium Signaling Proteins 115 31695 Dmef2;tub80
Calcium Signaling Proteins 116 29445 Dmef2;tub80
Calcium Signaling Proteins 117 25928 Dmef2;tub80
Calcium Signaling Proteins 118 58971 Dmef2;tub80
Calcium Signaling Proteins 119 28919 Dmef2;tub80
Calcium Signaling Proteins 120 44581 Dmef2;tub80
Calcium Signaling Proteins 121 25830 Dmef2;tub80
Calcium Signaling Proteins 122 64003 Dmef2;tub80
Calcium Signaling Proteins 123 34609 Dmef2;tub80
Calcium Signaling Proteins 124 32404 Dmef2;tub80
Calcium Signaling Proteins 125 33923 Dmef2;tub80
Calcium Signaling Proteins 126 33413 Dmef2;tub80
Calcium Signaling Proteins 127 29664 Dmef2;tub80
UAS-Protein Overexpression 1 W1118 Mhc
UAS-Protein Overexpression 2 63079 Mhc
UAS-Protein Overexpression 3 53753 Mhc
UAS-Protein Overexpression 4 55073 Mhc
UAS-Protein Overexpression 5 56495 Mhc
UAS-Protein Overexpression 6 56752 Mhc
UAS-Protein Overexpression 7 51636 Mhc
UAS-Protein Overexpression 8 58460 Mhc
UAS-Protein Overexpression 9 57355 Mhc
UAS-Protein Overexpression 10 59085 Mhc
UAS-Protein Overexpression 11 59055 Mhc
UAS-Protein Overexpression 12 32330 Mhc
UAS-Protein Overexpression 13 32110 Mhc
UAS-Protein Overexpression 14 51380 Mhc X br
UAS-Protein Overexpression 15 53716 Mhc
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UAS-Protein Overexpression 16 W1118 Mhc
UAS-Protein Overexpression 17 58723 Mhc
UAS-Protein Overexpression 18 63058 Mhc
UAS-Protein Overexpression 19 59843 Mhc
UAS-Protein Overexpression 20 63229 Mhc
UAS-Protein Overexpression 21 51671 Mhc
UAS-Protein Overexpression 22 53758 Mhc
UAS-Protein Overexpression 23 58357 Mhc X debcl
UAS-Protein Overexpression 24 59844 Mhc
UAS-Protein Overexpression 25 63050 Mhc
UAS-Protein Overexpression 26 51668 Mhc
UAS-Protein Overexpression 27 34048 Mhc
UAS-Protein Overexpression 28 56826 Mhc X dbx
UAS-Protein Overexpression 29 59053 Mhc
UAS-Protein Overexpression 30 57336 Mhc
UAS-Protein Overexpression 31 W1118 Mhc
UAS-Protein Overexpression 32 63150 Mhc
UAS-Protein Overexpression 33 53756 Mhc
UAS-Protein Overexpression 34 63216 Mhc
UAS-Protein Overexpression 35 58877 Mhc
UAS-Protein Overexpression 36 63059 Mhc
UAS-Protein Overexpression 37 44386 Mhc
UAS-Protein Overexpression 38 44597 Mhc
UAS-Protein Overexpression 39 43645 Mhc
UAS-Protein Overexpression 40 53760 Mhc
UAS-Protein Overexpression 41 44224 Mhc X dsx
UAS-Protein Overexpression 42 44609 Mhc
UAS-Protein Overexpression 43 44600 Mhc
UAS-Protein Overexpression 44 56197 Mhc X dronc
UAS-Protein Overexpression 45 W1118 Mhc
UAS-Protein Overexpression 46 39741 Mhc
UAS-Protein Overexpression 47 39749 Mhc
UAS-Protein Overexpression 48 39706 Mhc
UAS-Protein Overexpression 49 59048 Mhc
UAS-Protein Overexpression 50 58992 Mhc
UAS-Protein Overexpression 51 42222 Mhc
UAS-Protein Overexpression 52 44237 Mhc
UAS-Protein Overexpression 53 41802 Mhc
UAS-Protein Overexpression 54 9582 Mhc X sima
UAS-Protein Overexpression 55 39713 Mhc
UAS-Protein Overexpression 56 51190 Mhc X br
UAS-Protein Overexpression 57 39743 Mhc
UAS-Protein Overexpression 58 impL2 Mhc
UAS-Protein Overexpression 59 wImp Mhc
UAS-Protein Overexpression 60 W1118 Mhc
UAS-Protein Overexpression 61 42227 Mhc
UAS-Protein Overexpression 62 50891 Mhc
UAS-Protein Overexpression 63 44234 Mhc
UAS-Protein Overexpression 64 39703 Mhc
UAS-Protein Overexpression 65 41791 Mhc
UAS-Protein Overexpression 66 63077 Mhc
UAS-Protein Overexpression 67 63052 Mhc
UAS-Protein Overexpression 68 56766 Mhc
UAS-Protein Overexpression 69 55067 Mhc
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UAS-Protein Overexpression 70 51645 Mhc
UAS-Protein Overexpression 71 63078 Mhc
UAS-Protein Overexpression 72 58787 Mhc
UAS-Protein Overexpression 73 55046 Mhc
UAS-Protein Overexpression 74 53750 Mhc
UAS-Protein Overexpression 75 W1118 Mhc
UAS-Protein Overexpression 76 58359 Mhc
UAS-Protein Overexpression 77 59050 Mhc
UAS-Protein Overexpression 78 56769 Mhc
UAS-Protein Overexpression 79 32570 Mhc
UAS-Protein Overexpression 80 58712 Mhc
UAS-Protein Overexpression 81 38410 Mhc
UAS-Protein Overexpression 82 34490 Mhc
UAS-Protein Overexpression 83 37291 Mhc X da
UAS-Protein Overexpression 84 36496 Mhc X FRT
UAS-Protein Overexpression 85 33911 Mhc X ND-75 RNAi (internal control)
UAS-Protein Overexpression 86 37540 Mhc
UAS-Protein Overexpression 87 32572 Mhc X crebA
UAS-Protein Overexpression 88 33603 Mhc
UAS-Protein Overexpression 89 W1118 Mhc
UAS-Protein Overexpression 90 9453 Mhc
UAS-Protein Overexpression 91 8710 Mhc
UAS-Protein Overexpression 92 8711 Mhc
UAS-Protein Overexpression 93 27324 Mhc
UAS-Protein Overexpression 94 23639 Mhc X ab
UAS-Protein Overexpression 95 23878 Mhc
UAS-Protein Overexpression 96 26681 Mhc
UAS-Protein Overexpression 97 9895 Mhc
UAS-Protein Overexpression 98 26698 Mhc
UAS-Protein Overexpression 99 9233 Mhc
UAS-Protein Overexpression 100 9929 Mhc X exex
UAS-Protein Overexpression 101 9522 Mhc
UAS-Protein Overexpression 102 W1118 Mhc
UAS-Protein Overexpression 103 28810 Mhc
UAS-Protein Overexpression 104 23143 Mhc X gr63a
UAS-Protein Overexpression 105 9160 Mhc
UAS-Protein Overexpression 106 9533 Mhc X egfr
UAS-Protein Overexpression 107 9764 Mhc
UAS-Protein Overexpression 108 26675 Mhc
UAS-Protein Overexpression 109 8377 Mhc
UAS-Protein Overexpression 110 8784 Mhc X DCTN2
UAS-Protein Overexpression 111 6931 Mhc X FMR1
UAS-Protein Overexpression 112 5790 Mhc X aop
UAS-Protein Overexpression 113 8384 Mhc
UAS-Protein Overexpression 114 8380 Mhc
UAS-Protein Overexpression 115 W1118 Mhc
UAS-Protein Overexpression 116 8202 Mhc
UAS-Protein Overexpression 117 24465 Mhc
UAS-Protein Overexpression 118 913 Mhc X Abd-B
UAS-Protein Overexpression 119 9417 Mhc
UAS-Protein Overexpression 120 6631 Mhc
UAS-Protein Overexpression 121 4774 Mhc X E2f1
UAS-Protein Overexpression 122 26269 Mhc
UAS-Protein Overexpression 123 36318 Mhc
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UAS-Protein Overexpression 124 24504 Mhc
UAS-Protein Overexpression 125 9524 Mhc
UAS-Protein Overexpression 126 26881 Mhc
UAS-Protein Overexpression 127 9534 Mhc
UAS-Protein Overexpression 128 7073 Mhc
UAS-Protein Overexpression 129 26679 Mhc
UAS-Protein Overexpression 130 W1118 Mhc
UAS-Protein Overexpression 131 7086 Mhc
UAS-Protein Overexpression 132 6492 Mhc
UAS-Protein Overexpression 133 7221 Mhc X cbz
UAS-Protein Overexpression 134 5364 Mhc X egfr
UAS-Protein Overexpression 135 6846 Mhc X disco
UAS-Protein Overexpression 136 6705 Mhc
UAS-Protein Overexpression 137 29962 Mhc
UAS-Protein Overexpression 138 7107 Mhc
UAS-Protein Overexpression 139 7220 Mhc
UAS-Protein Overexpression 140 29663 Mhc
UAS-Protein Overexpression 141 30553 Mhc
UAS-Protein Overexpression 142 25102 Mhc
UAS-Protein Overexpression 143 5368 Mhc
UAS-Protein Overexpression 144 W1118 Mhc
UAS-Protein Overexpression 145 8553 Mhc
UAS-Protein Overexpression 146 29008 Mhc
UAS-Protein Overexpression 147 8861 Mhc
UAS-Protein Overexpression 148 39679 Mhc
UAS-Protein Overexpression 149 26878 Mhc
UAS-Protein Overexpression 150 8566 Mhc
UAS-Protein Overexpression 151 6489 Mhc
UAS-Protein Overexpression 152 6847 Mhc
UAS-Protein Overexpression 153 32105 Mhc
UAS-Protein Overexpression 154 6490 Mhc
UAS-Protein Overexpression 155 26649 Mhc
UAS-Protein Overexpression 156 6809 Mhc
UAS-Protein Overexpression 157 7219 Mhc X crebB
UAS-Protein Overexpression 158   W1118 Mhc
UAS-Protein Overexpression 159 6468 Mhc
UAS-Protein Overexpression 160 9319 Mhc X dl
UAS-Protein Overexpression 161 59052 Mhc X CG33156
UAS-Protein Overexpression 162 36325 Mhc
UAS-Protein Overexpression 163 56821 Mhc X fd59A
UAS-Protein Overexpression 164 8187 Mhc
UAS-Protein Overexpression 165 27647 Mhc
UAS-Protein Overexpression 166 5397 Mhc
UAS-Protein Overexpression 167 25080 Mhc X Gr64a
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d Mitochondrial complex I (CI) biogenesis can be studied in
Drosophila flight muscles
d Subcomplexes of !315, !550, and !815 kDa are formed
during CI assembly in Drosophila
d dNDUFS5 is required for converting an !700 kDa
subcomplex into the !815 kDa subcomplex
d dNDUFS5 is required to stabilize or promote incorporation of
dNDUFA10 into the complex
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Garcia et al. establish Drosophila as a
suitable resource for studying
mitochondrial complex I biogenesis. They
find that at least 42 of the 44 distinct
human complex I subunits are conserved
inDrosophila, andmany of these subunits
have specific roles in complex I assembly
in vivo.
Garcia et al., 2017, Cell Reports 20, 264–278




Regulation of Mitochondrial Complex I Biogenesis
in Drosophila Flight Muscles
Christian Joel Garcia,1,4 Jahan Khajeh,1,4 Emmanuel Coulanges,1 Emily I-ju Chen,2 and Edward Owusu-Ansah1,3,5,*
1Department of Physiology and Cellular Biophysics
2Proteomics Shared Resource at the Herbert Irving Comprehensive Cancer Center and Department of Pharmacology
3The Robert N. Butler Columbia Aging Center
Columbia University Medical Center, New York, NY 10032, USA





The flight muscles of Drosophila are highly enriched
with mitochondria, but the mechanism by which
mitochondrial complex I (CI) is assembled in this
tissue has not been described. We report the mech-
anism of CI biogenesis in Drosophila flight muscles
and show that it proceeds via the formation of
!315, !550, and !815 kDa CI assembly intermedi-
ates. Additionally, we define specific roles for several
CI subunits in the assembly process. In particular,
we show that dNDUFS5 is required for converting
an !700 kDa transient CI assembly intermediate
into the !815 kDa assembly intermediate. Impor-
tantly, incorporation of dNDUFS5 into CI is necessary
to stabilize or promote incorporation of dNDUFA10
into the complex. Our findings highlight the potential
of studies of CI biogenesis in Drosophila to uncover
the mechanism of CI assembly in vivo and estab-
lish Drosophila as a suitable model organism and
resource for addressing questions relevant to CI
biogenesis in humans.
INTRODUCTION
Mitochondrial complex I (CI) (NADH: ubiquinone oxidoreduc-
tase) is the first and largest of the electron transport chain com-
plexes in the mitochondrion and has a molecular mass ap-
proaching 1 MDa (reviewed in Hirst, 2013). Human CI has 44
distinct subunits (Table S1), 14 of which are directly involved in
transferring electrons from NADH to ubiquinone or in generation
of the membrane potential. Because these 14 subunits are
conserved from bacteria to humans and form the catalytic cen-
ters of the enzyme, they are referred to as the core or central sub-
units. The 30 remaining subunits are referred to as accessory or
supernumerary subunits because they are not directly involved
in catalysis and are expressed to varying extents among eukary-
otes (Table S1) (reviewed in Hirst, 2013). A current hypothesis is
that the accessory subunits may regulate reactive oxygen spe-
cies (ROS) formation, complex assembly or stability, and cellular
homeostasis in vivo. Of note, disease-causing mutations in
several accessory subunits have been identified (Berger et al.,
2008; Budde et al., 2000; Hoefs et al., 2008, 2011; Kirby et al.,
2004; Ostergaard et al., 2011; Scacco et al., 2003), and genetic
disruption of some accessory subunits in cell lines impairs CI as-
sembly (Guerrero-Castillo et al., 2017; Stroud et al., 2016). How-
ever, a definitive role for many of the accessory subunits in vivo
remains to be established.
CI has two major arms: a hydrophobic membrane arm and a
hydrophilic peripheral arm that juts into the mitochondrial matrix.
The two arms are oriented almost perpendicularly to each other,
resulting in a characteristic boot or L-shaped structure (Clason
et al., 2010; Efremov et al., 2010; Radermacher et al., 2006; Zick-
ermann et al., 2015). Several cryoelectron microscopy density
maps and higher resolution atomic structures of CI from various
eukaryotes have recently been described (Fiedorczuk et al.,
2016; Vinothkumar et al., 2014; Zhu et al., 2016; Zickermann
et al., 2015). The accessory subunits were found to form a
cage around the core subunits and were particularly concen-
trated around the membrane domain. These observations lend
further credence to the hypothesis that the accessory subunits
may be involved in stabilizing the complex during or after biogen-
esis in vivo.
Surprisingly, despite the outstanding genetic capabilities of
Drosophila, a systematic genetic analysis of CI assembly has
not been described in this organism. Instead, previous in vivo ge-
netic analyses of the regulation of eukaryotic CI assembly have
been performed, primarily in the aerobic fungus Neurospora
crassa (Duarte et al., 1995). Although theN. crassamodel of CI as-
sembly is renowned for being the first system forwhich amodel of
CI assemblywas described, there are notable deviations from the
assembly pathway inmammalian systems (Nehls et al., 1992; Tu-
schen et al., 1990). Thus, it is important to develop additional
genetically tractable CI assembly model systems that more
closely resembleand recapitulate thehumansystem. Importantly,
Drosophila has a comparable number ofCI subunits (similar to the
human and bovine enzymes) and more than a dozen putative as-
sembly factors, all of which have clear human orthologs,making it
a suitable model organism for studying CI assembly. Studying CI
assembly in Drosophila has the added advantage of being in an
in vivo context, in which the effects of both developmental signals
and environmental perturbations can be examined. Accordingly,
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wehave analyzed the role of several nuclear-encodedCI subunits
in CI assembly in Drosophilamuscles.
We describe the mechanism of CI assembly in Drosophila
flight muscles. Specifically, we show that many of the accessory
subunits regulate specific stages of CI biogenesis in vivo, such
that when their levels of expression are reduced, CI activity is
diminished because of impaired CI assembly. We demonstrate
that CI biogenesis in Drosophila involves the formation of
!315, !550, and !815 kDa assembly intermediates, and that
RNAi-mediated knockdown of either dNDUFS2 or dNDUFS3 de-
creases the amount of the!315 kDa assembly intermediate that
is formed. Furthermore, we show that a specific accessory sub-
unit, dNDUFA5, is required for the formation and/or stabilization
of the !315 kDa assembly intermediate in vivo. Additionally, we
define a specific role for another accessory subunit (dNDUFS5)
and show that it is required for converting a transient CI assem-
bly intermediate (an !700 kDa assembly intermediate) into the
!815 kDa assembly intermediate, during one of the terminal
steps of CI assembly. Four components of the mitochondrial
CI assembly (MCIA) complex (dECSIT, dNDUFAF1, dACAD9,
and dTIMMDC1) are associated with the!700 kDa assembly in-
termediate, further confirming that it is a true assembly interme-
diate in CI biogenesis. Importantly, incorporation of dNDUFS5
into CI is necessary to stabilize or promote incorporation of
dNDUFA10 into the complex. We also identify several roles for
many of the dNDUFB subunits. Altogether, our analyses reveal
how studies of CI biogenesis in Drosophila can uncover mecha-
nisms of CI assembly in vivo and establish Drosophila as an
important genetically pliable model organism for addressing
questions relevant to mammalian CI biogenesis.
RESULTS
Drosophila Flight Muscles Are Suitable for Studying CI
Assembly
CI consists of a hydrophilic matrix arm and a hydrophobic mem-
brane arm that are oriented almost orthogonally to each other
(Figure 1A). Subunits with the prefix NDUFA (NDUFA1-3 and
NDUFA5-13) were so named as they were originally thought
to be part of the matrix arm, whereas the NDUFB subunits
(NDUFB1–NDUFB11) are part of the membrane arm. In addition,
subunits that are found in the vicinity of the eight Fe-S clusters
(NDUFS) or single flavoprotein (NDUFV) are also localized in the
matrix. All the NDUFA and NDUFB subunits are accessory sub-
units (Figure 1A).We used theDrosophilaRNAi Screening Center
Integrative Ortholog Prediction Tool (DIOPT) to identify 42 puta-
tive orthologs of the 44 human CI subunits (Figure 1B; Table S1)
(Hu et al., 2011). To facilitate comparison with their human ortho-
logs, in this paper we refer to Drosophila orthologs of the human
CI subunits as dNDUFS1, dNDUFS2, and soon. Their designated
gene nomenclature in Drosophila is shown in Table S1.
To confirm whether the putative CI orthologs identified by
DIOPT were bona fide CI subunits in Drosophila flight muscles,
we isolatedmitochondria from thoraxes of wild-type flies, solubi-
lized their membranes in 1% digitonin, and resolved their oxida-
tive phosphorylation (OXPHOS) complexes into various bands
using blue native PAGE (BN-PAGE) (Rera et al., 2011; Wittig
et al., 2006). We solubilized the mitochondrial membranes in
1% digitonin because we found that 1% digitonin was the
optimal detergent concentration for isolating and resolving
OXPHOS complexes in their native state in Drosophila (Fig-
ure S1), as has been reported previously (Rera et al., 2011; Wittig
et al., 2006). Subsequently, we cut out each of the bands de-
tected by Coomassie staining of the gel and identified their
composition by mass spectrometry (Figure 1C). We confirmed
the existence of 37 of the 42 putative CI orthologs on the basis
of their presence in the band corresponding to the CI holoen-
zyme (band B) and/or supercomplex (band A) (Figure 1C; Tables
S1 and S2). Notably, the Drosophila ortholog of NDUFA4 (ND-
MNLL), a protein that was previously considered a CI subunit
but has been reassigned as a complex IV (CIV) subunit (Balsa
et al., 2012), co-migrated with the CIV band (band E) (Figure 1C;
Table S2). In addition, four of the subunits we were unable to
detect are highly hydrophobic membrane-embedded core sub-
units encoded in themitochondrion (ND2, ND3, ND4L, and ND6);
thus they may have escaped detection because of their highly
hydrophobic nature. Interestingly, these subunits were not iden-
tified in a previous proteomic analysis of CI in mouse cell lines
(Balsa et al., 2012).
Coomassie- or silver-stained native gels containing mitochon-
drial protein complexes from flies expressing RNAi to CI, com-
plex III (CIII), CIV, and complex V (CV) proteins further confirmed
the identities of the bands cut for mass spectrometry (Figure 1D).
Because our mass spectrometry data suggested that a portion
of CI might be co-migrating with CV and possibly CIII, we tested
whether this co-migration was the result of supercomplex forma-
tion. We were unable to find antibodies that cross-react with any
of the Drosophila CIII proteins, but antibodies that cross-react
with dNDUFS3 (a CI protein) and dATPsynb (a CV protein)
were commercially available and were used to examine the iden-
tity of ‘‘band A’’ via western blotting. As is evident in the silver
staining gel (Figure 1D), immunoblotting revealed that ‘‘band
A’’ was actually a doublet, and the lower band in the doublet cor-
responds to a dimer of CV, as has been observed in other con-
texts (Figure 1E) (Rera et al., 2011;Wittig et al., 2006). In addition,
CI in flight muscles was found to exist predominantly as the
holoenzyme, with a relatively small portion involved in CI-CIII
supercomplex formation, which migrates as an upper band in
the doublet (Figure 1E). Notably, the observation that CI in
Drosophila flight and skeletal muscles occurs predominantly as
the holoenzyme (i.e., free CI, not involved in supercomplex for-
mation) contrastsmarkedly with CI in cardiac or skeletal muscles
frommice, in which a significant portion of CI is trapped in super-
complex formation (Figure 1F). Thus, in addition to the genetic
capabilities of Drosophila, and the fact that it has a comparable
number of CI subunits as the human enzyme, it is a suitable
model for studying CI assembly because most CI in flight mus-
cles exists as the holoenzyme. Accordingly, a defect in CI
biogenesis can easily be scored and quantified. Consequently,
we decided to examine the role of the nuclear-encoded CI sub-
units in CI assembly.
Disruption of Several CI Subunits in Flight Muscles
Impairs CI Assembly
We found that loss-of-function alleles for many Drosophila CI
genes are lethal (not shown). Therefore, to ascertain which CI
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Figure 1. Drosophila Flight Muscles Are Suitable for Studying Complex I Assembly
(A) Schematic representation of how the 44 distinct subunits of bovine or ovine CI are arranged to produce the L-shaped topology; based on recent CI structures
described (Fiedorczuk et al., 2016; Vinothkumar et al., 2014; Zhu et al., 2016; Zickermann et al., 2015). The asterisk denotes subunits for which an ortholog was
not identified in Drosophila by DIOPT. NDUFAB1 occurs twice in the complex, giving rise to a total of 45 subunits.
(B) Summary of the experimental procedure for studying CI assembly in Drosophila. Transgenic RNAi constructs to the nuclear-encoded subunits were
expressed specifically in thoracic muscles using themhc-Gal4 driver. Mitochondria were isolated from thoraxes of 1-week-old flies, solubilized in 1% digitonin,
and analyzed by blue native PAGE (BN-PAGE).
(C) The constituents of each of the six major bands observed during BN-PAGEwas analyzed byMS. Thirty-eight subunits ofDrosophilaCI were confirmed byMS.
The 38 subunits correspond to 37 different orthologs of human CI. Two paralogs of human NDUFV1 were confirmed byMS (see Table S1). See Table S2 for all the
peptides identified in the six major bands shown.
(D) BN-PAGE (left) and silver staining (right) of samples from thoraxes following RNAi-mediated knockdown of complex I (CI), complex III (CIII), complex IV (CIV),
and complex V (CV) proteins to confirm the identities of the bands. SupCI and CV2 denote a supercomplex of CI and a dimer of CV, respectively. The exact RNAi
constructs expressed starting from left to right were to the white gene (wild-type [WT]), dNDUFV1 (CI), dNDUFS1 (CI), dUQCRC-2 (CIII), dUQCRC-Q (CIII),
dCox5A (CIV), cyclope (CIV), dATPsyn-b (CV), and ATPsyn-b (CV).
(E) Immunoblotting with anti-NDUFS3 and anti-ATPsynb antibodies of native gels to detect CI and CV, respectively. Note that band A is a doublet consisting
predominantly of a dimer of CV and a supercomplex of CI.
(F) BN-PAGE (top) and CI in-gel enzyme activity (bottom) indicate that most of CI exists as the holoenzyme in Drosophila melanogaster (DM) skeletal muscles, in
contrast to cardiac, soleus, extensor digitorum longus (EDL), and tibia muscles from mice where a significant portion of CI exists as a supercomplex.
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subunits are required for CI biogenesis in Drosophila, we used
the Gal4/UAS system to express transgenic RNAi constructs
(henceforth referred to as UAS-RNAi lines) to both core and
accessory CI subunits (Brand and Perrimon, 1993). We exam-
ined the effect of knocking down the subunits specifically inmus-
cles (using either Dmef2-Gal4 ormhc-Gal4). Transgenic expres-
sion of many of the UAS-RNAi constructs using Dmef2-Gal4,
a muscle-restricted Gal4 driver that is expressed strongly
throughout development, caused lethality (not shown). However,
a genetic cross between each of the UAS-RNAi lines and
mhc-Gal4 produced viable flies, as the mhc-Gal4 driver has a
weaker expression relative to Dmef2-Gal4 during the initial larval
stages (Figure S2). Accordingly, we decided to analyze CI as-
sembly in mitochondria isolated from thoraxes of mhc-Gal4/
UAS-CIRNAi flies (henceforth referred to as mhc>CIRNAi flies)
using BN-PAGE.
We observed that in general, both core and accessory sub-
units produced CI assembly defects whenever the extent of tran-
script knockdown was more than 50% (Figure 2A). To further
assess the extent of the CI assembly deficit for each subunit,
we quantified the amount of CI relative to the amount of CV in
each lane and normalized it to the corresponding value in the
wild-type lane. Interestingly, this revealed that some of the
most robust CI assembly deficits were observed when acces-
sory or supernumerary subunits (such as dNDUFA10–12 and
dNDUFB4–6) were genetically impaired (Figures 2A and 2B).
Similar results were obtained with silver staining of the protein
complexes in the native gels (Figure 2B). Finally, in-gel CI
enzyme activity assay revealed that the assembly deficits corre-
lated with a reduction in CI activity (Figure 2C). Altogether, these
results indicate thatmany of the core and accessory subunits are
essential for viability and biogenesis of the CI holoenzyme or
Figure 2. Disruption of Several CI Core and Supernumerary Subunits Impairs CI Assembly in Drosophila
(A) BN-PAGE, (B) silver staining, and (C) CI in-gel enzyme activity of mitochondria isolated from thoraxes following RNAi-mediated knockdown of the CI proteins
indicated (mhc-Gal4>dNDUFXRNAi). The values listed below each lane indicate the residual amount of CI normalized to the amount in the wild-type
(mhc-Gal4>w1118) lane.
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supercomplex in flight muscles. Accordingly, we turned our
attention toward elucidating the mechanism of CI assembly in
Drosophila flight muscles.
Proteomic Analyses and Immunoblotting Identify
Assembly Intermediates of CI
Studies from some mammalian cell lines have shown that CI
biogenesis proceeds via a series of assembly intermediates
that combine with each other, or other subunits, to form the
!950 kDa boot-shaped holoenzyme. The assembly intermedi-
ates generally correspond to partial or complete domains of
the three functional modules of CI. The NADH dehydrogenase
module (N module) is located at the tip of the matrix arm and
is the site of NADH oxidation. Situated between the N module
and the membrane is the Q module, which is responsible
for ubiquinone reduction. The proton-conducting P module in
the membrane arm can be subdivided into a proximal PP
module (roughly corresponding to the first half of the P module
that connects with the Q module) and a distal PD module
(Figure 3A).
The current model posits that CI assembly in mammalian
systems begins with the formation of a small assembly interme-
diate containing NDUFS2 and NDUFS3, which combines with
NDUFS7 and NDUFS8 (Figure 3B). This assembly intermediate
is the primary component of the Q module and ultimately com-
bines with ND1 to form an !315 kDa assembly intermediate
that is anchored to the mitochondrial inner membrane. The
!315 kDa assembly intermediate combines with an indepen-
dently formed !370 kDa assembly intermediate to form an
!550 kDa assembly intermediate (Figure 3B). The !550 kDa as-
sembly intermediate, which consists of the complete Q module
and a portion of the P module, grows by the addition of more
subunits to form the!815 kDa assembly intermediate, viamech-
anisms that are very poorly defined. At this point, the !815 kDa
assembly intermediate is generally considered to be composed
of the complete Q and P modules. Finally, an independently
formed assembly intermediate consisting of NDUFS1, NDUFV1,
NDUFV2, NDUFV3, NDUFS4, NDUFS6, and NDUFA12, which
together form the N module, is added as a ‘‘cap’’ to the
!815 kDa assembly intermediate to produce the !950 kDa
holoenzyme (Figure 3B; the !315, !370, !550, and !815 kDa
assembly intermediates were previously estimated as !400,
!460, !650, and !830 kDa subcomplexes, respectively; An-
drews et al., 2013; Vartak et al., 2014).
Because some flight muscles are formed by 24 hr after pupal
formation (Roy and VijayRaghavan, 1999), we decided to ascer-
tain the extent of CI biogenesis starting at 48 hr (i.e., 2 days) post-
pupariation. Specifically, we isolated mitochondria at various
time points and examined CI assembly via western blotting of
the native complexes. Because current models of mammalian
CI assembly postulate that NDUFS3 and ND1 are both part of
the !815, !550, and !315 kDa assembly intermediates, west-
ern blot with anti-NDUFS3 or anti-ND1 antibodies will be ex-
pected to detect these three assembly intermediates and
possibly lower molecular weight assembly intermediates (if the
respective epitopes are notmaskedwhen the assembly interme-
diate is formed). In addition, the fully assembled CI and CI-con-
taining supercomplexes will be expected to be detected as well.
Indeed, immunoblotting with anti-NDUFS3 revealed that a
portion of CI is assembled during pupal development and con-
tinues during the first 48 hr after flies eclose (emerge as adults
from pupae) (Figure 3C). Although we were able to detect the
!315 and !550 kDa assembly intermediates with the anti-ND1
antibody (Figure 3C), the higher molecular weight bands were
only weakly detectable, conceivably because the epitope to
which this antibody was raised for this hydrophobic subunit be-
comes less exposed to the aqueous environment during the final
stages of CI biogenesis (Figure 3C). Moreover, although we were
able to detect subcomplexes of CV thatmigrate with an apparent
mass of about 100 kDa at this stage of development (Figure S3),
we were unable to detect dNDUFS3-containing assembly inter-
mediates with an apparent mass of less than 200 kDa. There are
at least two possible explanations for this result: (1) the smaller
NDUFS3-containing assembly intermediatesmay not be present
at this stage, or (2) the epitope of dNDUFS3 in the smaller assem-
bly intermediates was inaccessible to the antibody, perhaps as
a result of being masked by bound assembly factors and/or
other interactors. Therefore, we used proteomic analyses to
distinguish between these two possibilities.
Mitochondria were isolated from thoraxes of wild-type flies
that had been aged for 24 hr after eclosure and subjected
to BN-PAGE. Subsequently, the region of the gel between !50
and !350 kDa was excised and divided into 14 slices (labeled
fractions A1–A14) for in-gel digestion and subsequent prote-
omics analyses (Figure 3D). We observed that dNDUFS2,
dNDUFS3, and dNDUFS7 co-migrated in fractions correspond-
ing to a mass of approximately 280–320 kDa (Figure 3D;
Table S3). Interestingly, the CI assembly factor, dNDUFAF4,
was also found in these fractions (Figure 3D; Table S3). In addi-
tion, dNDUFA5 co-migrated with dNDUFS2, dNDUFS3, and
dNDUFS7 (Figure 3D), confirming that it is a component of the
!315 kDa assembly intermediate in vivo. Importantly, although
several other CI subunits migrated in fractions corresponding
to a mass of approximately 50–250 kDa, neither dNDUFS2 nor
dNDUFS3 was found in these fractions. Thus, it appears that in
an in vivo context, in Drosophila flight muscles, the constituents
of the !315 kDa assembly intermediate are combined almost
synchronously.
Specific Subunits Regulate the Biogenesis or Stability of
Specific Assembly Intermediates of CI
If the assembly intermediates observed are bona fide intermedi-
ates in the pathway of CI assembly in Drosophila, then at least
some of these assembly intermediates will stall and accumu-
late, or they may disintegrate when specific CI subunits that
are required for CI assembly are disrupted (Figure 4A). To test
this hypothesis, we analyzed the CI assembly intermediates
from thoraxes of Mhc>CIRNAi flies 24 hr after eclosure using an
anti-NDUFS3 antibody. As expected, the various subunits that
produced CI assembly deficits in Figure 2 also resulted in a
reduction of the level of the holoenzyme or the CI-containing
supercomplex (Figures 4B–4F).
Disruption of dNDUFS1 and dNDUFV1, which are compo-
nents of the N module of CI and are thus expected to be added
as part of the ‘‘cap’’ during the final step in CI assembly, re-
sulted in a stalling and accumulation of the !815 kDa assembly





Figure 3. Proteomic Analyses and Immunoblotting Identify Assembly Intermediates of CI
(A) Schematic of CI showing the three modules of the enzyme. The NADH dehydrogenase module (N module) is located at the tip of the matrix arm and is the site
of NADH oxidation. Situated between the N module and the membrane arm is the Q module, which is responsible for ubiquinone reduction. The proton-con-
ducting P module is in the membrane arm.
(B) The current model of CI assembly in mammalian systems (reviewed in Vartak et al., 2014). The assembly process begins with the formation of an assembly
intermediate containing NDUFS2 and NDUFS3, which combines with NDUFS7 and NDUFS8. The subcomplex of NDUFS2, NDUFS3, NDUFS7, and NDUFS8
ultimately combines with ND1 to form the !315 kDa assembly intermediate that is anchored to the membrane. The !315 kDa subcomplex (also called the Q
module) combines with an independently formed!370 kDa assembly intermediate to form an!550 kDa assembly intermediate. This assembly intermediate that
consists of the Qmodule and part of the Pmodule grows by the addition of more subunits to form the!815 kDa assembly intermediate, via mechanisms that are
very poorly defined. The!815 kDa assembly intermediate now consists of the complete Q and Pmodules. Finally, the Nmodule is added to produce the 950 kDa
(legend continued on next page)
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intermediate (Figure 4B). However, unexpectedly, disruption of
dNDUFA6 and dNDUFA12 also stalled the !815 kDa subcom-
plex (Figure 4C). RNAi-mediated knockdown of dNDUFS2,
dNDUFS3, dNDUFS5, dNDUFS7, and dNDUFS8 led to a reduc-
tion in the amount of the !815 kDa assembly intermediate (rela-
tive to wild-type), as they impaired some of the initial steps of CI
biogenesis (Figure 4B). In addition, the amount of the !315 kDa
assembly intermediate was drastically reduced when the
expression of dNDUFS2, dNDUFS3, or dNDUFS7 was impaired
(Figure 4B), in line with our proteomic results in Figure 3D and
current mammalian CI assembly models that show that the first
step in CI biogenesis involves the formation of an assembly in-
termediate consisting of NDUFS2 and NDUFS3 (Figure 3B) (re-
viewed in Vartak et al., 2014). Notably, we found that RNAi-
mediated knockdown of dNDUFA5 depleted the !315 kDa
assembly intermediate (Figure 4C). Combining this result, with
our proteomic data showing that dNDUFA5 co-migrates with
dNDUFS2, dNDUFS3, and dNDUFS7 (Figure 3D), we conclude
that although dNDUFA5 is an accessory subunit, it is a critical
component of, and required for formation or stabilization of
the !315 kDa assembly intermediate (i.e., the Q module)
in vivo.
Disruption of most of the dNDUFB subunits did not markedly
alter the stability or extent of accretion of the CI assembly in-
termediates 24 hr after eclosion (Figure 4D), but by 48 and
72 hr after eclosion some notable and consistent phenotypes
between the two time points were observed (Figures 4E and
4F). For instance, RNAi-mediated disruption of dNDUFB3
decreased the extent of accumulation of all the assembly
intermediates, and the 550 kDa assembly intermediate accu-
mulated when dNDUFB1, dNDUFB8, and dNDUFB11 were
impaired at both time points (i.e., 48 and 72 hr post-eclosion).
Surprisingly, although none of the NDUFB subunits are known
to be part of the 315 kDa assembly intermediate, the extent of
accumulation of the 315 kDa assembly intermediate was
diminished when the expression of dNDUFB1, dNDUFB4,
dNDUFB5, dNDUFB6, and dNDUFB10 were reduced (Figures
4E and 4F). Taken together, these results indicate that specific
subunits regulate the biogenesis or stability of specific CI
assembly intermediates during CI assembly in Drosophila
thoraxes.
Identification of an !700 kDa Assembly Intermediate of
CI in Drosophila
An assembly intermediate that accumulates between the
!550 and !815 kDa assembly intermediates was detected
on immunoblots of samples from mhc>dNDUFS5RNAi and
mhc>dNDUFC2RNAi thoraxes (Figure 4B). We estimate its
size to be !700 kDa because it co-migrates with CV, previously
estimated to be !700 kDa in blue native gels (Figure 5A) (Ab-
drakhmanova et al., 2006). The accumulation of the !700 kDa
assembly intermediate in samples frommhc>dNDUFS5RNAi tho-
raxes was notable, because it suggested that this could be the
point of entry of dNDUFS5 during CI assembly. NDUFS5 is a
membrane-associated accessory subunit that extends into the
intermembrane space; it is currently unclear at what point it be-
comes incorporated into CI. In contrast to the !315, !550, and
!815 kDa assembly intermediates, the !700 kDa assembly in-
termediate was not readily perceptible by anti-NDUFS3 immu-
noblotting in the wild-type sample or most of the other mutant
samples isolated 24 hr after eclosure (Figure 4B). This raised
the possibility that it could simply be a degradation product,
perhaps emanating from the !815 kDa assembly intermediate.
To determine whether the !700 kDa assembly intermediate is
a true assembly intermediate, we decided to look at earlier time
points (6 and 12 hr post-eclosion) to ascertain whether it ever ap-
pears in wild-type samples. Immunoblotting at these time points
revealed that accumulation of the !700 kDa assembly interme-
diate in mhc>dNDUFS5RNAi thoraxes is present by the 6 hr
time point and gradually tapers off afterward (Figure 5B). Impor-
tantly, at the 6 hr time point, a faint band corresponding to the
!700 kDa assembly intermediate can be observed in wild-type
samples, indicating that the !700 kDa assembly intermediate
exists in wild-type samples and rapidly matures to the
!815 kDa assembly intermediate. The stalling of the !700 kDa
assembly intermediate inmhc>dNDUFS5RNAi thoraxes occurred
concurrently with an accumulation of both the !550 and
!315 kDa assembly intermediates, and a diminution of the
!815 kDa assembly intermediate relative to wild-type
levels. Thus, dNDUFS5 may be required for converting the
!700 kDa assembly intermediate into the !815 kDa assembly
intermediate, such that when this fails, there is a backlog
of the !700, !550, and !315 kDa assembly intermediates.
To test this hypothesis, we compared the assembly
intermediates that accumulate in mhc>dNDUFS5RNAi,
dNDUFS1RNAi and mhc>dNDUFS5RNAi,dNDUFV1RNAi thoraxes
with that in mhc>dNDUFS1RNAi and mhc>dNDUFV1RNAi tho-
raxes, respectively. We reasoned that because the !815 kDa
assembly intermediate accumulates in mhc>dNDUFS1RNAi and
mhc>dNDUFV1RNAi thoraxes (Figure 4B), if dNDUFS5 is required
for converting the !700 kDa assembly intermediate into
the !815 kDa assembly intermediate, then the extent of accu-
mulation of the !815 kDa assembly intermediate in either
mhc>dNDUFS5RNAi,dNDUFS1RNAi and/or mhc>dNDUFS5RNAi,
dNDUFV1RNAi thoraxes should be reduced relative to
mhc>dNDUFS1RNAi and mhc>dNDUFV1RNAi, respectively. In
agreement with this proposition, we observed that the accumu-
lation of the !815 kDa assembly intermediate was significantly
fully assembled complex. Assembly factors or chaperones that assist in this process but are not present in the fully assembled complex have been omitted for
clarity.
(C) Western blot of samples obtained from thoraxes from pupae aged between 2 and 4 days after pupariation and of flies from 0.5 to 48 hr post-eclosure to detect
the assembly intermediates, fully assembledCI, and a supercomplex containing complex I (supCI) after BN-PAGE. The anti-NDUFS3 antibody strongly detects CI
and supCI and weakly detects the !315, !550, and !815 kDa assembly intermediates after a short exposure. However, after a longer exposure, the !315 and
!550 kDa assembly intermediates can clearly be seen. At right, the membrane was stripped and re-probed with anti-NDI. Anti-ND1 detects the !315 and
!550 kDa assembly intermediates and a very faint band corresponding to CI. (D) Proteomic analyses of assembly intermediates that form in the native gel sized
between !50 and !350 kDa. See Table S3 for all the peptides identified.







Figure 4. Specific Subunits Regulate the Biogenesis or Stability of Specific Assembly Intermediates of CI
(A) Left: schematic of the distribution of assembly intermediates on immunoblots as a result of RNAi-mediated disruption of various CI subunits. Right: description
of how various results can be interpreted.
(B–D) Distribution of assembly intermediates in thoraxes dissected 24 hr after eclosion with transgenic RNAi expression of the CI subunits shown. In panels
labeled ‘‘long exposure,’’ the region of the membrane just at or below CI was cut and imaged.
(B) The !815 kDa assembly intermediate accumulates in thoraxes expressing transgenic RNAi to dNDUFS1 and dNDUFV1; and the !315 kDa assembly
intermediate is decreased in thoraxes expressing transgenic RNAi of dNDUFS2, dNDUFS3, and dNDUFS7. In addition, another assembly intermediate accu-
mulates in thoraxes expressing RNAi to dNDUFS5 and dNDUFC2 (denoted by an asterisk).
(C) The!815 kDa assembly intermediate stalls in thoraxes expressing transgenic RNAi to dNDUFA6 and dNDUFA12; and the!315 kDa assembly intermediate is
attenuated in thoraxes expressing transgenic RNAi of dNDUFA5.
(D) There were no overt alterations in assembly intermediates at this time point when the dNDUFB subunits were disrupted.
(E and F) Distribution of assembly intermediates in thoraxes dissected 48 hr (E) and 72 hr (F) after eclosion with transgenic RNAi expression of theNDUFB subunits
shown. RNAi-mediated knockdown of the expression of dNDUFB3 decreased the extent of accumulation of all the assembly intermediates, and the 550 kDa
assembly intermediate accumulated when the expression of dNDUFB1, dNDUFB8 and dNDUFB11 were reduced. In addition, the extent of accumulation of the
315 kDa assembly intermediate was diminished following RNAi-mediated disruption of dNDUFB1, dNDUFB4, dNDUFB5, dNDUFB6, and dNDUFB10 at both the
48 and 72 hr time points.
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attenuated in mhc>dNDUFS5RNAi,dNDUFS1RNAi thoraxes
relative to mhc>dNDUFS1RNAi thoraxes (Figure 5C). This was
also accompanied by an accumulation of the !700 kDa
assembly intermediate (Figure 5C). Similar results were ob-
tained by comparing mhc>dNDUFS5RNAi,dNDUFV1RNAi and
mhc>dNDUFV1RNAi thoraxes (Figure 5C). Accordingly, we
deduce from these results that when dNDUFS5 expression
levels are impaired, the transient !700 kDa assembly intermedi-
ate stalls and accumulates, impeding progression of CI biogen-
esis and ultimately resulting in a bottleneck of the !550 and
!315 kDa assembly intermediates as well.
To gain further insight into the identity of the !700 kDa as-
sembly intermediate, a single gel slice encompassing the region
shown in Figure 5A was excised from native gels containing
samples from wild-type and mhc>dNDUFS5RNAi thoraxes. Pro-
teins from the gel slice were digested and analyzed by liquid
chromatography (LC) mass spectrometry (MS), and a label-
free spectral counting approach was used to generate a heat-
map for some of the proteins that showed altered expression
levels between the samples. In agreement with our results
showing a stalling and accumulation of the !700 kDa assembly
intermediate in this portion of the gel, we observed that several
CI subunits were upregulated in themhc>dNDUFS5RNAi sample
relative to wild-type (Figure 5D). However, in stark contrast to
the other CI subunits, we consistently observed (in six biolog-
ical replicates taken at different time points of the day to control
for circadian regulation) that dNDUFA10 was downregulated
in the mhc>dNDUFS5RNAi sample, indicating that incorporation
of dNDUFS5 into CI is necessary to stabilize or promote incor-
poration of dNDUFA10 into the complex (Figure 5D). In
mammalian systems, at least five CI assembly factors—ECSIT,
TMEM126B, NDUFAF1, ACAD9, and TIMMDC1—are typically
found associated with CI assembly intermediates and have
been dubbed the mitochondrial complex I assembly (MCIA)
complex (Guarani et al., 2014; Heide et al., 2012; Nouws
et al., 2010; Vogel et al., 2007). We found four of these assem-
bly factors (dECSIT, dNDUFAF1, dACAD9, and dTIMMDC1)
associated with the 700 kDa assembly intermediate that
were upregulated in the mhc>dNDUFS5RNAi samples, further
confirming that it is a true assembly intermediate in CI biogen-
esis (Figure 5D; Table S4).
The Distal Portion of the Membrane Arm of CI Is
Assembled Independently of the Matrix Arm
We noticed that in some instances in which CI assembly was
impaired, an additional band accumulated between the CIII and
CIV bands in both the Coomassie- and silver-stained gels (arrows
in Figures 2A and 2B). A closer examination revealed that the
accumulation of this intermediate was more readily evident in
samples in which subunits localized to the hydrophilic matrix
domainwere disrupted (i.e., the dNDUFS, dNDUFV, and dNDUFA
subunits) (Figure 1A). In line with our observations described in
Figures 3, 4, and 5, we hypothesized that this band was likely
another CI assembly intermediate that had stalled and accumu-
lated as a result of a block inCI biogenesis.Wedecided to identify
the constituents of this putative assembly intermediate via MS.
We cut out the region of the gel corresponding to the stalled
assembly intermediate in the wild-type, mhc>dNDUFS5RNAi,
and mhc>dNDUFV1RNAi thoraxes (Figure 6A) and used label-
free quantification of peptides to ascertain which subunits and
possibly assembly factors were altered between the two sam-
ples. Several components of the ETC machinery were downre-
gulated, but there was a dramatic increase in CI subunits that
are part of the distal membrane domain (i.e., all the dNDUFB
subunits as well as dNDUFAB1, dNDUFC2, ND4, and ND5) (Fig-
ures 6B and 6C; Table S5). We note that there was no obvious
accumulation of this assembly intermediate in blue native or sil-
ver-stained gels when any of these subunits (i.e., the dNDUFB
subunits or NDUFAB1 and NDUFC2 subunits) were disrupted
(Figures 2A and 2B). Notably, many of these membrane-associ-
ated subunits were present in the corresponding gel slice from
the wild-type samples (although at lower levels). All the compo-
nents of the MCIA complex (i.e., dECSIT, dNDUFAF1, dACAD9,
dTMEM126B, and dTIMMDC1) were also found associated with
this assembly intermediate. Based on current assignments of the
various CI subunits, this assembly intermediate is clearly the
distal portion of the membrane arm (Fiedorczuk et al., 2016; Vi-
nothkumar et al., 2014; Zhu et al., 2016; Zickermann et al., 2015).
Figure 5. Identification of an !700 kDa Assembly Intermediate of CI in Drosophila
(A) Top: immunoblots of samples obtained from wild-type and mhc>dNDUFS5RNAi thoraxes of flies aged for 6 hr after eclosure depicting co-migration of the
!700 kDa intermediate and CV. Left and middle: anti-NDUFS3 antibodies detect the fully assembled CI, the !700 kDa subcomplex, and other assembly in-
termediates in dNDUFS5RNAi thoraxes. Note that in themiddle, the region of themembrane just belowCI was cut and imaged. Right: anti-ATPsynb detects the CV
monomer (700 kDa) and dimer as shown. Bottom:mitochondrial protein complexes fromwild-type andmhc>dNDUFS5RNAi thoraxeswere resolved by BN-PAGE,
and the region corresponding to the !700 kDa assembly intermediate (i.e., CV, demarcated) was cut out, subjected to tryptic digestion, and analyzed by label-
free quantitative LC-MS/MS.
(B) Immunoblots from samples obtained after 6, 12, and 24 hr post-eclosure from thoraxes in which NDUFS1, NDUFS3, NDUFS5, and NDUFV1 were knocked
down as a result of transgenic RNAi expression. Note that the !815 kDa assembly intermediate accumulates as a result of disruption of NDUFS1 and NDUFV1,
and the!700 kDa assembly intermediate stalls and accumulates in NDUFS5mutants at all time points. Importantly, upon prolonged exposure of the immunoblot,
a band corresponding to the!700 kDa assembly intermediate can also be observed in wild-type samples (denoted with the asterisk in the bottom panel), which
confirms that it is an authentic, albeit transient assembly intermediate.
(C) The accumulation of the !815 kDa assembly intermediate was significantly attenuated in mhc>dNDUFS5RNAi,dNDUFS1RNAi thoraxes relative to
mhc>dNDUFS1RNAi thoraxes; instead there is an accumulation of the !700 kDa assembly intermediate. Similar results were obtained when samples from
mhc>dNDUFS5RNAi,dNDUFV1RNAi thoraxes were compared with samples from mhc>dNDUFV1RNAi thoraxes.
(D) Proteomic changes in the gel slice sample from wild-type andmhc>dNDUFS5RNAi thoraxes corresponding to the !700 kDa assembly intermediate. Relative
protein abundance among biological samples is expressed by spectral counts on a log scale. Several CI subunits and CIAFs, most notably components of
the MCIA complex, are upregulated in the !700 kDa assembly intermediate. However, the amount of dNDUFA10 (denoted with an asterisk) is reduced in
mhc>dNDUFS5RNAi thoraxes relative to wild-type. See Table S4 for all the peptides identified.
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Proposed Model of CI Assembly in Drosophila Muscle
We propose a model for CI assembly in Drosophila flight
muscles in which dNDUFS2, dNDUFS3, dNDUFS7, dNDUFS8,
and dNDUFA5 are combined in essentially one step to form
the Q module, which is anchored to the membrane by dND1
(Figure 7). This assembly intermediate corresponds to the as-
sembly intermediate in mammalian systems that was previously
referred to as the !400 kDa subcomplex but has recently been
A B
C
Figure 6. CI Assembly in Drosophila Involves an Assembly Intermediate Containing Several Membrane-Associated Accessory Subunits
(A) Mitochondrial protein complexes from wild-type, mhc>dNDUFS5RNAi, and mhc>dNDUFV1RNAi thoraxes were separated by BN-PAGE, and the region
corresponding to the accumulated assembly intermediate (demarcated) was cut out, subjected to tryptic digestion, and analyzed by label-free quantitative LC-
MS/MS.
(B) Proteomic changes in the gel slice samples from wild-type, mhc>dNDUFS5RNAi, and mhc>dNDUFV1RNAi thoraxes. Relative protein abundance among
biological samples is expressed by spectral counts on a log scale. The color scale bar indicates the range of protein expression levels. See additional information
in Table S5.
(C) Schematic representation highlighting the membrane subunits that are upregulated in the gel slice (shown in red font) from the mhc>dNDUFS5RNAi and
mhc>dNDUFV1RNAi thoraxes.
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re-estimated as the !315 kDa subcomplex (Andrews et al.,
2013; Vartak et al., 2014). This is consistent with the observation
that assembly intermediates containing dNDUFS2, dNDUFS3,
dNDUFS7, dNDUFS8, and dNDUFA5 co-migrate in blue native
gels (Table S2) and that immunoblotting with both anti-ND1
and anti-NDUFS3 detects the !315 kDa assembly intermediate
(Figure 3C).
Subsequently, another assembly intermediate consisting
of some of the subunits in the membrane domain is formed.
This assembly intermediate comprises part of the P module
(i.e., partial P1) and is conjugated to the Q module to
form an assembly intermediate that corresponds to the
!550 kDa (formerly!650 kDa) assembly intermediate previously
described in mammalian systems (Figure 7). Although proteomic
analyses of the assembly intermediate that accumulates in
mhc>dNDUFS5RNAi and mhc>dNDUFV1RNAi thoraxes shows
that all the dNDUFB subunits as well as dNDUFC1, dNDUFAB1,
ND4, and ND5 subunits are present in the subcomplex (see
Table S5), it is unlikely that all the membrane subunits are incor-
porated into the complex at this stage under normal (wild-type)
conditions. We hypothesize that the accumulation of the mem-
brane accessory subunits in response to genetic disruption of
thematrix subunitsmay be a compensatorymitochondrial stress
signaling mechanism impinging on the nucleus and resulting in a
system that is poised to rapidly resume CI biogenesis if and
when the missing matrix subunit becomes available. The accre-
tion of the partial P module under conditions in which other com-
ponents of the CI assembly machinery are impaired provides
further evidence that the various modules of the complex (i.e.,
the Q, P, and N modules) are assembled largely independently
of each other in vivo.
The !550 kDa assembly intermediate grows by the addition
of more subunits to form a transient assembly intermediate
of!700 kDa (Figure 7); we postulate that dNDUFS5 is then incor-
porated at or just prior to this stage together with possibly
dNDUFA10 to rapidly convert the!700 kDa assembly intermedi-
ate to the !815 kDa assembly intermediate, consisting of the
complete P and Q modules (Figure 7). Finally, the N module is
added to produce the CI holoenzyme (Figure 7).
DISCUSSION
We have exploited the genetic capabilities of Drosophila to un-
cover the mechanism of CI assembly in vivo in Drosophila flight
Partial Q
Partial P1











Q + Partial P3




Figure 7. Proposed Model of CI Assembly in Drosophila Flight
Muscle
An assembly intermediate consisting of dNDUFS2, dNDUS3, dNDUFS7,
dNDUFS8, and dNDUFA5 combined in essentially one step to form the
Q module, which is anchored to the membrane by ND1. Subsequently, an
independently formed subcomplex comprising membrane-associated sub-
units (partial P1) is conjugated to the Qmodule, and possibly other subunits, to
form an assembly intermediate comprised of the Q module and part of the
P module (Q + partial P2). This grows by the addition of more subunits to form
a transient assembly intermediate of !700 kDa (Q + partial P3). We propose
that dNDUFS5 is then incorporated at this step, to promote incorporation or
stabilization of dNDUFA10. Subsequently, the transient !700 kDa assembly
intermediate is rapidly converted to the !815 kDa assembly intermediate,
consisting of the complete P and Q modules (Q + P). Finally, the N module is
added to produce the CI holoenzyme.
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muscles. Our immunoblotting and proteomic analyses reveal
that during CI assembly inDrosophila, the first membrane-bound
major assembly intermediate that forms contains at least the
following six subunits: dND1, dNDUFS2, dNDUFS3, dNDUFS7,
dNDUFS8, and dNDUFA5. On the basis of its constituents and
migration pattern in native PAGE, we conclude that this assem-
bly intermediate is the same assembly intermediate traditionally
referred to as the !315 kDa assembly intermediate from studies
on mammalian CI assembly and corresponds to the Q module
of CI (Andrews et al., 2013; Vartak et al., 2014). Consistent with
their roles in regulating formation of the Q module, we found
that genetic disruption of dNDUFS2, dNDUFS3, dNDUFA5,
and dNDUFS7 attenuated the amount of the!315 kDa assembly
intermediate formed.
Unexpectedly, we found an !700 kDa assembly intermediate
that is short-lived (at least relative to the !315, !550, and
!815 kDa assembly intermediates), as it is rapidly converted
into the !815 kDa assembly intermediate. Importantly, our pro-
teomic analyses revealed that incorporation of dNDUFS5 into CI
around this stage is necessary to stabilize or promote incorpora-
tion of dNDUFA10 into the complex. Similar to the !315, !550,
and !815 kDa assembly intermediates, the !700 kDa subcom-
plex is a true assembly intermediate, as it can be detected
in wild-type muscles as well. Additionally, components of the
MCIA complex are associated with the !700 kDa assembly
intermediate, as has been reported for other assembly interme-
diates observed in mammalian systems. RNAi-mediated disrup-
tion of dNDUFS5 led to a stalling and accumulation of this other-
wise transient assembly intermediate, to a point at which it is
readily detectable by western blots, most likely because this is
the stage at or around which dNDUFS5 is incorporated into the
complex.
It is possible that mutations in some accessory subunits
will have both primary and secondary effects. As a case in
point, dNDUFS5 disruption may first impair conversion of the
!700 kDa assembly intermediate to the !815 kDa assembly
intermediate and consequently impair CI assembly (as we
have shown), but ultimately, the accumulation of the
!700 kDa assembly intermediate can activate the mitochon-
drial unfolded protein response as well as other stress
signaling cascades, with far-reaching consequences (Haynes
et al., 2013; Jensen and Jasper, 2014; Owusu-Ansah and
Banerjee, 2009; Owusu-Ansah et al., 2008, 2013). As another
example, when dNDUFB3 was disrupted, no specific assem-
bly intermediates were stalled or disintegrated. Instead, there
was a general reduction in the level of expression of all assem-
bly intermediates. It is possible that disruption of dNDUFB3
activates stress signaling pathways that induce apoptosis or
culminate in a general reduction of protein synthesis, leading
to a reduction in CI assembly.
We find that at least 42 of the 44 distinct human CI proteins are
conserved in Drosophila. The two human CI proteins for which a
clear ortholog was not readily identified in Drosophila by DIOPT
are NDUFA3 (9 kDa) and NDUFC1 (6 kDa), which are two of the
smallest subunits of the complex. Interestingly, obvious ortho-
logs of NDUFC1 are not found in C. elegans or Yarrowia lipoly-
tica, and the orthologs in vertebrates such as zebrafish and Xen-
opus have very weak homology (DIOPT score of 1) to the human
protein. Therefore it is possible that this subunit has significant
sequence diversion in Drosophila and although present
was not recognized by DIOPT. For most of the CI subunits in
which multiple paralogs were identified by DIOPT (i.e., NDUFS2,
NDUFS7, NDUFV2, NDUFA7, and NDUFB2), only one of the pa-
ralogs was detected as a bona fide CI subunit in flight muscles.
However, as an exception to this general rule, two of the three
paralogs of NDUFV1 were detected as part of CI in skeletal
muscles via MS. ND-51 (CG9140) appears to be the authentic
ortholog of human NDUFV1, as it is highly expressed in skeletal
muscles relative to ND-51L (CG11423) and is comparable in size
to the human ortholog (both are about 51 kDa). ND-51L is a
77 kDa protein with a stretch of about 200 amino acids at the
N terminus that is not present in either the Drosophila paralog
(ND-51) or human ortholog (NDUFV1). It remains to be deter-
mined whether the expression of the subunits with multiple
paralogs are regulated in a tissue-specific manner to generate
mitochondria with varied CI activities or whether they are regu-
lated in the same tissue in response to different environmental
conditions to fine-tune the activity of CI.
In summary, we have described the mechanism of CI assem-
bly in Drosophila flight muscles and defined specific roles for
some of the accessory subunits in CI assembly. Importantly,
although CI dysfunction has been implicated in a large number
of pathologies, we find that knocking down the expression of
various antioxidant enzymes or mitochondrial protein quality
control genes does not solely impair CI assembly, indicating
that destabilization of CI may not be the sole underlying factor
in many mitochondrial disorders (Figure S4). In addition, our
proteomic analyses established that incorporation of dNDUFS5
into CI is necessary to stabilize or promote incorporation of
dNDUFA10 into the complex. We note that our analyses of CI
assembly in an in vivo setting, in which CI biogenesis is subject
to both developmental and environmental cues, revealed that
many of the accessory subunits are required for both assembly
and viability. Moreover, several NDUFB subunits (dNDUFB1,
dNDUFB4, dNDUFB5, dNDUFB6, and dNDUFB10) seem to
regulate the stability of the 315 kDa assembly intermediate, in
apparent deviation from what will be expected from current
models of mammalian CI assembly. However, the mechanism
of CI biogenesis in Drosophila flight muscles is remarkably
similar to what has been described in mammalian systems,
and the differences observed here may be due to the fact that
we have analyzed CI assembly in an in vivo setting. Accordingly,
Drosophila is a suitable organism for addressing questions
relevant to mammalian CI biogenesis. We anticipate that future
studies using the full repertoire of genetic tools and resources
in Drosophila should foster the discovery of paradigms for regu-
lating CI assembly in humans.
EXPERIMENTAL PROCEDURES
Drosophila Strains and Genetics
For a list of stocks used and detailed experimental procedures, see Supple-
mental Experimental Procedures.
BN-PAGE
BN-PAGE was performed using NativePAGE gels from Life Technologies,
following the manufacturer’s instructions.
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Silver Staining
Silver staining of native gels was performed with the SilverXpress staining kit
from Life Technologies, following the manufacturer’s protocol.
In-Gel CI Activity
CI activity in native gels was assayed by incubating the native gels in 0.1mg/ml
NADH, 2.5 mg/ml nitrotetrazolium blue chloride, and 5 mM Tris-HCl (pH 7.4) at
room temperature.
Immunoblotting
For immunoblotting of samples in native gels, protein complexes from native
gels were transferred to polyvinylidene fluoride (PVDF) membranes (Bio-Rad)
and probed with the relevant antibodies using standard procedures.
MS Analyses
After MS with a Thermo Fusion Tribrid mass spectrometer, tandem mass
spectra from raw files were searched against a Drosophila protein database
using the Proteome Discoverer 1.4 software (Thermo Finnigan). The Proteome
Discoverer application extracts relevant MS/MS spectra from the .raw file and
determines the precursor charge state and the quality of the fragmentation
spectrum. The Proteome Discoverer probability-based scoring system
rates the relevance of the best matches found by the SEQUEST algorithm.
The Drosophila protein database was downloaded as FASTA-formatted
sequences from Uniprot protein database (database released in May 2015).
The peptide mass search tolerance was set to 10 ppm. A minimum sequence
length of seven amino acids residues was required. Only fully tryptic peptides
were considered. To calculate confidence levels and false discovery rates
(FDR), Proteome Discoverer generates a decoy database containing reverse
sequences of the non-decoy protein database and performs the search
against this concatenated database (non-decoy + decoy). Scaffold (Proteome
Software) was used to visualize searched results. The discriminant score was
set at less than 1% FDR determined on the basis of the number of accepted
decoy database peptides to generate protein lists for this study. Spectral
counts were used for estimation of relative protein abundance between
samples.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and five tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2017.06.015.
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